Numerical modelling of inhaled particle transport and deposition in human and rat nasal cavities by Shang, Y
NUMERICAL MODELLING OF INHALED
PARTICLE TRANSPORT AND DEPOSITION
IN HUMAN AND RAT NASAL CAVITIES
Yidan Shang, B.S.,
School of Engineering - Aerospace, Mechanical and Manufacturing,
College of Science, Engineering and Health,
RMIT University
A thesis submitted for the degree of
Doctor of Philosophy
September 2016
Declaration
I certify that except where due acknowledge has been made, the work is that of the
author alone; the work has not been submitted previously, in whole or in part, to
qualify any for any other academic award; the content of the thesis is the result of
work which has been carried out since the official commencement date of the approval
research program; and, any editorial work, paid or unpaid, carried out by a third party
is acknowledged.
Yidan Shang
School of Engineering - Aerospace, Mechanical and Manufacturing Engineering,
College of Science, Engineering and Health, RMIT University
Acknowledgments
I would firstly thank my primary supervisor Prof Jiyuan Tu. I would never have
the chance to start this project and work in this fantastic group without Jiyuan’s
support. He has given me a lot of confidence in the past few years and I have
always been encouraged and inspired from his comments. I would particularly thank
my secondary supervisor Dr Kiao Inthavong for keeping me on track, watching my
back and always being there whenever I need any help. His guidance, patience and
enthusiasm have been constant sources of inspiration to me.
I have been fortunate to work with many brilliant colleagues in the CFD-Group.
I would like to thank Dr Jingliang Dong for his excellent suggestions and ideas, Dr
Xiangdong Li for his insights into the work related to particle motion simulation,
Dr Lin Tian for her ideas in simulation conducting and paper writing. I appreciate
the help from Ke Sun and Jiawei Ma for their contributions to the nasal model
reconstruction. I would also like to acknowledge all of my other friends and colleagues
with whom I have worked closely. Learning from and working with all of you has made
my PhD full of joy.
Last but not least, I want to thank my family for all the support, love and trust
you have given me. To mum and dad, you both have always been the model of my
life and the motive for me to be a better self. My huge thank you goes to my wife,
Wei, for always encouraging me no matter what decision I make. Finally, thank my
baby, for coming at such an amazing time. I love you all so much.
3
Publication during Candidature
Peer Reviewed Journal Publication:
1. Inthavong, K., Shang, Y. D., and Tu, J. Y. (2014). Surface mapping for visu-
alization of wall stresses during inhalation in a human nasal cavity. Respiratory
Physiology & Neurobiology, 190(1):54-61,
DOI: 10.1016/j.resp.2013.09.004, IF=1.916
2. Li, Z., Mumford, K. A., Shang, Y. D., Smith, K. H., Chen, J., Wang, Y.,
and Stevens, G. W. (2014). Analysis of the nonrandom two-liquid model for
prediction of liquid-liquid equilibria. Journal of Chemical & Engineering Data,
59(8):2485-2489,
DOI: 10.1021/je500204v, IF=1.835
3. Shang, Y. D., Inthavong, K., and Tu, J. Y. (2015). Detailed micro-particle
deposition patterns in the human nasal cavity influenced by the breathing zone.
Computers & Fluids, 114:141-150,
DOI: 10.1016/j.compfluid.2015.02.020, IF=2.071
4. Shang, Y. D., Dong, J. L., Inthavong, K., and Tu, J. Y. (2015). Comparative
numerical modeling of inhaled micron-sized particle deposition in human and
rat nasal cavities. Inhalation Toxicology, 27(13):694-705,
DOI: 10.3109/08958378.2015.1088600, IF=2.26
5. Li, X. D., Yan, Y. H., Shang, Y. D., and Tu, J. Y. (2015). An eulerian-
eulerian model for particulate matter transport in indoor spaces. Building and
Environment, 86:191-202,
DOI: 10.1016/j.buildenv.2015.01.010, IF=3.804
6. Shang, Y. D., Dong, J. L., Inthavong, K., and Tu, J. Y. (2017). Computational
fluid dynamics analysis of wall shear stresses between human and rat nasal
cavities. European Journal of Mechanics B/Fluids, 61, Part 1, 160-169,
IF=1.687
4
7. Dong, J. L., Shang, Y. D., Inthavong, K., Tu, J. Y., Chen, R., Bai, R., Wang,
D., and Chen, C. (2016). From the cover: Comparative numerical modeling of
inhaled nanoparticle deposition in human and rat nasal cavities. Toxicological
Sciences, 152(2):284-96,
DOI: 10.1093/toxsci/kfw087, IF=4.307, Cover Paper
8. Tong, X. W., Dong, J. L., Shang, Y. D., Inthavong, K., and Tu, J. Y. (2016).
Effects of nasal drug delivery device and its orientation on sprayed particle de-
position in a realistic human nasal cavity. Computers in Biology and Medicine,
77:40-48,
DOI: 10.1016/j.compbiomed.2016.08.002, IF=1.683
9. Tian, L., Inthavong, K., Liden, G., Shang, Y. D., and Tu, J. Y. (2016).
Transport and deposition of welding fume agglomerates in a realistic human
nasal airway. The Annals of Occupational Hygiene, 60(6):731-47,
DOI: 10.1093/annhyg/mew018, IF=2.245
Conference Publication:
1. Shang, Y. D., Inthavong, K., and Tu, J. Y. (2013). Application of surface
mapping to visualize wall shear stress and particles deposition in a realistic
human nasal cavity. APCOM & ISCM 2013, 11-14 Dec, Singapore.
2. Shang, Y. D., Dong, J. L., Inthavong, K., and Tu, J. Y. (2015). How reliable
is the extrapolation? localized particle deposition patterns in human/rat nasal
cavities. IMECE 2015, 13-19 Nov, Houston, TX, USA
5
Publication Included in this Thesis
Inthavong, K., Shang, Y. D., and Tu, J. Y. (2014). Surface mapping for visualization
of wall stresses during inhalation in a human nasal cavity. Respiratory Physiology &
Neurobiology, 190(1):54-61, incorporated as Chapter 4.
Contributor Statement of Contribution
Shang, Y. D.
Wrote program code (100%)
Conducted simulation (60%)
Wrote the paper (30%)
Inthavong, K
Conducted simulation (40%)
Wrote the paper (60%)
Tu, J. Y. Edited the paper (10%)
Shang, Y. D., Inthavong, K., and Tu, J. Y. (2015). Detailed micro-particle depo-
sition patterns in the human nasal cavity influenced by the breathing zone. Computers
& Fluids, 114:141-150, incorporated as Chapter 5, Section 1.
Contributor Statement of Contribution
Shang, Y. D.
Wrote program code(100%)
Conducted simulation (100%)
Wrote the paper (60%)
Inthavong, K Wrote the paper (30%)
Tu, J. Y. Edited the paper (10%)
6
Tian, L., Inthavong, K., Liden, G., Shang, Y. D., and Tu, J. Y. (2016). Trans-
port and deposition of welding fume agglomerates in a realistic human nasal airway.
The Annals of Occupational Hygiene, 60(6):731-47, incorporated as Chapter 5, Sec-
tion 2.
Contributor Statement of Contribution
Shang, Y. D.
Conducted simulation (20%)
Wrote the paper (20%)
Tian, L
Wrote program code (50%)
Conducted simulation (70%)
Wrote the paper (50%)
Inthavong, K
Wrote program code (50%)
Conducted simulation (10%)
Wrote the paper (20%)
Liden, G Edited the paper (5%)
Tu, J. Y. Edited the paper (5%)
Shang, Y. D., Dong, J. L., Inthavong, K., and Tu, J. Y. (2017). Computa-
tional fluid dynamics analysis of wall shear stresses between human and rat nasal
cavities. European Journal of Mechanics B/Fluids, 61, Part 1, 160-169, incorporated
as Chapter 6.
Contributor Statement of Contribution
Shang, Y. D.
Wrote program code (100%)
Conducted simulation (80%)
Wrote the paper (50%)
Dong, J
Conducted simulation (20%)
Wrote the paper (30%)
Inthavong, K Edited the paper (10%)
Tu, J. Y. Edited the paper (10%)
7
Shang, Y. D., Dong, J. L., Inthavong, K., and Tu, J. Y. (2015). Comparative
numerical modeling of inhaled micron-sized particle deposition in human and rat nasal
cavities. Inhalation Toxicology, 27(13):694-705, incorporated as Chapter 7, Section 1.
Contributor Statement of Contribution
Shang, Y. D.
Wrote program code (100%)
Conducted simulation (80%)
Wrote the paper (50%)
Dong, J
Conducted simulation (20%)
Wrote the paper (30%)
Inthavong, K Edited the paper (10%)
Tu, J. Y. Edited the paper (10%)
Dong, J. L., Shang, Y. D., Inthavong, K., Tu, J. Y., Chen, R., Bai, R., Wang,
D., and Chen, C. (2016). From the cover: Comparative numerical modeling of in-
haled nanoparticle deposition in human and rat nasal cavities. Toxicological Sciences,
152(2):284-96, incorporated as Chapter 7, Section 2.
Contributor Statement of Contribution
Shang, Y. D.
Wrote program code (100%)
Conducted simulation (80%)
Wrote the paper (25%)
Dong, J
Conducted simulation (20%)
Wrote the paper (40%)
Inthavong, K Edited the paper (10%)
Tu, J. Y. Edited the paper (5%)
Chen, R Edited the paper (5%)
Bai, R Edited the paper (5%)
Wang, D Edited the paper (5%)
Chen, C Edited the paper (5%)
8
Abstract
This thesis focuses on health risk assessment of inhaled particles on human
nasal cavities. Inhaled micron- and nano-sized particles may exhibit thera-
peutic or toxic effects on the human nasal cavity. The nasal cavity play an
important role in particle filtering, air-distribution, and air-conditioning.
Due to its invasive nature, traditional in-vivo research have been challeng-
ing in narrow human nasal airways. Conventionally, laboratory rats have
been used to predict human’s toxicological response to inhaled particle.
Experiments on human nasal replica casts have been widely used to study
the fluid dynamics as well as toxicological studies associated with particle
deposition.
Two major research gaps remain between these preliminary studies and
clinical applications. Because of the intricate nasal geometry, it is difficult
to accurately visualise the results inside the nasal cavity or on the nasal
wall. Due to significant nasal geometric difference, the reliability of exist-
ing extrapolation from rat to human is questioned. Recently, with rapid
development of medical imaging and computational algorithm, Computa-
tional Fluid Dynamics (CFD) provides a powerful approach to conduct
simulation on nasal models, which can be accurately reconstructed from
CT-scan.
The main body of this thesis is composed of four parts. In the first
part (Chapter 2-3), I performed a comprehensive literature review, in-
cluding anatomy, in-vivo and in-vitro experimental studies and numerical
stdies, to identify the research gaps between previous studies and real clin-
ical application. In the second part (Chapter 4), I developed an unique
surface-mapping technique to project the pressure and wall shear stress
distributions from 3D to 2D domain. This technique lays a solid founda-
tion for visualising particle deposition locations on the entire nasal wall.
In the third part (Chapter 5), I investigated two factors that influence
particle deposition within human nasal cavities. The breathing zone near
nostrils dominates micron-sized particles’ trajectories and thus influencing
both the deposition efficiency and the deposition pattern. With respect
to nano-sized particles, I performed simulation for welding particles and
found the shape factor of agglomerates play a role in deposition patterns
not only in the nasal cavity, but also in the entire upper respiratory air-
way. In the fourth part (Chapter 6-7), a CAD model of Sprague-Dawley
rat was reconstructed from Micro-CT scan and simulation were performed
to compare with human case. Despite the visualisation application, the
surface-mapping technique also enables an approach to eliminate individ-
ual and inter-species variations by normalising the 2D domain. Airflow
behaviour, pressure and wall shear stress distributions, microparticle and
nanoparticle deposition patterns were compared between two species. I
proposed a scaling factor as a first step to establish a practical extrapola-
tion model from rat to human.
In summary, I developed novel techniques to gain insight into the fluid
dynamics and particle movement within human and rat nasal cavities.
This allows complete data access in the nasal cavity, thus enabling direct
inter-individual and inter-species comparisons. Airflow behaviour, pres-
sure and wall shear stress distributions, and detailed particle deposition
patterns were examined. Results were compared between human and rat
to establish an appropriate extrapolation method. This study lays a solid
foundation to perform CFD simulation in lower respiratory system and
sub-layers such as mucus, tissue and blood flow, which are critical for
future clinical applications.
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Chapter 1
Introduction
1.1 Motivation
The nasal cavity is an important part of the upper respiratory airway and is the
front line defender of the whole respiratory system with three principal functions: air
conduction, air filtering and air conditioning. The nasal cavity can be split into three
major parts: vestibule, middle passage and olfactory region. It contains two large
air-filled chambers that connect the ambient environment with the lower respiratory
system. Air conditioning takes place when the air passing through the nasal passages,
providing sufficient warming, moistening and removal of particulate materials for well-
condition air before entering into the lung.
During respiration, some contaminants contained in the inhaled air cause health
risks. For example, the risks of exposure to Particulate Matter (PM) in the outdoor
environment has brought great concerns world-wide as millions of deaths are linked
to its exposure annually. In the indoor environment, exposure to contaminants in
workshops such as welding fume agglomerates and wood dust also cause serious health
problems and workers safety concerns (Tian et al., 2007; Kim et al., 2015; Tian
et al., 2016). These pollutants are efficiently filtered by the delicate structure of nasal
cavity during inspiration and mostly captured by the mucus layer. The mixture of
mucus and contaminants are moved towards nasopharynx by mucociliary clearance
and eventually swallowed into gastrointestinal system.
On the other hand, the nasal cavity offers opportunities in bio-medical applica-
tions. Due to the existence of abundant blood vessels, the nasal cavity performs as an
ideal route for systemic drug delivery and this nasal administration avoids the pain of
intravascular administration and the digestion of drugs in the gastrointestinal tract.
It has been widely used to treat respiratory diseases such as nasal congestion, allergy
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and asthma. The olfactory region at the ceiling of the nasal cavity provides an alter-
native route to the central nerve system, bypassing the Blood Brain Barrier (BBB),
and therefore bringing a new approach to treat neurological psychiatric diseases and
disorders (Dhuria et al., 2010; Murao et al., 2012). The disadvantage of the nasal
administration is that it has been difficult to deliver drugs to specific targeted sites
and it may bring serious side effects to patients if the drug is over-loaded (Roland
et al., 2004; Inthavong et al., 2006).
Therefore, to investigate the physiological response of human respiratory system
to inhaled materials, including the toxicological effects of airborne contaminants, the
pharmaceutical efficiency of the nasal drug administration, it is required to accurately
determine the inhaled materials deposition sites and predict their interactions with
components on the nasal surface (eg. mucus, cilia, epithelial tissues, blood vessels
etc). In-vivo measurements on human volunteers is a challenge due to ethical issue.
Instead, extracted nasal cavity from cadavers and plastic nasal casts have been widely
adopted for experiments (Weibel, 1965; Churchill et al., 2004). The disadvantages of
these experiments are that they are costly and reveal limited phenomenon of airflow
patterns within the nasal cavity. Furthermore, the inevitable shrinkage of the nasal
geometry after death and the unrealistic respiration boundary conditions lead to
considerable inaccurate and unrepeatable results.
Due to the rapid development of bio-medical imaging techniques such as computed
tomography (CT) and magnetic resonance imaging (MRI) in recent decades, accurate
geometrical data of human anatomy such as nasal cavities and respiratory tracts can
be obtained without invasive and irreversible interventions. When coupled with CAD
techniques and computational algorithms, respiratory system models can be recon-
structed with great fidelity and then simulated by the Computational Fluid Dynamics
(CFD) techniques, therefore guaranteeing cost-effective, repeatable and relatively ac-
curate solutions. The advanced graphical analysis methods (post-processing) of CFD
present detailed air flow path lines, air pressure distributions and velocity contours
within the nasal cavity and these in turn are comparable with the experimental results
for mutual validation (Wen et al., 2008; Doorly et al., 2008c). In addition, CFD gains
insight into air-nasal heat transfer, particle trajectories and particle deposition pat-
terns on the nasal surface, which is difficult to achieve in experimental measurements.
Nevertheless, the simulation is highly dependent on multi-discipline techniques, such
as the selection of numerical schemes, the quality of mesh grids, model equations and
initial boundary conditions. By adjusting simulation parameters, CFD provides a way
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to gain deep understanding of the mechanisms of nasal air flow distributions and par-
ticle deposition consequences. For example, airborne welding fume particles usually
agglomerate into structured long straight strings of beads due to magnetic moments
of iron, manganese and nickel oxides under particular welding conditions. This is
difficult and costly to conduct experimentally and even more difficult to predict its
deposition in the human nasal cavity in-vivo. Alternatively, using CFD provides it is
cost-effective to run simulation by merely modifying the form of physical equations
embedded in the CFD algorithm.
The toxicological response of inhaled particles are usually determined experimen-
tally and can be performed by laboratory animals (rats, mice, monkeys etc.), which
are used as surrogates to evaluate the physiological effects of inhaled foreign particles
on human subjects. This is due to their similar anatomy of the respiratory system,
as well as similar genetic, biological and behavior characteristics. However, an under-
lying issue is the difficulty in extrapolating the experimental data to human subjects
because of the different geometrical shape of nasal cavities. For example, in the hu-
man case the surface area of the olfactory region represents 5-10% of the total surface
area but it is approximately 50% in the rat case (Schroeter et al., 2008) and the
geometrical comparison is depicted in Figure 1.1. Empirical particle dosimetry math-
ematical models have been developed by either experimental or numerical approaches
to predict the deposition efficiencies in the respiratory tracts, and compared between
human and rat (Anjilvel and Asgharian, 1995; Asgharian et al., 2001, 2014). In ad-
dition, comparative studies of some particular toxic chemical compounds deposition
in human and laboratory animals have been conducted (Garcia and Kimbell, 2009;
Schroeter et al., 2013, 2014). However, these models either failed to achieve results
for general airborne particles, or not able to predict the detailed particle deposition
patterns in different anatomical regions of nasal cavities.
A reliable and practical extrapolation strategy have not yet been established to
date. The primary reason is that the nasal geometries are too complicated to analyze.
The feature of each human nasal chamber is shaped by three highly folded turbinates,
bounded by three nasal meatus (superior, middle and inferior), therefore featured
numerical results are deeply hided no matter which perspective is observed from.
Contour and velocity vector analysis based on cross-sections were widely used in
previous studies and wall shear stress along perimeters of cross-sectional slices were
mapped out to have quantitative analysis (Elad et al., 2006; Doorly et al., 2008b).
It has been a challenge to comprehensively reveal the numerical results on the entire
nasal cavity, let alone the practical comparative studies between species.
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Figure 1.1: Contiguous airway passages and their locations in heads for human and
rat. Faces are colored in gray and bones are colored in yellow.
This thesis reports the investigation of detailed airflow patterns and particle tra-
jectories within human/rat nasal cavities and in the surrounding environment using
computational fluid dynamics (CFD) with results validated by reported experimental
data. In addition to knowledge provided by previous researchers, this thesis con-
tributes a series of novel concepts such as surface-mapping technique initially proposed
in (Inthavong et al., 2014), reasonable design of anatomical division strategy com-
parable between different species (Shang et al., 2015a) and new numerical methods
of simulating long straight nanoparticle agglomerates (Tian et al., 2016). Therefore,
this thesis provides an approach to achieve following outcomes:
• To accurately reveal nasal airflow and particle deposition patterns characterized
by the nasal morphology and particle properties.
• To lay a foundation of comparative and extrapolative results between human
and other laboratory animals.
• To improve the evaluations related to environmental health and clinical appli-
cations of nasal drug delivery.
1.2 Hypotheses and Objectives
CFD modelling was used for simulating the air flow and particle tracking, and cou-
pled with codes in Matlab, Mathematica and other commercial software to further
post-process and analyse the results to reveal more detailed physiological functions of
human/rat respiratory systems. The commercial CFD package Ansys Fluent (Ansys,
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Inc.) was adopted for simulation. To balance the computational efforts and the out-
comes, both geometric and numerical models were reasonably simplified for revealing
key features of the research.
This thesis is based on following hypotheses:
1. Airflow and particle deposition patterns in nasal airways can be visualised in a
standardised way regardless of inter-dividual variations.
2. The breathing zone influence the airflow behaviour and particle deposition sites
in the human nasal cavity.
3. Particle shape factors influence the movement and deposition patterns of nano-
particle agglomerate in the human nasal cavity.
4. The wall shear stress distribution, which is determined by airflow behaviours,
is comparable between human and rat nasal cavity walls.
5. The differences of particle deposition patterns between the human and the rat
nasal cavities can be predicted by CFD simulations.
6. An applicable extrapolation model can be established from the rat case to the
human case for predicting humans toxicological response to inhaled particles.
The specific aims of this thesis are:
1. To reconstruct realistic human and rat nasal cavity geometries using CAD soft-
ware and keeping the key features based on nasal anatomy literature.
2. To investigate the air flow and particle transport in the ambient environment
surrounding the face.
3. To analyze the validated simulations of air flow patterns and particle deposition
patterns and compare these between species
4. To develop a visualization method that comprehensively reveals the CFD re-
sult within the intricate nasal geometry and lay a solid foundation for future
simulations of the interaction between inhaled particles and the physiological
sub-structures of the nasal surface such as mucus, cilia, tissue and blood vessels.
7
1.3 Thesis Outline
This chapter briefly explains the motivation, background and objects of this thesis.
The following chapters address these research questions of the thesis are outlined:
Chapter 2 expands the background into a comprehensive literature review re-
lated to respiratory system research including key aspects of anatomy and physiol-
ogy. Previous experimental and numerical approaches for investigating basic airflow
mechanism and preliminary particle deposition analysis in the human nasal cavity
are reviewed and discussed. Literature of the rat case is also reviewed accordingly
and previous extrapolative approaches from rat experimental data to humans are
briefly addressed. The literature reviewed lay solid foundation of the research in the
following chapters.
Chapter 3 demonstrates the detailed process of reconstructing medical CT im-
ages into CAD models and general numerical methods of computational fluid dy-
namics used in this thesis. These methods include mesh grid generation, governing
equations (Navier-Stokes equations), multi-phase simulation and some extensively
used post-processing methods.
Chapter 4 develops and tests some new numerical methods beyond the tradi-
tional ones introduced in Chapter 3. This chapter introduces a novel post-processing
technique named surface mapping to significantly extend the capacity of nasal cavity
analysis. Examples of advanced analysis of pressure and wall shear stress within the
human nasal cavity are given and compared with results from previous research.
Chapter 5 enters the main body of the thesis and presents two successive research
outcomes. The simulation range of particle tracking is extended from ambient space
into the human nasal cavity. Firstly, the functions of the breathing zone located in
front of nostrils is discussed. The results show that the breathing zone significantly
influences airflow patterns and particle trajectories, therefore the facial features and
sufficient external space are necessary for the nasal cavity airflow simulation. In
the second part, simulation of inhaled welding fume agglomerate deposition in the
human nasal cavity was performed. The agglomerates are usually in forms of long
straight chains, branches and compact groups, and this successfully extends the scope
of particle tracking simulation into arbitrary shaped particles.
Chapter 6 further extends the scope of air flow simulation into a Sprague-Dawley
rat, reconstructed from medical images of Micro-CT data. Both the human and rat
nasal cavities were divided into anatomical regions accordingly for comparison of
morphology and physiology of two species. Air flow patterns and wall shear stress
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(WSS) distributions within nasal cavities are presented which are coupled with surface
mapping technique and the correlations between two species are analyzed in detail
and compared between species.
Chapter 7 applies knowledge of particle tracking simulations and anatomical
division strategy into an inter-species investigation. Micro- and nano- sized particle
depositions were simulated separately in both human and rat nasal cavities. General
particle deposition results are validated by matching with reported experimental data
and particle deposition patterns featured by high particle deposition regions were
analysed. Based on the statistics of particle deposition locations, a new extrapolation
model from rat to human is proposed for potential clinical application.
Chapter 8 presents the conclusion of this thesis by summarizing innovative out-
comes from chapter 4 to chapter 7 and discusses further investigations required.
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Chapter 2
Literature Review
2.1 Overview of the Human Respiratory System
Most of our trillions of cells must exchange gases with ambient air via the respiratory
system. Anatomically, the components of human respiratory system can be divided
into two parts: the upper respiratory system and the lower respiratory system. The
upper respiratory system is located outside the thorax and it consists of external
nose, nasal cavity, paranasal sinuses and pharynx, while the lower respiratory system
is located inside the thorax and it consists of the trachea, bronchi, bronchioles and
alveolar sacs of the lungs as shown in Figure 2.1. The larynx, which lies between
the root of the tongue and the upper end of the trachea, is the transitional part that
joints upper and lower respiratory systems (Rizzo, 2015).
On the other hand, according to physiology, the respiratory system can be divided
into respiratory portion and conducting portion. It is widely acknowledged that the
respiratory system pulls air into and out of the lungs along the respiratory passage-
ways. The respiratory portion is located at the respiratory bronchioles, alveolar sacs,
alveolar ducts and the alveoli, where the gas exchange between air and blood occurs.
The internal bronchi and the bronchioles form the bronchial tree and provide the
extensive surface area (estimated 70-140 m2) (Rizzo, 2015). The entire bronchial tree
has intimate contact with small branches of arteries and the pulmonary capillaries is
the fundamental structure for gas and chemical exchange (Patton, 2016). The con-
ducting portion starting from the entrance of the nasal cavity (anterior nares) and
ending at terminal bronchioles and it properly distributes and conditions the airflow
streams before entering into the respiratory portion for gas exchanging.
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Figure 2.1: Anatomy of human respiratory system (Wikipedia-Contributors, 2016)
Tracing the movement of airflow, it would be found that air passes through the
following structures in sequence: anterior naris, nasal cavity, pharynx, larynx, trachea,
bronchial tree and eventually alveolar sacs. The airflow from the ambient air is at
first split into two streams and enters into left and right nasal chambers. The coarse
particulate matters (such as sand, wood dust and insects) from air are efficiently
screened by the nasal hairs on the vestibule that is located behind the anterior nares
(Cauna, 1982; Mygind et al., 1982). The airflow in each chamber is then divided
into three sub-streams (superior, middle and inferior) at the lateral side of the nasal
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cavity for sufficient conditioning, before merging into a main stream at the posterior
naris with the air streams in the other chamber. By the time the main stream leaves
trachea, it is split again into the left and right primary bronchi, then distribute into
countless branches through secondary bronchi, tertiary bronchi and bronchioles, and
reach every corner of the lungs. The cone-shaped lungs completely fill the pleural
portion of the thoracic cavity. The left lung is slightly smaller than right lung to
allow room for the heart, and each lung is divided into lobes by fissures. The paired
lungs present asymmetric structures as the left lung is divided into two lobes (superior
and inferior) while the right lung is divided into three lobes (superior, middle and
inferior).
The respiratory system provides some additional functions apart from airflow con-
duction. For example, the nasal cavity houses olfactory nerves to detect odorant, and
tonsils as parts of lymphoid system provide immune protection of respiratory. The
larynx has an alternative name voice box, because it serves an important function of
producing sound apart from conducting airflow as shown in Figure 2.2. The key com-
ponent is called vocal folds that controls the airflow when the air passes the narrowest
part of the respiratory tracts rima glottides. It is formed by irregularly shaped plates
of hyaline and elastic cartilage. The surface of vocal cords is covered with stratified
squamous epithelium to protect the mucosa from abrasion as the air passing through
this region is usually rapidly moving and fluctuating. The vibration of vocal cords is
caused by the expelled air from lungs passing through the rima glottides. Sounds are
further modified in the delicate structures of upper respiratory system (including na-
sopharynx, nasal cavity and paranasal sinuses) and oral cavity (including oropharynx,
soft and hard palate, tongue, teeth and lips).
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Figure 2.2: Frontal view of larynx (Patton, 2016)
By the time the air reaches the respiratory portion, the air has been sufficiently
filtered, warmed and humidified by the conducting portion. Airborne contaminants
such as particulate matters and pathogens are removed by the mucociliary clearance
in the nasal cavity (Cheng et al., 1996a), and the humidity and temperature are
properly conditioned within acceptable limits with the help of mucus layer as shown
in Figure 2.3. The mucus layer is a mucous membrane, consisting mucus and cilia,
underneath which are an epithelium and an underlying layer of areolar. The under-
lying layer of areolar tissue is called lamina propria, with the component of mucous
glands discharging secretions onto the epithelial surface and then propelled by the
dense cilia (Ross and Pawlina, 2006). The continuous mucus layer covers almost the
entire surface of conducting portion except the nasal vestibule region and the infe-
rior portion of pharynx (e.g. epiglottis and vocal cords), where covered by stratified
squamous epithelium to protect the mucus layer from abrasion and chemical attacks.
The mucus in both upper and lower respiratory tracts are propelled by the sweeping
movements of cilia and moved towards the laryngopharynx, and eventually swallowed
through the esophagus.
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Figure 2.3: Microscopic views of typical respiratory mucosa consisting of mucus, cilia
and underlying tissue taken by A, Light micrograph and B, SEM (Patton, 2016).
In summary, the respiratory system serves five major functions:
1. Provide large surface area for exchanging of O2, CO2 and airborne chemicals
between air and circulating system.
2. Distributing the airflow streams to enhance the efficiency of gas exchange.
3. Producing sound controlling its frequency for social communication.
4. Protecting the respiratory epithelial tissue from changing of environmental vari-
ations such as dehydration and extreme air temperature, and from invasion by
airborne contaminants.
5. Improving the detection efficiency of olfactory stimuli conducted by olfactory
receptors in the olfactory bulbs.
2.2 The Anatomy of Human Nasal Cavity
The nasal cavity is located at the center of the skull and divided into left and right
chambers by a bony and cartilaginous septum. It consists of three major components:
the vestibule, the main passage (respiratory region), and the olfactory region.
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Figure 2.4: The anatomy of human nasal cavity (Encyclepedia-Britannica-Inc, 2012)
As the entrance of the nasal cavity, the vestibule starts from anterior nares and
forms the shape of the external nose that connects the atmospheric air. The 90-degree
bend shaped vestibule region turns from vertical towards horizontal and it serves as
front-line filter that efficiently captures airborne contaminants by the direct inertial
impact and coarse nasal hairs entrapment. The vestibule is covered by the strati-
fied squamous epithelium and the sebaceous glands discharge secretions to help trap
particulate matters. Different with the mucus layer that covers the rest of the nasal
cavity, these secretions cannot be moved by the mechanism of mucociliary clearance.
Both the squamous epithelium and secretions become thinner at the posterior re-
gion, where undergoes smooth transition into the respiratory epithelium in the main
passage.
The nasal valve region, the location that presents the minimal cross-sectional area
(30-40 mm2), significantly controls the internal airflow pattern. It is the transitional
region between the vestibule and the main passage and usually locates less than 2 cm
distal in the nasal passage and forms an angle of approximately 10-15 degrees against
the lower edge of the upper lateral cartilage (Bailey, 1998). The cross-sectional area
of the anterior main passage expands rapidly along the direction of airflow and then
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forms a luminal space that constitutes most of the volume of the nasal cavity. Three
shelf-like turbinates (or conchaes) deeply insert into the main passage and form three
narrow and curved air chambers called superior, middle and inferior meatuses in the
lateral side. The main passage is covered with a ciliated, pseudostratified columnar
respiratory epithelium that continuously discharges secretion of mucus. The respi-
ratory mucosa provides rich blood supply and usually present the colour of bright
pink or red especially over the inferior turbinate, which is the largest turbinate. This
specific intricate structure of the lateral walls provides a large surface area and sig-
nificantly increases the efficiency of air-conditioning, which allows sufficient warming,
moistening and filtration.
The lateral walls of the main passage provide narrow openings into four paired
air-filled spaces called paranasal sinuses as shown in Figure 2.5 according to their
locations: Maxillary sinus, Frontal sinus, Ethmoid sinus and Sphenoid sinus. Among
them, the sphenoid sinuses drain into the spaces above the superior conchae, posterior
ethmoidal sinuses drain into the superior meatuses and the rest of the paranasal
sinuses drain into the middle meatus. The sinuses produce large amount of mucus and
sweep it into the main passage through the ostium to increase the nasal immunological
defense against pathogens. In addition, the hollow sinuses lighten the weight of the
skull and provide large spaces to resonate the sound. However, due to the narrowness
of the ostium, the pathogens entered into sinuses are difficult to be removed, therefore
causing severe infections (rhinitis) that require physical drainage.
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Figure 2.5: Locations of four paired paranasal sinuses in frontal and side views
(Terese-Winslow-LLC, 2012)
The septal walls are located at the midline of the nasal cavity and it is normally
smooth at young age. Abundant arteriovenous plexus beneath the septal epithelium
makes it an ideal target for nasal drug administration for cold, allergy and rhinitis
treatment that minimize the side effects (Navarro et al., 2001). However, approxi-
mately 80% of adults are found to have slightly deviated septum (displacement of the
nasal septum from the midline of the nasal cavity) as the nasal cavity grows. The
septum deviation sometimes causes the symptom of sleep apnea, which repeats many
times each night and subsequently causes symptoms related to chronic lack of oxygen
and daytime sleepiness.
The olfactory region is located at the dome of the nasal cavity and covered with
pale or yellowish olfactory epithelium. This specific epithelium consists olfactory
nerve cells, olfactory sensory neurons and provides abundant lymphatic plexus as
shown in Figure 2.6. Human’s olfactory region has a surface area of 2-10 cm2 (reported
for adults) that varies from person to person (Proctor and Andersen, 1982). It is
relatively smaller when compared to animals with an acute sense of smell, for example
dogs have more than 150 cm2. Odorant (Gas molecules or chemicals) is dissolved
in the mucus the unique olfactory cilia helps mix the covering mucus to enhance
the olfactory detection efficiency. When the level of odorant in the mucus reaches
a threshold, an action potential is generated and passes to the olfactory nerves in
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the olfactory bulb, and finally enters the olfactory centres of the brain. However,
the olfactory pathways also bring risks. It has long been recognized that inhaled
ultrafine particles could bypass the Blood-Brain-Barrier (BBB) via olfactory nerves
and translocate into the olfactory bulb and even into the brain (Oberdrster et al.,
2004; Bai et al., 2010). For example, some Mn ions can penetrate the barrier and
accumulate in the basal ganglia of the brain (mainly in the globus pallidus) and exerts
neurotoxic effects (Lam et al., 1978; Al-Shamma et al., 1979).
Figure 2.6: Locations of olfactory epithelium, olfactory bulb and neural pathways of
olfaction (Patton, 2016).
At the posterior region of the main passage, two nasal chambers gradually merge
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into a structure called posterior nares (or choanae), which is the starting point of
pharynx. It is another 90-degree curved passage that turns the airflow from horizontal
towards vertical. The pharyngeal tonsils are located on the posterior wall opposite
the posterior nares and function as immune defender when the airborne contaminants
reach this area. Three divisions of the pharynx are nasopharynx, oropharynx and
laryngopharynx. The pharynx region serves as a platform that connects other organs
with seven openings: two auditory tubes opens into the middle ear, two posterior
nares opens into paired nasal cavity, an opening is called fauces to connect with the
oral cavity and two openings into the larynx and esophagus, which are switched by
the epiglottis (Patton, 2016). The soft palate separates the nasopharynx from the
oral cavity and forms the floor of nasopharynx. When obstructed by the enlarged
soft palate caused by obesity, this flexible structure is often vibrated by the turbulent
airflow and produces noises commonly known as snoring (Bertram, 2008).
The morphological variation of human upper respiratory airways have been widely
investigated among people with different health conditions, age and race. For exam-
ple, it was found that nasal obstruction, which increases resistance to the airflow,
is frequently experienced by individuals. This can be caused by natural nasal cy-
cle (Huizing and De Groot, 2003) or physiological response to the environmental
temperature. Some anatomical anomalies or sino-nasal pathologies, such as septum
deviation, nasal polyps, turbinate/mucosa hypertrophy, tonsillitis and rhinitis, also
bring regional obstruction or nasal passage enlargement (Tu et al., 2012). Morpho-
logical variations of human nasal airway are found for people living in different eco-
geographical locations due to adaptation to local climates. Exchange of heat and
moisture mostly occur in nasal cavity and it is mainly controlled by the amount of
contact between nasal mucosa and the air (Franciscus and Long, 1991; Mowbray and
Gannon, 2001; Clement and Gordts, 2005). For example, small airway cross-sectional
area, large external protrusion and small constricted nostrils are developed to en-
hance heat and moisture exchange in cold and dry environment. On the contrary,
large airway cross-sectional area, small external protrusion and large constricted nos-
trils are found for people living in hot and moist environment. Noback et al. (2011)
concluded the morphological variations of nasal airways according to the demand
for air-conditioning, during both inspiration and expiration, as listed in Table 2.1.
Therefore, the appearance of nasal morphology can be defined by classification of
ethnic groups (Tu et al., 2012), such as leptorrhine nose for Caucasians, platyrrhine
for African Americans, paraleptorrhine for Hispanics and subplatyrrine for Asians.
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Table 2.1: Air-conditioning demands according to climate variations (Noback et al.,
2011)
2.3 Inter-species Variations of Anatomy
Laboratory animals such as rats are widely used for inhalation bioassays to predict
the inhaled particles’ toxicity to human nasal passages and paranasal sinuses. Al-
though rats share the similar overall nasal structures with human (vestibule, middle
passage, olfactory region, pharynx and larynx etc.), rats present different physiolog-
ical responses to inhaled chemicals. For example, inhaled formaldehyde gas causes
cancer in rats’ nasal passages, while limited reports have been found among occupa-
tionally exposed humans (Kerns et al., 1983; Holmstrm et al., 1989). To assess rats as
models for inhalation studies, the anatomy and physiology of rat’s nasal cavity need
to be comprehensively compared with those of humans.
The adaption to the crawling position results in a tandem upper respiratory air-
way, through which the airflow can travel linearly from nostrils to the end of the
trachea (Schreider, 1986). Rats are unique obligatory nose breather because the
epiglottis isolate the oral cavity from the airway during rest breathing conditions
(Proctor and Chang, 1983). The homologous structure of nasal valve in humans does
not exist in the rat nasal cavity. Instead, small cartilaginous named atrioturbinates
projects into the anterior vestibule, and a narrow nasopalatine canal connects the
nasal cavity with the oral cavity (Negus and Straatsma, 1960; DeSesso, 1993; Hebel
and Stromberg, 1986). Unique swell bodies are found in the inferior nasal septum
of rat nasal cavity and they contain several vascular spaces with superficial plexus
of thin-walled veins underneath the epithelium (Negus and Straatsma, 1960). Swell
bodies are usually engorged during relaxing conditions to minimise the cross-sectional
area of nasopharyngeal duct, therefore forcing the airflow into the upper portion of
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nasal cavity, which houses the highly specialised olfactory epithelium. On the con-
trary, swell bodies are collapsed to maximise nasopharyngeal duct when the rat is
in active, which increases the ventilation rate of the respiratory system (Negus and
Straatsma, 1960; Reznik, 1990), while the corresponding structure does not exist in
the human nasal cavity.
Figure 2.7: Anatomy of the rat nasal cavity from lateral view (Hebel and Stromberg,
1986)
The most striking nasal anatomical difference between rat and human is the struc-
ture of turbinates. Different with clearly discerned three comma-shaped turbinates
in the human nasal cavity, the rat nasal cavity possesses additional turbinates. Two
turbinates named nasal turbinate and maxilloturbinate project into the lateral wall of
rat’s middle passage superiorly and inferiorly, just behind the vestibule region. Con-
sequently, three three meatus (superior, middle and inferior) are formed and join with
each other to form the flat oval nasopharyngeal duct posteriorly. The olfactory region
of rat exhibits T-shaped profile with scroll-like folds caused by a group of turbinates.
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Four turbinates (ectoturbinate I-IV) are located superiorly and three turbinates (en-
doturbinate II-IV) are located inferiorly, in which the endoturbinate is subdivided into
two lamellae (Hebel and Stromberg, 1986). This elaborate arrangement of turbinate
significantly increases the surface area of the rat nasal cavity, especially in the olfac-
tory region. Consequently, less ancillary structures are needed for the rat case. The
rat nasal cavity does not possess ethmoid sinuses and the relative volume of maxillary
sinus is much smaller than that of human.
Figure 2.8: Coronal view comparisons of nasal cavities for human and rat (DeSesso,
1993). EC: ethmoid sinuses, MS: maxillary sinus
Similar with human case, the respiratory epithelium covers the majority area in
the rat nasal cavity discharges mucus to condition the respiratory airflow and remove
particulate matters. Swallowing through the esophagus is not the dominant option
for the mucociliary clearance in the rat case. Comparing with the mucus movement
direction in human nasal cavity, a much great portion of mucus is directed towards
nostrils for the mechanism of anterior mucociliary clearance, and eventually removed
by licking and sneezing (Proctor and Chang, 1983; DeSesso, 1993).
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2.4 Airflow Studies in Nasal Cavities
Previously researches investigated the airflow distribution within nasal cavities for
gaining insight into the nasal air-conditioning. For humans, early investigations have
determined characteristic flow rates based on experiments in volunteers. During light
breathing condition, the average flow rates for adults range between 5-12 L/min. The
flow rate increases to 12-40 L/min during light physical exercise, triggering the switch
from pure nasal flow to oral-nasal flow. In extreme forced inhalation conditions, the
flow rate can reach as high as 150 L/min. The oscillatory effets of the unsteady
flow are sufficiently low, thereby the nasal airflow can be treated as quasi-steady flow
especially for low flow rates (Chang, 1989; Hahn et al., 1993; Subramaniam et al.,
1998; Hooper, 2001; Tu et al., 2012).
In-vivo measurements within human nasal cavities require invasive equipment
such as radioactive particles and probes. It is not applicable due to the ethical
issue and the narrowness of nasal passages. Instead, the rigid cast models have
been widely used for in-vitro experiments for decades, since Swift and Proctor (1977)
quantitatively measured the airflow velocity field in a cast model of human nasal
cavity. The experiments in replica casts showed that laminar airflow dominated the
nasal cavity at a flow rate of 7.5 L/min (125 ml/s) and considerable turbulence
occured in some high-speed regions such as downstream of nasal valve as the flow
rate increased to 12.48 L/min (208 ml/s). Hahn et al. (1993) and Keyhani et al.
(1997) suggested that laminar flow dominants the nasal cavity for the flow rate up to
24 L/min.
In early years, many researchers such as Girardin et al. (1983) and Hornung et al.
(1987) used cadavers to reproduce human nasal cavity cast models. With the develop-
ment of Medical Radiology, CT and MRI techniques were introduced and widely used
to accurately depict the nasal geometry since 1990s (Schreck et al., 1993; Hahn et al.,
1993; Park et al., 1997; Kelly et al., 2000). These investigations found that most air-
flow pass through the middle and inferior passages. In addition, three meatus serve the
streamlining or laminating function. Contradictory to the previous suggested func-
tion of air-conditioning enhancement, low airflow rate pass through three meatuses.
The delicate nasal structure effectively protects the olfactory region because only a
small portion of airflow can reach the olfactory region in rest breathing conditions. In
compensation, elevating the inspiratory flow rate (sniffing) can considerably level up
the olfactory efficiency. The combination of water and dye, transparent 3D printed
cast model and particle image velocimetry (PIV) technique were used to visualise the
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airflow velocity and streamlines (Churchill et al., 2004; Doorly et al., 2008c,b). Using
these techniques, they found a jet behind the nasal valve and turbinates suddenly
divide the airflow into sub-streams, therefore forming high wall shear stress regions
that enhanced heat transfer and humidification. Besides, the low wall shear stress
distributions indicate low flow rates passing through the superior passages, which is
mainly occupied by olfactory region. In addition, dye filaments also revealed a large
recirculation in the upper part of the nasal cavity as shown in Figure 2.9.
Figure 2.9: Airflow patterns visualised by neutrally buoyant dye filaments and flooded
contours. A jet is found behind the nasal valve and a large recirculation was found
in the upper nasal cavity. (A): Depicts neutrally buoyant dye filaments representing
airflow streamlines. (B) and (C) From a mid-sagittal slice through the anterior part of
the nasal airway, corresponding to the region in the box demarcated in (A). (Doorly
et al., 2008c)
24
With rapid development of computational capability and algorithm, CFD became
a alternative way to investigate the airflow patterns in the nasal cavity. In early
studies, it was difficult to reconstruct the nasal cavity CAD model due to its irreg-
ular and highly-folded shape. Elad et al. (1993) created a 3D nose-like model to
numerically investigate the air-conditioning function in the nasal cavity using FIDAP
(Fluent Inc.), followed by Naftali et al. (1998) , Wolf et al. (2004) and Elad et al.
(2006)’s nasal airflow simulations using the same model. These studies revealed that
the inferior turbinate, the middle turbinate and the nasal valve play a role in heat and
water transport between air and nasal cavity. Coupling with CT/MRI data, the CFD
simulation has been popular in recently years because medical scanning data reflect
the anatomically accurate nasal geometric information. Subramaniam et al. (1998),
Horschler et al. (2003) and Wen et al. (2008) conducted simulations in rest and light
exercise conditions and found swirling currents existed in the vestibule region. In
addition, they discovered more vortices occured in posterior nasal valve, entrance of
nasopharynx, middle lateral meatus, in the vicinity of turbinate tips, upper olfactory
region. Xiong et al. (2008) and Ge et al. (2012) investigated the airflow patterns
in paranasal sinuses included nasal cavities. They found that the air mass flow rate
entering the maxillary sinuses through ostiums were less than 0.006% of the total flow
rate, and this was confirmed by the negligible wall shear stress values in the maxillary
sinus region.
The difference in morphology between individuals such as age, sex and ethnnicy
also cause airflow variations. Zhu et al. (2011); Abouali et al. (2012) evaluated and
compared the effects of differences of nasal morphology among three healthy male
subjects from Caucasian, Chinese and Indian ethnic groups and found significant
variations of nasal airflow patterns. White et al. (2011) and Noback et al. (2011) con-
cluded the adaptation of morphological features to environment, such as temperature
and humidity. To standardise the nasal morphology, Liu et al. (2009) collected 30
sets of head CT scans and produced an representative model, while Gambaruto et al.
(2012) used Fourier descriptors of three nasal cavity models to produce an averaged
model. Despite this, intra-individual differences are also found between the structure
of the left and right nasal chambers, health conditions, as well as temporal variations
caused by nasal cycling (Eccles, 1996).
The inter-species variations of airflow behaviours between human and laboratory
animals are much larger than inter-individual variations. Similar with human case,
replica casts and CFD simulations were also widely used to investigate airflow patterns
in rat nasal airways. To extrapolate local physiological influences in rats to potential
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disease outcome in humans, Morgan et al. (1991) studied inspiratory nasal airflow in
transparent acrylic replicas of rat nasal passages using a water-dye siphon system.
Based on dye streamlines, the anterior rat nasal airway model was considered to
play a role in local mixing of inhaled air. Kimbell et al. (1997) comprehensively
simulated airflow patterns in a F344 rat reconstructed from serial-step histological
sections. Rat can reshape the vestibule (to be upturned) to enhance the olfactory
detection efficiency during sniffing. The inhaled airflow was divided into five streams
immediately after entering the anterior naris. Four of them joined together and exited
ventrally through the nasopharygeal duct and the remaining stream flowed bypassing
the olfactory region, leaving a Z-shaped pattern when viewed in sagittal view. Garcia
and Kimbell (2009) conducted a CFD simulation focusing on the olfactory region of a
rat and found approximately 20% of inhaled air was diverted to the olfactory region,
while the majority of the flow exited the nasopharynx. Meanwhile, site-specific nasal
lesions have been recognized in rats after inhalation exposure to chemical toxicants
such as formaldehyde (Cassee et al., 1996; Kimbell, 2006; Schroeter et al., 2014).
2.5 Particle Deposition Studies in Nasal Cavities
People inhale airborne particles through nasal airways and some types of particles ex-
hibit adverse effects on human’s physiological systems.Experimental researches widely
use particle deposition efficiency and particle inhalability to determine particles’ tox-
icological effects on the human body.
The deposition efficiency (DE) is defined as the ratio of particle amount deposited
in the nasal cavity and the total amount inhaled. With lower DE, more particles
travel through the nasal cavity and enter into the lower respiratory system. For
those captured by the nasal cavity, the toxicological effect varies with deposition
locations. Deposition on the vestibule presents neglect toxicity because this region
is covered with squamous epithelium and it serves filtration function instead of air-
conditioning. While deposition inside sinuses cause serious infections and sometimes
physical drainage is required. The expression of DE is:
DE =
number of particles deposited
number of particles inhaled
× 100% (2.1)
Inhalability is also called aspiration efficiency (AE), which represents the fraction
of particles that are inhaled through nose or mouth during breathing (Phalen, 2000;
Kennedy and Hinds, 2002). When the inhalability is low, most particles bypass the
human body and therefore presenting less damage to the respiratory system. For
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obligatory nose breathing condition, this can be simplified by measuring the airflow
speed and characteristic areas:
AE =
AcVc
AnVn
(2.2)
Where Ac and Vc are the critical area and farfield particle velocity from the up-
stream source, while An and Vn is the area and airflow mean velocity at the nostril.
2.5.1 Microparticle
Micron-sized particles can present in every aspects of daily life. For example, environ-
mental exposures such as pollen and particulate matter (PM) often cause hay fever,
rhinitis and asthma. Workers suffer from occupational exposures to wood dust, glass
fibre and smoke. Undesired deposition locations of nasal drug delivery may present
adverse repercussion due to toxicity (Enarson and Chan-Yeung, 1990; Bousquet et al.,
2001; Oberdrster et al., 2005).
American Conference of Governmental Industrial Hygienists (Soderholm, 1985)
adopted Vincent and Armbruster (1981)’s recommendation to using following empir-
ical expression for predicting inhalability I:
I = 0.5[1 + exp(−0.06dae)]± 0.1 (dae < 100µm) (2.3)
Where dae is the equivalent aerodynamic diameter of microparticles (compared
with water).
dae = dp
√
ρp
1000
(2.4)
The inhalability is nearly 100% when the particle size is smaller than 10 µm and
rapidly decreases as particle size increases. Small particles suspend in the air near
the dust source and follow the airflow streams when inhaled into the respiratory air-
ways (ASHRAE Fundamentals, 2009). This expression was based on experiments in
wind tunnel with various windspeeds up to 8 m/s, therefore the inhalability remains
nearly 50% for dae > 30µm. However, this expression does not accurately predict
the inhalability in calm air or low windspeed conditions. Dai et al. (2006) experi-
mentally measured the inhalability in calm air (windspeed < 0.3m/s) in-vivo and
using a manikin. They found that the inhalability was much lower compared with
that suggested by Soderholm (1985) and it reduced to 0 (cut-off size) when the dae
approached to 135 µm. Facial features also affect the inhalability. Inthavong et al.
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(2013a) numerically investigated the inhalability under low wind environment using
a manikin model and found that the flow field in the free stream remains unifrom
unitl reaching the near body region. Vector plots showed breathing zone was less
than 5 cm from nostrils and this region significantly affected the trajectories of small
particles (dae < 10µm).
The deposition efficiency of microparticles has been widely investigated in-vivo
based on experiments on volunteers. Many factors, including particle size, airflow
rate and nasal geometric features (mainly shapes of the nostril and the nasal valve),
work together to influence the particle deposition efficiency (Kesavanathan et al.,
1998). In-vivo experiments showed that, in generally, most micro particles (4-30 µm)
deposite in the anterior part of the nasal cavity. In addition, the exhalation period
considerably contribute to the total deposition efficiency (Keck et al., 2000; Wiesmiller
et al., 2003). However, the disadvantages of in-vivo experiments were difficulties to
(i) measure particle deposition amount, (ii) to locate particle deposition sites, and
(iii) to exclude large inter-subjects variations.
To overcome disadvantages of in-vivo experiments, in-vitro replica models are
widely used for measuring particle deposition in the human nasal cavity. Swift (1991)
and Guilmette et al. (1994) manufactured two nasal replicas based on the same MRI
dataset and conducted deposition expriments with particle size 0.6-12 µm and with
steady inspiratory flow rate 7-50 L/min. They did not conlude these massive results
into an elegant and compact form until Ha¨ußermann et al. (2002) proposed an Inertial
Parameter IP which correlates to the impactionmicro-sized particle:
IP = d2aeQ (2.5)
Where Q represents the airflow rate. Kelly et al. (2004a) used two nasal replicas
manufactured by different methods (SLA and VIPER) and investigated microparticle
deposition efficieny with high accuracy. The particle size ranged from 1 to 10 µm
and the flow rate was 20-40 L/min. It matched Cheng et al. (2001)’s data very
well, with slightly lower deposition efficiency. They found that for inertial parameter
(IP ) less than 2,000 µm2cm3/s, the efficiency approached to zero, which means most
particles entered into the lower respiratory system. As particle inertia increased, the
deposition efficiency rapidly rose and reached 100% at IP = 25, 000µm2cm3/s. For
larger IP , the efficiency remains 100%. Furthermore, if I take particle density (ρ),
nasal geometric freatures (dc) and fluid viscosity (µ) into consideration, a particle
Stokes Number (Stk) was widely used to normalise the deposition data (Shanley
et al., 2008; Wang et al., 2009; Si et al., 2013). The Stk is defined as:
28
Stk =
2ρd2Q
9piµd3c
(2.6)
Hsu and Chuang (2012)’s in-vivo measurements in Asian volunteers indicated that
ethnic variations have limited influence on the microparticle deposition curve. In
general, numerical results showed similar deposition trend with that of experimental
data, except small variations caused by CAD model roughness (Shi et al., 2007;
Schroeter et al., 2011) and turbulence dispersion modifications (Inthavong et al.,
2011b). Shanley et al. (2008) proposed an expression to fit the simulated data with
β = 250:
Ed = 1− exp(−β(Stk)2) (2.7)
Despite the overall deposition efficiency, the detailed particle deposition locations
can be predicted by CFD simulations. Wang et al. (2009) visualised the particle
deposition patterns, along with transparent nasal cavity frames. The preferential
deposition sites for microparticles were found near the nasal valve and the upper
region of vestibule, where a 90-degree curve occures.
The microparticle deposition efficiency share the same trend of ‘higher inertia,
higher efficiency’ with human case, according to in-vivo and in-vitro experiments
(Cheng et al., 1990; Kelly et al., 2001; Kelly and Kimbell, 2001). However, due to
significant anatomical differences, the threshold of particle filtration varies. Schroeter
et al. (2012)’s numerical study showed that the microparticle deposition efficiency
started to rise at IP = 20µm2cm3/s and approached 100% at IP = 300µm2cm3/s,
whereas corresponding values for the human case were 2,000 and 25,000. The rat’s
nasal cavity exhibited much stronger filtration than that of human’s. Visualisations
of particle patterns revealed two preferential deposition regions for microparticles, one
in anterior vestibule and the other one in the olfactory region. As inertia increased,
particles progressed from olfactory region towards vestibule region.
2.5.2 Nanoparticle
Current nanotechnology prosperity has produced various products based on nano-
materials such as quantum dots, carbon nanotubes and nano-medicines, leading to
increased human exposure to airborne nanoparticles (Abbott and Maynard, 2010;
Raj et al., 2012; Vance and Marr, 2015). Unique chemical and physical properties
of nanoparticles bring health concerns. Besides symptions occured in the nasal cav-
ity, dessolved particles translocate into other systems or organs across physiological
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broundaries. Particles deposited in the olfactory region may bypass the blood-brain-
barrier and enter into the central nerve system. Due to the continues mucus layer
covering the nasopharynx and the auditory tube, it provides a route to transfer rhini-
tis into the middle ear. Particles depositied in the bronchial tree may translocate into
extra-pulmonary sites such as interstitium, lymph and circulation system (Oberdrster
et al., 2004; Elder et al., 2006; Doty, 2015).
Due to chemical reaction and electrostatic force, nanoparticles are usually grouped
into structured agglomerates, such as long straight strings, branches and other forms
of compact shapes (VE, 2007; Sowards et al., 2010). For example, the typical size
of welding fume agglomerates range from 10 nm to 100 nm. For irregular-shaped
particles, Tran-Cong et al. (2004) proposed an empirical equation to model particle
motion based on random particle orientation. Inthavong et al. (2013b) adopted two
equivalent diameters and a shape factor called the ‘degree of circularity’ (Wadell,
1933) to modify particle drag coefficient. These three parameters are the volume
equivalent sphere diameter (dn =
3
√
6V/pi), the surface equivalent sphere diameter
(
√
4Aproj/pi) and the circularity (c = pi(dA/Pproj)).
For spherical submicron or nanoparticles, deposition efficiency exhibits a differ-
ent trend from that of microparticles. Cheng et al. (1996a,b) investigated a variety
of volunteers’ nasal cavities in-vivo. They found that under natural relax breathing
condition (10 L/min), high deposition (up to 80%) occured for 1 nm particles, while
it droped significantly to 10% as particle size approached to 50 nm. This was sup-
ported by Kelly et al. (2004b)’s in-vitro experiment using replica models and Wang
et al. (2009)’s numerical results. The deposition mechanism of nanoparticle is dif-
ferent from that of microparticles. Instead of inertial impaction, Brownian diffusion
dominates the nanoparticle deposition, thereby the nanoparticle’s movement is rela-
tively detached from the air streams and spread throughout the nasal cavity like a
teabag in hot water. Comparing with the Brownian force, the gravity force acting on
nanoparticles can be neglected.
The nanoparticle deposition efficiency also share the same trend of ‘higher particle
size, lower efficiency’ with human case, according to in-vivo and in-vitro experiments
(Cheng et al., 1990; Gerde et al., 1991). The deposition efficiency is larger than
70% for size smaller than 5 nm and less than 10% for size larger than 200 nm.
Schroeter et al. (2012)’s simulation matched the experimental data well and showed
relatively evenly distributed patterns for nanoparticles in rat nasal cavity. The 1 nm
particles deposited primarly in the anterior vestibule region and progressed backwards
to olfactory region as the flow rate increased. As the particle size increases, the
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rapid drop in diffusivity resulted in more uniformly distributed patterns. The typical
particle deposition curves are shown in 2.10 for comparison between human and rat.
Figure 2.10: Typical particle deposition efficiencies for (a) human and (b) rat, with
size range from 1 nm to 10 µm, under rest breathing condition.
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Chapter 3
Methodology
3.1 Reconstruction of Nasal Cavity Models
The respiratory system models for CFD simulation are originally based on CT scan
images obtained from hospital and laboratory for human and rat, respectively. In
total, four models from Asian volunteers labeled as NC01-NC04 and one model from
Sprague-Dawley rat labeled as RNC01 are used in this thesis. Among them, NC01
and NC04 extend the nasal cavity part into lower respiratory system towards the
lung, including oral pharynx, larynx, trachea and two bifurcations of bronchi while
NC02, NC03 and RNC01 contains nasal cavity part only. Two models NC01 and
NC02 have been investigated previously. The results of NC01 have been published
in (Inthavong et al., 2006; Tian et al., 2007; Inthavong et al., 2008a,b; Wen et al.,
2008; Inthavong et al., 2009a; Wang et al., 2009; Inthavong et al., 2011a,b,c, 2013b),
while the results of NC02 have been published in (Ge et al., 2012; Inthavong et al.,
2012a,b, 2013a,b). The detailed descriptions of NC01-NC04 and RNC01 can be found
in http://www.cfdresearch.com/inhalation.php.
3.1.1 Computed Tomography (CT)
CT was invented in 1972 and it dramatically increased diagnostic information when
compared with x-ray technique, as it shows cross-sectional views of patient anatomy
that brings three-dimensional information. CT data are collected slice by slice from
the volunteer by rotating x-ray beams and special electronic detectors. Several x-rays
are emanated from tubes and falls onto the detector for one translation across the
object. After one translation, the tube and detector rotate by 1 degree to collect
another signal. This procedure is repeated at least 180 times for each CT slice and
then moves forward for next slice (Seeram, 2015). One of critical problems is that
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during the scanning, some portions of the entire volume data may be distorted due to
the movement of the respiratory tracts, especially the trachea and lung. Volunteers
were required to hold the breath during the CT data acquisition and the scanning
was conducted immediately when the rat was terminated. Attenuation of photons is
detected when the x-ray passes through an object depends on the electron per gram,
atomic number, tissue density and radiation energy used. As different anatomical
structures such as bones, tissues and air perform different capabilities of absorbing
and scattering the x-ray beam, they are clearly distinguished by different gray scales
stored as raw data in the ‘data acquisition system’ as shown in Figure 3.1.
Figure 3.1: The essential components of a CT scanner including electron gun, x-ray
tube, detector and data acquisition system. The data is collected slice by slice and
converted into 3D data based on gray scales values for each voxel (Seeram, 2015).
The gray scale data is usually ranged from 0-255 or 0-4095, depending on whether
8-Bytes or 16-Bytes format the Dicom file (a common medical imaging file type)
exported from the CT machine is using. Figure 3.2 illustrates the range of gray scale
value for common structures of bone, tissue and air. The bone performs the highest
attenuation of x-ray due to its high density while the air allows almost 100% of x-ray
passing through it. The remarkable difference of attenuation between soft tissue and
air present clear boundaries of nasal airway passages.
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Figure 3.2: The relationship between biological structures and gray scale ranges
(Seeram, 2015).
A coronal CT slice of human head (NC04) is shown as an example in Figure
3.3 and the pixel information in the zoom-in picture presents the original gray scale
values translated by the CT machine. The brightest region with the gray scale value
as high as 3000 is due to the high density of bones while the gray and smooth region
represents the tissue, such as skin, epithelium, brain etc. The ambient space, nasal
airway passages, sinuses and external acoustic meatus are clearly identified by the
dark regions and their shapes can be conveniently recognized by the sharp transition
of gray scale values from 0 to 1000 according to the third picture of Figure 3.3.
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Figure 3.3: An example of CT image slice and its gray scale values for pixels. The
gray scale is ranged from 0 to 4095 in this case. The example is based on CT data of
NC04 used in Chapter 6 and 7.
3.1.2 Nasal CAD Model Reconstruction
Based on the sliced images obtained from the CT machine, two further steps are
needed to reconstruct the practical CAD nasal models for mesh grid generation and
CFD simulation: segmentation and surface reconstruction (Russ, 2015).
Segmentation is a processing technique used to partition the structure of interest
based on certain criteria. It can be processed manually by selecting the regions of
interest slice by slice. However, it is usually time-consuming and with low-accuracy
given hundreds or even thousands CT slices. On the other hand, purely automated
segmentation can’t avoid over-extracting or under-extracting voxels in some regions
due to fluctuating of exposure rate over the whole scan process (Tu et al., 2012).
Therefore, a semi-automated segmentation balancing the efficiency and accuracy is
chosen, with manual adjusting and modifications as complement.
Particularly for the nasal passage reconstruction, I focus on the border between
the nasal epithelium and the nasal passage filled with air. According to Figure 3.2,
firstly the displaying threshold is assigned to be 0-50% of the maximum gray scale
value covering the air and soft tissue to discard the bone part and highlight the
border. Take the third picture in Figure 3.3 as an example, an extraction threshold
of gray scale value approximately 0-1000 is set to distinguish between air and tissue
for automated segmentation, so that the pixels located at the top-left are selected as
a contiguous region representing the nasal cavity passage while the regions of tissue
and bone are discarded. Manual intervention is needed to exclude undesired parts
such as sinuses, esophagus and other luminal spaces in the head and neck apart from
the nasal airways.
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The external boundary surface of the solid nasal volume extracted from previous
step represents the realistic geometry of the nasal passage. Considerable smooth-
ing process for the volume data is required to guarantee the smoothness of further
extracted surface. The surface can be exported into some CAD formats:
• STL (S Tereo Lithography) file records surface data with small triangulated
facets and are popular for rapid proto-typing manufacturing. Each facet is
represented by three vertices and its normal direction. As STL is the simplest
format, the number of triangles should keep in a reasonable range to avoid the
unmanageable file size (too many triangles) and obvious hexagon shaped surface
(too few triangles).
• IGES (Initial Graphics Exchange Specification) file contains both geometrical
and non-geometrical description and performs as a platform independent format
allowing inter-software translation. However, the IGES standard database for
interpretation is too complicated that some useless information leads to a very
large file size (Tu et al., 2012).
In the reconstruction works of this thesis, general surface geometry is in the form of
STL file and the featured points and boundary curves are exported as IGES file. They
are further processed by noise data canceling, peaks removing, surface smoothing and
geometry optimization in a commercial software Geomagic. The detailed procedure
of nasal airway model reconstruction are presented in Figure 3.4.
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Figure 3.4: Flow charting demonstrating the CT-image acquisition, segmentation and
surface reconstruction (Tu et al., 2012).
3.2 Fundamentals of Gas-Phase Modeling
The scales of nasal cavities, no matter for human or rat, are large enough to be
considered as a continuum regardless of the effects from molecular scale phenomenon.
Macroscopic fluid properties such as velocity, pressure, temperature, density, shear
stress and their space and time derivations can be applied into the fluid behavior.
The so called governing equations or incompressible Navier-Stokes (NS) equations
for fluid flow and heat transfer are widely used as the foundation of CFD technique.
Additional mechanisms such as turbulence modelling are the modified equations based
on the governing equations. They incorporate some physical principles:
1. the computational domain consists of cells separated by mesh grid as control
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volumes;
2. mass is conserved for the fluid in the computational domain except boundary
inlets or outlets;
3. the momentum of the fluid obeys the Newtons Second Law and the rate of
changing is subjected to the sum of forces acting on each control volume;
4. The energy of fluid obeys the First Law of Thermodynamics.
3.2.1 Governing Equations
Principle (2) - (4) can be concluded into a common form called transport equation:
∂ϕ
∂t
+ (~v · ~O)ϕ = ~O · (Γ~Oϕ) + Sϕ (3.1)
where ϕ is a general fluid property, t represents time, Γ is a general diffusion
coefficient and Sϕ is the source term. This transport equation can be translated as:
[Rate of changing of ϕ]+[Convection of ϕ] = [Diffusion of ϕ]+[Source termof ϕ]
(3.2)
Particularly, for the mass conservation equation, the ϕ is replaced with the fluid
density ρ and for diffusion is discarded. When applied into three-dimensional Carte-
sian coordinate, transport equation becomes:
∂ρ
∂t
+
∂(ρu)
∂x
+
∂(ρv)
∂y
+
∂(ρw)
∂z
= 0 (3.3)
considering the fluid is incompressible, ∂ρ/∂t = 0, therefore the mass conservation
equation is transformed into:
∂u
∂x
+
∂v
∂y
+
∂w
∂z
= 0 (3.4)
For the momentum equation, the ϕ and Γ are replaced with fluid velocity ~v and
viscosity µ respectively, and the fundamental source term for the momentum is the
force caused by pressure gradient, therefore the transport equation is transformed
into:
∂u
∂t
+
∂(uu)
∂x
+
∂(vu)
∂y
+
∂(wu)
∂z
=
µ
ρ
(
∂2u
∂x2
+
∂2v
∂y2
+
∂2w
∂z2
) (3.5)
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∂u
∂t
+
∂(uv)
∂x
+
∂(vv)
∂y
+
∂(wv)
∂z
=
µ
ρ
(
∂2u
∂x2
+
∂2v
∂y2
+
∂2w
∂z2
) (3.6)
∂u
∂t
+
∂(uw)
∂x
+
∂(vw)
∂y
+
∂(ww)
∂z
=
µ
ρ
(
∂2u
∂x2
+
∂2v
∂y2
+
∂2w
∂z2
) (3.7)
Here the viscosity µ is assumed constant. For the energy equation, the ϕ is
replaced with temperature T , and the transport equation is modified into:
∂T
∂t
+
∂(uT )
∂x
+
∂(vT )
∂y
+
∂(wT )
∂z
=
k
ρCp
(
∂2T
∂x2
+
∂2T
∂y2
+
∂2T
∂z2
) (3.8)
where k, Cp and ST are the thermal conductivity, thermal capacity and internal
thermal source, respectively.
In summary, if the velocity vector is simplified into ~v = u~i+ v~j +w~k, and replace
µ and k
ρCp
with the kinetic viscosity ν = µ/ρ and thermal diffusivity Γ respectively,
governing equations can be written in compact forms:
~v · ~O = 0 (3.9)
∂~v
∂t
+ (~v · ~O)~v = −1
ρ
~Op+ ν~O2~v (3.10)
∂T
∂t
+ (~v · ~O)T = Γ~O2T + ST (3.11)
3.2.2 Turbulence Modeling
In fluid dynamics, turbulence flow is a flow regime characterized by chaotic property
changes, including low momentum diffusion, high momentum convection, rapid pres-
sure and velocity fluctuation in space and time. The fluctuating velocities transport,
disperse and mix the fluid across different regions rapidly and break the layered mo-
tion that is presented in laminar flow. Reynolds Number (Re), the ratio between
inertia forces and viscous forces, is widely used to evaluate the extent of turbulence,
Re =
Inertia forces
V iscous forces
=
ρud
µ
(3.12)
where ρ is the fluid density, u is fluid velocity, d is the characteristic length of the
obstacle or hydraulic diameter of the internal flow and µ is the fluid viscosity.
Usually, the flow is laminar for Re<2000 and fully turbulent for Re>4000 for
internal circular pipe flows. For Re between 2000 and 4000, it is usually considered as
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transitional flow. At low Reynolds number, the flow is dominated by the viscous forces
therefore the naturally occurred disturbances are dissipated efficiently whereas at high
Reynolds number, the inertia forces are sufficiently large to amplify the naturally
occurred disturbances, thus causing unstable flow regimes.
For turbulent flow, the direct numerical solution (DNS) method for the time-
independent Navier-Stokes equations is not applicable due to extreme computational
requirement. To reduce the computational cost and time, a varying fluctuating com-
ponent ϕ′(t) is introduced as a complement to the mean variable 〈ϕ(t)〉:
ϕ(t) = 〈ϕ(t)〉+ ϕ′(t) (3.13)
The turbulence intensity I is defined by the ratio between fluctuating velocity and
mean velocity,
I =
u′
〈u〉 =
√
(u′x
2 + u′y
2 + u′z
2)/3√
(u2x + u
2
y + u
2
z)
(3.14)
Figure 3.5: Transport variable fluctuating with time in the turbulent flow.
With this assumption, the continuity and momentum Equation 3.10 can be ex-
panded into:
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∂ 〈~v〉
∂t
+ 〈~v〉 · ~O 〈~v〉+ ~v′ · ~O~v′+ 〈~v〉 · ~O~v′+ ~v′ · ~O 〈~v〉 = −1
ρ
~O 〈p〉− 1
ρ
~Op′+ ν~O2 〈~v〉+ ν~O2~v′
(3.15)
Average these terms, I get:
∂ 〈~v〉
∂t
+ 〈~v〉 · ~O 〈~v〉+
〈
~v′ · ~O~v′
〉
= −1
ρ
~Op+ ν~O2~v (3.16)
Similarly, the mass conservation Equation 3.9 is expanded into:
〈~v〉 · ~O+ ~v′ · ~O = 0 (3.17)
By averaging each term, I get:
〈~v〉 · ~O = 0 (3.18)
The new term
〈
~v′ · ~O~v′
〉
created in the averaged momentum Equation 3.16 is
related to the Reynolds Stress tensor:
Rij = ρ
〈
v′iv
′
j
〉
(3.19)
According to Equations 3.17, 3.17, 3.18 and 3.19,
〈
~v′ · ~O~v′
〉
i
=
1
ρ
∂j
〈
v′iv
′
j
〉
=
1
ρ
∂jRij (3.20)
Boussinesq introduced the simplest turbulence model by assuming the turbulent
shear stress is proportional to the deformation rate of the mean velocity (Hinze, 1975):
τturb = −ρ
〈
v′iv
′
j
〉
= ρνt
∂ 〈vi〉
∂xj
(3.21)
Where the νt is the turbulence kinetic viscosity. Therefore, the momentum equa-
tion is transformed into:
∂ 〈~v〉
∂t
+ 〈~v〉 · ~O 〈~v〉 = −1
ρ
~Op+ (ν + νt)~O2~v (3.22)
Based on the assumption of T = 〈T 〉 + T ′, the energy equation is transformed
into:
∂ 〈T 〉
∂t
+ 〈~v〉 · ~OT +
〈
~v′ · ~OT ′
〉
= Γ~O2 〈T 〉+ ST (3.23)
41
Similar to the Boussinesq assumption, the turbulence transport of temperature is
proportional to the gradient of the mean temperature:
hturb = −ρ 〈v′iT ′〉 = Γt
∂ 〈T ′〉
∂xj
(3.24)
where Γt is the turbulence thermal diffusivity. The corresponding Prandtl number
and turbulence Prandtl number can be defined respectively as:
Pr =
µ
Γ
, P rt =
µt
Γt
(3.25)
Therefore, the energy equation is transformed into:
∂ 〈T 〉
∂t
+ 〈~v〉 · ~O 〈T 〉 = ( ν
Pr
+
νt
Prt
)~O2 〈T 〉+ ST (3.26)
Comparing with the original Navier-Stokes equations, the turbulent nature of the
fluid flow enhances the diffusion for both momentum and temperature. In summary,
governing equations can be rewritten as Reynolds-Averaged Navier-Stokes (RANS)
equations in following forms:
〈~v〉 · ~O = 0 (3.27)
∂ 〈~v〉
∂t
+ 〈~v〉 · ~O 〈~v〉 = −1
ρ
~Op+ (ν + νt)~O2~v (3.28)
∂ 〈T 〉
∂t
+ 〈~v〉 · ~O 〈T 〉 = ( ν
Pr
+
νt
Prt
)~O2 〈T 〉+ ST (3.29)
3.2.3 k − ω Turbulence Model
The internal airflow within the respiratory system experiences laminar, transitional
and turbulent regimes. It was suggested that the flow remained laminar with an
inhalation flow rate up to 24 L/min for the human nasal cavity (Keyhani et al., 1997).
However, as the flow rate increases, the highly-folded geometry of nasal cavity, extra-
thoracic area and lung airways promote inertial disturbances and bring considerable
turbulence.
k − ω turbulence model has been widely adopted for respiratory flows because it
predicts transitional flow accurately with a low level of turbulence (Bardina et al.,
1997). The standard k − ω model (Wilcox, 1998) is a two-equation model and it
solves two additional transport equations for turbulence kinetic energy k, and for the
specific turbulence energy dissipation rate ω,
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k =
∑
i
~vi
2 ω =
ε
k
(3.30)
where ε = µt(
∂u′i
∂xj
) is the turbulence dissipation rate. The turbulent kinetic vis-
cosity νt is evaluated by:
νt = α
k
ω
(3.31)
For standard k − ω model, α = 1; while for k − ω-SST (Shear Stress Transport
k − ω) model and LRN-k − ω (Low Reynolds Number k − ω) model, α works as a
coefficient that damps the turbulence viscosity.
Two additional transport equations for k and ω are:
∂k
∂t
+ ~v · ~Ok = (ν + σkνk)~O2k + Pk −Dk (3.32)
∂ω
∂t
+ ~v · ~Oω = (ν + σwνω)~O2ω + Pω −Dω (3.33)
Where P and D represent the production and dissipation of k and ω, σk and σw
are turbulent Prandtl numbers for k and ω, respectively.
Recently, the four-equation k − ω-SST model (Menter, 1994) that was improved
from standard k−ω model has attracted considerable attention for the modelling the
airflow in respiratory airflow (Tu et al., 2012). It uses the standard k − ω model in
the inner region of the boundary layer and gradually switches to the standard k − ε
model in the outer region.
3.3 Fundamentals of Multi-Phase Modeling
3.3.1 The Eulerian - Eulerian Method
The Eulerian-Eulerian model solves two sets of conservations equations, one for each
phase. The conservation equations take the following form:
The continuity equation:
∂(αiρi)
∂t
+ ~O · (αiρi ~Ui) = 0 (3.34)
The momentum equation:
∂
∂t
(αiρi ~Ui) + ~O · [αi[ρi ~Ui ~Ui − µi(~O ~Ui + ( ~Ui)T )]] = αi(Sbuoy − ~OPi) + ~Fij (3.35)
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where, i and j are the phase denotations (i, j = a for the air phase and i, j = p
for the particle phase). α is the volume fraction αa = 1 − αp. ρ, ~U and P represent
the density, velocity and pressure, respectively.
The heat transfer within the particles and between the particulate phase and the
air phase was ignored in this study. Therefore, the energy equation was solved only
for the air phase:
∂
∂t
(αaρaHa) + ~O · [αa(ρa ~UaHa − λa~OTa)] = 0 (3.36)
where, H and λ is the enthalpy and thermal conductivity, respectively.
Sbouy is the momentum source due to buoyancy, which is defined in terms of a
reference density ref:
Sbuoy = (ρi − ρref )g (3.37)
When modelling the inter-phase forces ~Fij, the spherical particle assumption was
employed. For a spherical micron particle submerged in continuous fluid, the forces
that may be significant include the drag force ~FD, the turbulent dispersion force ~FTD
and the virtual mass force ~FVM , which are defined by Equations 3.39, 3.40 and 3.41,
respectively.
~Fap = − ~Fpa = ~FD + ~FTD + ~FVM (3.38)
~FD =
3
4
CD
dp
αpρa
∣∣∣ ~Up − ~Ua∣∣∣ ( ~Up − ~Ua) (3.39)
~FTD = −CTDρaka~Oαa (3.40)
~FVM = CVMαpρa(
d ~Up
dt
− d
~Ua
dt
) (3.41)
Although the inter-phase forces are formulated in a mechanistic way, the coeffi-
cients (e.g. CD, CTD and CVM) are generally determined empirically. For the spherical
particles of this study, the turbulent dispersion coefficient was modelled according to
(de Bertodano et al., 1994) and a constant CVM was employed for the virtual mass
coefficient (Inc, 2011). The drag coefficient CD is a function of the particle Reynolds
number Rep and was modelled using the Florin correlation (Florin, 1978), which is
valid for Rep 6 2000.
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CD =
24
Rep
(1 + 0.149Re0.687p ) (3.42)
3.3.2 Eulerian - Lagrangian Method
The Eulerian - Lagrangian model solves the same Eulerian equations for the airflow
field but use different approaches for particle transport. The Lagrangian model uses
the equation of motion to track the particle movement. The drag force ~FD, the
buoyancy force Fbuoy and the virtual mass force FVM are considered here in order to
keep the same inter-phase momentum transfer mechanisms as those considered in the
Eulerian-Eulerian model.
mp
d ~Up
dt
= ~FD + ~Fbuoy + ~FVM (3.43)
~FD =
1
2
pid2p
4
ρa
∣∣∣ ~Up − ~Ua∣∣∣ ( ~Up − ~Ua) (3.44)
~Fbuoy =
pid3p
6
(ρp − ρa)g (3.45)
~FVM =
CVM
2
pid3p
6
ρa(
d ~Up
dt
− d
~Ua
dt
) (3.46)
Being different from the Eulerian-Eulerian model, the effect of turbulent disper-
sion on particle transport is modelled in the Lagrangian model by adding an eddy
fluctuating component onto the mean air velocity. It is the fluctuating component of
the air velocity that causes the dispersion of particles in turbulent flow. Therefore,
the local air velocity is redefined by:
~Ua =
∑
i
[Ua + Φ(
2T
3
)0.5] (3.47)
where, Φ is a normally distributed random number which accounts for the ran-
domness of turbulence about a mean value, and T is the temperature.
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Chapter 4
Surface-mapping Method for
Visualising Wall Shear Stress
The main findings of this chapter have been published in:
Surface mapping for visualization of wall stresses during inhalation in a human
nasal cavity. Respiratory Physiology & Neurobiology, 190(1):54-61
Abstract:
Airflow analysis can assist in better understanding the physiology however the
human nasal cavity is an extremely complicated geometry that is difficult to visualize
in 3D space, let alone in 2D space. In this paper, an anatomically accurate 3D surface
of the nasal passages derived from CT data was unwrapped and transformed into a
2D space, into a UV-domain (where u and v are the coordinates) to allow a complete
view of the entire wrapped surface. This visualization technique allows surface flow
parameters to be analyzed with greater precision. A UV-unwrapping tool is developed
and a strategy is presented to allow deeper analysis to be performed. This includes:
1. the ability to present instant comparisons of geometry and flow variables be-
tween any number of different nasal cavity models through normalization of the
2D unwrapped surface;
2. visualization of an entire surface in one view and;
3. a planar surface that allows direct 1D and 2D analytical solutions of diffusion
of inhaled vapors and particles through the nasal walls.
This work lays a foundation for future investigations that correlates adverse and
therapeutic health responses to local inhalation of gases and particles.
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4.1 Introduction
The fluid dynamics behavior and physical interactions between the surface wall, in-
haled air and particles all occur simultaneously during inhalation. Visualization of
fluid and particle flow during inhalation can provide insight and a better understand-
ing into the physics involved in respiration. During nasal inhalation, moving air
passing over the nasal cavity walls creates a shearing of the fluid producing airflow-
induced mechano-physical stress in the form of a wall shear stress (Elad et al., 2006).
Recent WSS mapping on surface walls in hemodynamic studies have helped estab-
lish causative-effect relations in understanding morphology and risk assessments of
aneursyms (Reneman et al., 2006; Goubergrits et al., 2012). Similarly, such mappings
can assist in understanding the link between the complex nasal morphology and its
physiological functions, which contribute toward many current research fields includ-
ing nasal surgery (Rhee et al., 2011; Kim et al., 2013), particle inhalation and its
toxicology (Inthavong et al., 2009a), and physio-logical function (Elad et al., 2008;
Lee et al., 2010).
Doorly et al. (2008c) analyzed the effect of flow instability on wall shear stress
(WSS), by mapping out the WSS occurring along the perimeter of one cross-sectional
slice. The profile was taken along the cross-sectional perimeter slice which means
that WSS profile scan only be viewed along the specified slices. Using this method
would be difficult in displaying many possible WSS profiles along the perimeter of
cross-section slices to map out the entire cavity wall. An alternative is to display a
WSS contour over the 3D domain. This would allow a qualitative result that can
reveal local concentrated stresses. However the representation of 3D model results is
limited to digital media where software is needed to rotate the model to obtain the
desired view. Even under this method, not all surfaces can be viewed adequately,
with ease.
An alternative is to transform the 3D model into a 2D representation by the
UV mapping technique used in computer graphics. The letters U and V denote the
coordinate axes of the 2D plane while X, Y, Z are retained in the coordinate axes
of the 3D object. The 2D map provides an overview of the entire geometry, where
both septal and lateral wall surfaces can be plotted simultaneously - a feature that
is prohibitive in 3D models. The UV mapping is highly effective for reporting results
in 2D format, e.g. paper reports.
Furthermore, a recurring theme emerging from recent studies of nasal inhalation
(Chung and Kim, 2008; Wen et al., 2008; White et al., 2011; Zhu et al., 2011; Na et al.,
47
2012; Abouali et al., 2012) is the differences found in nasal morphology between
individuals which has been attributed to age, sex, and ethnicity (Churchill et al.,
2004). Intra-individual differences are also found between the structure of the left and
right nasal airways, as well as temporal variations caused by nasal cycling (Eccles,
1996). Recently a single representative model of the human nasal cavity was produced
by Liu et al. (2009) based on measurements of 30 sets of computed tomography
(CT) scans of nasal airways was created, while Gambaruto et al. (2012) presented
an averaged geometry using Fourier descriptors and medial axis transforms of cross-
sectional slices of three nasal cavities.
Figure 4.1: Nasal cavity geometry with sectioned slices, labeled as S1-S7. Three
cross-sections are shown taken at S2, S4, and S6.
In this study, a UV-unwrapping strategy and data management and analysis tool
is developed to allow new methods of respiratory flow analysis and direct comparisons
between different models. The UV unwrapping approach allows:
1. the ability to present instant comparisons of geometry and flow variables be-
tween any number of different nasal cavity models through normalization of the
2D unwrapped surface;
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2. visualization of an entire surface in one view and;
3. a planar surface for direct 1D and 2D analytical solutions of diffusion of inhaled
vapors and particles through the sub-nasal walls.
An executable program for data management and analysis is developed as part of
the unwrapping methodology and this is available online at http://www.cfdresearch.com/tt-
uvUnwrapping.php..This work lays a foundation for future investigations that incor-
porates toxicology and health responses to local inhalation of gases and particles by
creating additional UV-layers underneath the unwrapped surface map that represents
the sub-nasal wall layers, e.g. mucus, tissue, and blood layers.
4.2 Method
4.2.1 Computational Model
A computational fluid dynamics (CFD) model of a human nasal cavity obtained
through CT scans from a healthy 25-year old, Asia male (170 cm height, 75 kg mass)
has been created (Inthavong et al., 2011a) and for brevity the details of its model
construction and verification can be found in Inthavong et al. (2009a) and Wen et al.
(2008). Grid independence was tested and the mesh was refined in the near wall and
regions of high curvature. The nasal cavity was meshed with unstructured tetrahedral
cells (3.7 million cells, 318 MB in computational memory size) with 10 prism layers
attached on the wall using a HPxw6600 16 Gb RAM, 8 processor workstation. For
turbulent flow regimes, typically for flow rates greater than 20 L/min the maximum
y+ value was in the order of 101 (y+max = 0.48).
The computational model was divided into eight sections, by seven slices and
labeled as S1-S7 (Figure 4.1). The regions S1 and S2 are contained in the anterior
third with S2 slicing through the nasal valve region, S3-S6 are in the main nasal
passage which displays the turbinate intrusions into the airway and the well-defined
septal walls, while S7 is in the posterior third containing the airway curvature into the
nasopharynx. Two straight extension pipes, one at the inlet, and one at the outlet
were created into the geometry to satisfy a fully developed flow assumption, each
having a length of ten times its diameter.
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4.2.2 UV-unwrapping
Figure 4.2: Flow chart showing the conversion process of a 3D nasal cavity geometry
into a 2D surface representation.
The flow process of converting a 3D model to 2D surface is outlined in a flow chart
given in Figure 4.2. The data containing information regarding the 3D nasal cavity
geometry from Ansys-Fluent CFD commercial software is outputted as an ascii file
format and accessed through Matlab. The data is rearranged so that it con-forms to
the .obj file format. This allows the data to be read into an open source (Blender,
Blender Foundation) or commercial 3D modeling software (Unfold3D, Polygonal De-
sign, France). Within the software, the 3D model is unwrapped at a defined seam
based on the ISOMAP algorithm (Tenenbaum et al., 2000). The converted 2D ge-
ometry with new coordinates in the UV domain is exported back into Matlab and is
coupled with solution data obtained from CFD in the form of the flow variables and
particle deposition. A Matlab Graphical User Interface (GUI) is developed as shown
in Figure 4.3 to act as an intermediary function to couple the two separate sets of
data.
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Figure 4.3: Developed GUI of Matlab program to read in the CFD and 2D-model
geometry data. This tool is available online at http://www.cfdresearch.com/tt-
uvUnwrapping.php.
Graphically Figure 4.4 presents the flow process. First the nasal cavity is divided
into the left and right chambers. Each chamber is then unwrapped by creating a
cutting slice along the bottom of the geometry to create a common reference boundary
in which the surface coordinates can be related to. This common boundary edge is
separated by the inlet and outlet of the nasal chamber. Furthermore the selection of
the nasal floor ensures correct topology in the UV-domain for regions of overlapping
geometry such as that found in the meatus airway.
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Figure 4.4: Flow process in unwrapping the surface of a 3D model into a 2D domain.
Characteristic lines are defined at the apex of the septum wall, middle meatus, and
inferior meatus.
4.2.3 Flow Modeling and Boundary Conditions
The geometry and mesh were inputted into a commercial CFD software, Ansys-
Fluent v14.5, where the governing equations for fluid flow were modeled, to simulate
the steady flow field in nasal cavity. Inhaled air through the nasal cavity is induced by
a pressure drop between nostril and lung caused by the movement of the diaphragm.
The inlet has a pressure boundary condition set to zero-gauge pressure to mimic the
ambient surrounding environment. To simulate flow patterns of different flow rates,
the outlet was set with the required negative pressure to induce a given flow rate.
Experimental work by Hahn et al. (1993) and Kelly et al. (2000), and numerical
simulations by Keyhani et al. (1997) have suggested laminar flows up to a rate of 24
L/min. In this study, a laminar flow field was adopted for the flow rates 3-15 L/min,
and transitional SST turbulence model was chosen for flow rates 20-40 L/min. For
brevity the flow modeling equations can be found in software manual (Ansys, 2007),
and the model setup and its verification for this nasal cavity model has been reported
in Wen et al. (2008) and Inthavong et al. (2011c).
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4.3 Results and Discussion
4.3.1 Pressure Drop Comparisons
The pressure difference taken between the nostril inlet and nasal pharynx was ob-
tained at flow rates from 3 L/min to 40 L/min with the corresponding Reynolds
numbers of 527-7022, where the characteristic length is based on an averaged hy-
draulic diameter over fourteen cross-sections throughout the airway. The simulated
results of the pressure drop between the nostril inlets and the posterior nasal wall
at the nasopharynx for different inhalation rates are shown in Figure 4.5 where good
agreement with the literature is found especially at flow rates less than 20 L/min,
where a laminar flow regime is applied. By taking the square root of the pressure
drop, the flow rate and simulated CFD results can be represented by a curve fit:
√
∆P = 0.225Q+ 0.338 (4.1)
Where Q is the flow rate in L/min.
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Figure 4.5: Pressure drop in a nasal cavity model between the CFD predicted result-
sand recent experimental and numerical data in the literature. The regression linefor
the CFD predicted is represented by
√
P = 0.225Q+ 0.338, while using Equation 4.3
produces
√
P = 0.24245Q.
Since the pressure curve versus flow rate should converge at the origin (0, 0) but
does not in Equation 4.1, an alternative relationship with the airway geometry, flow
rate, and pressure drop can be applied if I first assume the following Bernoulli’s
equation:
P1
ρg
+
u21
2g
+ h1 =
P2
ρg
+
u22
2g
+ h2 (4.2)
Where ρ is the density of air and g is gravitational acceleration. Neglecting the
small difference in height, h1 and h2, the pressure drop can be recast as:
P2 − P1 = 1
2
ρ(u2 − u1) (4.3)
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Bernoulli’s principle is valid for inviscid flows only and therefore an averaged
velocity parameter is used in place of the velocity difference caused by viscosity in
the complex nasal cavity geometry. Replacing the velocity with an overall volume
flow rate with a cross-sectional area term:
∆P =
1
2
ρ
Q2
A2ave
(4.4)
Where Q is the flow rate, the unit of which is normally given in the literature as
L/min, Aave is the averaged cross-sectional area. However since the units of velocity
(m/s) are different to the flow rate units, then a conversion factor of 1/(36.0 × 104)
reflects the change in dimensions is used. Then taking the square root of the function,
the equation becomes:
√
∆P =
1
Aave(6.0× 104)
√
1
2
ρQ = kQ (4.5)
k can be treated as a constant equal to 1
Aave
(6.0 × 104)
√
1
2
ρ. Since the cross-
sectional area varies throughout the flow domain, an averaged value is calculated by
taking fourteen slices perpendicular to the curved airway (additional slices distributed
in between each of the slices S1-S7 shown in Figure 4.1). Integration of each slice over
each interval distance is performed and then averaged, resulting in Aave = 5.38×10−5
m2. The constant k from Equation 4.4 is then equal to 0.24245, which is the gradient
of the curve fit to predict the pressure drop.
One limitation of Equation 4.4 is that it is in the form P ∝ Qb, where b is a power
of 2 while experimental studies in the literature have reported values of 1.76-1.87 for
adults (Garcia et al., 2009), and 1.91 for infants (Golshahi et al., 2010). Another
limitation of Equation 4.4 is that most data in Figure 4.5 come from CFD studies.
In-vivo, wall compliance may result in a pressure-flow relationship that departs from
the P ∝ Qb proportionality predicted by Equation 4.4.
4.3.2 Visualization and Geometry Normalization for Nasal
Cavity
In 3D space the nasal cavity can be portrayed from one perspective view only. This
limits the ability to inspect specific regions that may not lay on the same surface.
Specifically, Figure 4.6 demonstrates the ability of the UV-unwrapping to define four
specific locations, namely A, B, C, and D with one view in 2D space rather than four
views required in 3D space.
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Figure 4.6: Identification of four specific locations, A, B, C, D located on nasal cavity
1 (NC01 model) that can be viewed simultaneously in 2D space, but requires four
different perspective views in 3D space.
A single view of the entire surface allows direct comparisons left and right cham-
bers and also local regions of any fluid flow variables or particle deposition patterns
that occur on the surface. While this can be achieved in 3D space, rotation, and
surface transparency or culling is needed to visualize regions that are hidden behind
anatomical structures, such as the meatus passage.
The UV-unwrapping allows direct comparisons between the left and right cham-
bers of the nasal cavity which exhibit geometry differences due to nasal cycling, mucus
secretion, and other physiological response to the external environment. Further vari-
ations can be found between individual nasal cavity geometries due to sex, race, and
age. For direct comparisons to be made in this case, the UV-unwrapped surface needs
to be normalized in its U and V coordinates. Figure 4.7 shows two nasal cavities,
namely NC01 [nasal cavity 1 found in Wen et al. (2008)] and NC02 [nasal cavity 2
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found in Ge et al. (2012)] which exhibit geometric differences. Three characteristic
lines, serving as visual markers, are created based on the ceiling of the meatus bound-
aries. These lines are the medial nasal septum line that separates the septum and the
lateral sides; the middle meatus which is the middle line and is the shortest, and; the
inferior meatus which is closest to the floor of the main nasal passage, and hence its
position close to the cutting slice shown in Figure 4.4.
Figure 4.7: Normalization of the coordinates U and V of the two different nasal
cavities (NC01 and NC02) that have been unwrapped. Three characteristic lines,
medial nasal septum, middle meatus, and inferior meatus serving as visual markers
are shown in (a) nasal cavity 1 (NC01) model.
From the unwrapped surfaces some of the differences include the nostril shape,
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turbinate intrusions, and nasopharynx curvature. Normalization of the U and V
coordinate produces a map that shares the same extents between the two inherently
different geometries. The normalized UV map shows that the middle meatus in NC01
is closer to the medial nasal septum line while the NC02 model shows a more even
distance between the three characteristic lines. The normalized UV map provides
a means direct comparisons between individual nasal cavity geometries and also for
identifying persistent flow features despite differences in geometries.
4.3.3 Applications of UV-unwrapped Surface
4.3.3.1 Pressure Distribution Mapping
The results from a flow rate of 10 L/min are presented to reflect typical flow behavior
and patterns arising from a low inhalation or breathing rate. Figure 4.8 shows the
pressure contour on the nasal cavity walls of the right and left chambers in 3D and
in the UV-domain. In general, the pressure distribution decrease smoothly along
the nasal cavity from nostril to nasal pharynx. The rate of decrease differs between
each chamber due to the differing asymmetrical geometries caused by the nasal cycle.
During CT scanning one nasal chamber is usually more patent than the other as a
result of congestion (swelling) of the erectile tissue (cavernous tissues of the mucosa)
while at the same time decongestion (shrinking) occurs to the erectile tissue in the
other chamber (Eccles, 1996). The pressure distribution is then influenced by the
resistance caused by the geometry of each chamber.
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Figure 4.8: Surface pressure distribution mapping from a 3D model to the 2D UV-
plane for an inspiratory flow rate 10 L/min. Ppeak= 5 Pa. The three red lines running
in the axial direction are the characteristic lines defined in Figure 4.6. Local regions
labeled as ‘A’ and ‘B’ are local minimum or low pressure that is surrounded by higher
pressure values.
The differences in geometry between the left and right nasal chambers can be seen
from the UV-domain where there is higher pressure in the region between nostril and
slice S4 in the left chamber. For each chamber, the high-pressure regions are found
at the upper regions of S1 and S2 which is due to the air flow velocity turning from
a vertical to horizontal direction.
The nasal valve region is the region that contains the minimum cross-sectional area
where the flow accelerates through a converging passageway before decelerating as the
flow diverges outwards. This flow phenomenon is characterized by an acceleration in
the inhaled air as the passageway narrows, before deceleration through the increase
in the cross-sectional area of the passageway. Correspondingly the pressure prior to
the minimum cross-sectional area must exhibit a negative pressure gradient, leading
to a local mini-mum pressure as the flow accelerates, and then produce a positive
pressure gradient leading to an increase in the pressure again as the flow decelerates.
This region is labeled as ‘A’ which can be seen in the vicinity of the S2 slice line where
a local minimum or lower pressure is found surrounded by higher pressure values. As
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the flow enters the turbinate region, the surface walls caused by the indentation of
the middle turbinates cannot be typically visualized in 3D since it is sheltered from
view. These surface walls in the UV-domain are labeled as ‘B’, which is the region
between the inferior and middle meatus characteristic lines. After the S4 slice the flow
begins to recover from the divergence in spatial volume in the main nasal passage.
The pressure becomes more uniform just prior to the inhaled air from both left and
right chambers merge at S6.
4.3.3.2 WSS Distribution Mapping
Perimeter WSS profiles in the middle turbinate region at the S4 slice are shown for
the right and left chamber in Figure 4.9a and b respectively. The bulk fluid flow
remains close to the septal wall and splits into two local regions - one superiorly
located near the meatus bifurcation, and one inferiorly located near the floor of the
nasal passage. Local WSS peaks in the perimeter profile, correlate with the flow field
and is a good indicator of the bulk flow distribution. The perimeter profile technique
provides highly detailed WSS distribution over the surface of a cross-section, but
requires a substantial number of slices to capture the entire 3D domain.
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Figure 4.9: Velocity magnitude contour map for an inspiratory flow rate 10 L/min
on the cross-section slice S4 and its circumferential WSS profile for the (a) right
chamber rand (b) left chamber. (c) UV mapping technique to display the shear stress
distribution mapping from a 3D model to the 2D-plane.
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The WSS distribution in 3D and its conversion into the UV-space is given in Figure
4.9c. Using this technique, the entire wall surface can be displayed in one image. In
the literature, maximum shear stresses have been found in the range of 0.2 Pa (Elad
et al., 1993) on the septal wall across the inferior turbinate at a peak inspiration of20
L/min. Comparatively, the stresses in uniform regions of large arteries are in the
range of 1.5-2 Pa (Nucci et al., 2003). Under a flow rate of 10 L/min local peaks of
approximately 0.3 Pa are found in the region between the middle meatus and lateral
wall in both chambers. Interestingly other local peaks are found only in the anterior
region of each chamber, e.g. region before S4. In particular, high shear stresses are
found on slices 1 and 2 on both the lateral and septal sides. This suggests the inhaled
air disperses laterally and shears across the side walls of each chamber as it enters
the nasal vestibule. As shear stresses are linearly related to the local velocity, these
values significantly increase as breathing efforts increase. High shear stresses that are
concentrated locally may also cause irritation of the blood vessels within that area.
Figure 4.10: Local peaks, identified with the red arrows, are found near slice S4. The
three red lines running in the axial direction are the characteristic lines defined in
Figure 4.4.
Using the UV-domain, the WSS can be visualized with 3D peaks to highlight
the distribution over the surface wall. This visualization is shown in Figure 4.10
62
where along each of the three characteristic lines (red lines), the WSS was found to
be close to zero. These lines are located at the roof of each of the inferior, middle
meatus and the main nasal passages where very low flows exist. The surrounding
WSS distribution around this near zero region is also void of many high WSS regions
which suggests that the inhaled air passing through the middle section of the nasal
airway is smoother and stable than that occurring in the anterior half of the nasal
chambers. By mapping out the distribution of the stresses on the nasal cavity walls,
insight into the mechanoreceptor response can be predicted.
4.4 Conclusion
A nasal cavity model in 3D space was transformed into a 2D space, namely the
UV-domain. Using this visualization technique, flow parameters along the surface
wall that is typically difficult to visualize and analyze can be presented to provide
a deeper in sight into the physiological mechanisms involved with respiratory air-
flows. The pressure distribution was mapped onto the UV-domain which showed a
higher resistance in the anterior regions of the left nasal chamber, suggesting that the
geometry is susceptible to impediment to flow. This may be in the form of a more
narrowed geometry, high curvatures or regions leading to flow separation. Wall shear
stresses, which lead to mechano-physical responses in the epithelium surfaces, are
mapped which revealed the most vulnerable regions in the form of peaks occurring
in the anterior nasal chambers and at the entrance of the middle meatus passageway.
This mapping technique allows precise predictions of local regions that are disposed to
high shearing which is not possible in 3D. The visualization technique presented can be
used to make direct comparisons for different shaped geometries by normalizing each
UV-mapped geometry. Extension to multiple models can be per-formed following the
flow process presented in the methodology. In this study, a visualization technique
is presented that takes a 3Dwrapped surface and maps it onto a 2D UV-domain,
which extends the current CFD technology and capability in visualizing the fluid flow
dynamics and particle deposition patterns.
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Chapter 5
Analysis of Particle Deposition
Patterns in Human Nasal Cavity
The main findings of this chapter have been published in:
• Detailed micro-particle deposition patterns in the human nasal cavity influenced
by the breathing zone. Computers & Fluids, 114:141-150
• Transport and deposition of welding fume agglomerates in a realistic human
nasal airway. The Annals of Occupational Hygiene, 60(6):731-47
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5.1 The Influence of the Breathing zone on Micro-
particle Deposition in Human Nasal Cavity
Abstract:
The breathing region connects the nasal cavity with the outside environmental
air where flow is accelerated through the nostrils. Particles introduced into the nasal
cavity without considering the breathing region neglect the influence of facial features
and realistic boundary conditions at the nostrils. In this study, a new nasal cavity
model is reconstructed combining facial features and an ambient environment focus-
ing on the breathing region. The inhaled air from outside the nose is investigated
and compared with a model that consists of the nasal cavity alone. An improved
2D surface mapping technique is applied to the 3D nasal cavity to visualize the par-
ticle deposition patterns onto a planar geometry. Using this technique, deposition
of micron particles from 0.4 µm to 30 µm were investigated, and trajectories of 2.5
µm, 10 µm and 20 µm were compared with the ‘nasal-only’ case. Particle deposition
efficiency curves and particle trajectories are plotted to show that the inclusion of the
external nose and breathing region causes:
1. a change in the fluid flow within the anterior nasal cavity half but the flow
patterns regulate in the posterior half;
2. minimal difference for 2.5 µm particle deposition patterns;
3. significant differences in 10 and 20 µm particle deposition patterns where more
particles are deposited in the posterior nasal regions.
5.1.1 Introduction
The human nasal cavity plays an important role in respiration due to its three ma-
jor physiological functions: air-conditioning, filtering and olfaction. The inhaled air
flow behavior in the nasal cavity can be investigated by reconstructing the airway
from computed tomography (CT), magnetic resonance imaging (MRI), or in-vitro by
plastination of cadavers. Experimental studies of airflow behavior have been per-
formed using particle image velocimetry (PIV) (Kelly et al., 2000; Chung and Kim,
2008), or by dye injection into the flow stream (Croce et al., 2006; Doorly et al.,
2008c). However, due to the complex geometry, and perturbation introduced by ex-
perimental equipment, direct measurements inside cast models are difficult (Doorly
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et al., 2008a). When considering particle inhalation, this problem becomes further
compounded.
Computational Fluid Dynamics (CFD) analysis of nasal function have been inves-
tigated since the pioneering work by Keyhani et al. (1997). Since then computational
studies have investigated its anatomical form, airflow patterns, and fluid-particle in-
teractions to gain a better understanding of: respiration function (Horschler et al.,
2003; Wen et al., 2008; Inthavong et al., 2009b; Horschler et al., 2010); air-conditioning
(Garcia et al., 2007; Elad et al., 2008); and surgical implications (Zhao et al., 2006b;
Chen et al., 2010; Moghadas et al., 2011; Abouali et al., 2012; Na et al., 2012). When
a secondary particle phase is introduced, inhaled particles coupled to the airflow field,
allow studies of nasal drug delivery (Cheng et al., 2001; Inthavong et al., 2006; Kim-
bell et al., 2007; Inthavong et al., 2011c; Fung et al., 2012); and inhalation toxicology
(Frederick et al., 2001; Kimbell, 2006; Tian et al., 2007) or general particle deposition
studies (Inthavong et al., 2008b; Karakosta et al., 2015). The work by Wang et al.
(2009) indicated deposition efficiency for 22 µm particles in the nasal cavity reached
100% for light breathing and revealed deposition hot spots for micron-particles. Sim-
ilarly, Shi et al. (2007) and Shanley et al. (2008) produced high deposition for 20 µm
particles at a flow rate of 7.5 L/min; all collecting in the anterior nasal cavity.
Within these studies a lacking feature is the omission of the external nose and
facial features. This simplification influences the airflow patterns significantly in
the breathing zone, outside the nasal cavity (Kennedy and Hinds, 2002; Anthony and
Flynn, 2006b; Anthony, 2010). The exclusion of the outer environment means that an
artificial and representative boundary condition the nostril inlet is applied. Recently
Taylor et al. (2010) investigated airflow in the nasal cavity by comparing different in-
flow boundary conditions (flat, parabolic and using an external face) and showed that
regional wall shear stress and olfactory flux are sensitive to inflow boundary profiles
by up to 100%. Later, studies by Zhu et al. (2011) and Lu et al. (2014a) compared
nasal airway flow patterns for three and ten computational models, respectively, that
included the external nose and face. However, these two studies did not consider
particle inhalation.
Since airborne particles are transported by the fluid phase, the effects caused by
facial features on particle deposition in the respiratory system should be considered.
Studies by Se et al. (2010b) and Inthavong et al. (2013a) investigated the inhalability
of particles via a realistic human head and indicated velocity vectors were directed
slightly upwards towards the nostril opening, leading to a lower critical area for small
particles and a higher critical area for heavy particles. Li et al. (2012) included a nasal
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cavity model inside a simplified standing mannequin and placed in a large room. Their
results showed the airflow field in the breathing zone exhibited high acceleration and
particle track profiles at the nostril openings were not uniformly distributed, which
is typically the case when the external environment is omitted.
In this study, I investigate the influence of the external nose and face on fluid and
particle dynamics during inhalation. A new computational nasal model connected
with realistic facial features was generated from CT scans and reconstructed carefully
via image processing software. The airflow field was simulated by CFD from the
external environment into the nasal cavity through to the nasopharynx. These results
were compared with results obtained from the same nasal cavity model but without
the external facial features and environment. Instead of an entire large room I focus
on the breathing region reduce computational costs and increasing the resolution of
the flow field in the breathing region. To identify and compare the precise particle
deposition position, a mapping technique to convert the 3D nasal cavity onto a 2D-
plane is presented. Particles with sizes from 0.4 µm to 30µm were investigated and
representative sizes (2.5 µm, 10 µm, and 20 µm representing PM2.5, PM10 and larger
ambient particles respectively) were tracked and its deposition positions in the nasal
cavity plotted for both models.
5.1.2 Method
5.1.2.1 Computational Geometry
An integrated human respiratory model including a nasal cavity and head was recon-
structed from computed tomography (CT) images of an Asian male and labelled as
‘NC03’. CT images (dimension: 512 × 512 × 512 with pixel size 0.5 mm) were seg-
mented semi-automatically using the medical image-processing software Materialise-
Mimics to extract a 3D volume. This was refined manually, by excluding noise and
repairing unrealistic regions. Further step-like surface regions were improved and
smoothed using the 3D modelling software Geomagic Studio. For simplicity, open-
ings to sinuses were omitted as their impact to air flow pattern and micron particle
deposition were negligible (Ge et al., 2012). The facial details were retained while
the back of the head was omitted. An artificial straight pipe extension of 5 cm was
attached to the nasopharynx to allow a more realistic boundary condition at the out-
let. The surrounding ambient air was modelled with a simple cubic volume having
dimensions of 15 cm-width, 12 cm-height and 20 cm-depth shown in the isometric
view in Figure 5.1.
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Figure 5.1: Computational model of the nasal cavity, combined with detailed facial
features and the external domain. (a) Frontal view of the whole model with an
artificial extension attached at the nasopharynx for the outlet. (b) Isometric view of
the computational domain. (c) Thirteen cross sections along the main flow path and
shapes of posterior nasal valve, turbinate and choanae regions labelled as C-C’, G-G’
and J-J’.
Thirteen cross sections (from A-A’ to M-M’) were created along the main flow path
of the nasal cavity geometry. The main passages are bounded by three bony folds
(inferior/middle/superior turbinate), beneath which narrow airway passages called
the meatuses are located. They expand from C-C’ located posterior to the nasal
valve, and finally merge together in the choanae labelled as J-J’. The narrow main
passage is represented by cross-section G-G’.
5.1.2.2 Mesh Generation
The nasal cavity geometries were imported to ICEM-CFD to generate the mesh.
Inside the nasal cavity domain, a mesh grid of 7.5 million unstructured tetrahedral
cells was created with mesh size of 0.5 mm. For the ambient air in front of the face, 2.0
million tetrahedral cells with the mesh size of 4 mm were first generated. Around the
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breathing zone 4 mm away from the tip of nostrils where air was accelerated rapidly,
the mesh grid size was further refined to 2 mm (Figure 5.2). Twenty prism layers
adjacent to the nasal wall with total height of 0.2 mm were generated to improve the
boundary layer resolution. Considering the narrowed meatuses and turbinate passages
(somewhere approximately 1 mm), the mesh was further refined to guarantee sufficient
resolution of the airflow field in the narrowest region. The entire mesh required
approximately 1 GB of RAM and 10 h to converge (below 10−7 for residuals) when
running in the Ansys Fluent 14.5 in parallel on two 2.53 GHz quad core processors. A
mesh independence test was performed prior against lower resolution meshed models,
by investigating velocity profiles at a number of locations inside and outside the nasal
cavity, and by comparing the particle deposition efficiency on the nasal cavity wall.
Figure 5.2: Computational mesh of the ‘with-face’ model. (a) mesh of the external
domain with a base mesh size of 4 mm and refinements in the breathing region with
mesh size of 2 mm and (b) relative mesh of the external domain with inside the nasal
cavity that has a mesh size of 0.5 mm.
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5.1.2.3 Surface Mapping Technique
Visualising particle deposition on the intricate nasal cavity wall in 3D is difficult
because of the high curvature and overlapping surfaces. A surface mapping technique
projecting the nasal cavity surfaces from 3D space to 2D space was developed. This
was based on the ISOMAP algorithm (Tenenbaum et al., 2000) and is coupled with
sub-programs written in Matlab 2013b (Inthavong et al., 2014). The nasal cavity was
divided into left and right chambers, and cut along the bottom of each chamber to
guarantee correct topology. It was further separated into smaller anatomical regions
of interest by characteristic curves. In this study, I improve the surface mapping
technique presented by Inthavong et al. (2014) with new sub-regions shown in Figure
5.3. The new mapping is achieved through the following steps:
1. Separate each chamber into the vestibule (region-1), the main passage (region-2
to region-10) and the nasopharynx (region-11) by cutting along the two cross
sections at C-C’ and J-J’.
2. Divide the main passage region into lateral part and septal regions (region-3)
by curves located at the top of the geometry.
3. Further separating the lateral region into 8 sub-regions: atrium, olfactory, su-
perior/middle/inferior turbinate and superior/middle/inferior meatus, to dis-
tinguish particle deposition positions on the nasal walls.
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Figure 5.3: (a) Top view of the nasal cavity labelled and colour coded with the region
numbers b) Lateral view of the nasal cavity. Dashed lines located at the top of cavity
are constrained lines that become the horizontal lines in the 2D mapping, while the
other constrained lines are located at the posterior nasal valves and the choanae which
become the vertical lines in the 2D mapping. (c) the 2D mapped model sub-divided
into eleven regions according to the anatomy.
Among the separated regions, the olfactory region situated at the top of the nasal
cavity is highly sensitive to toxic particle deposition due to its direct access to the
brain (Si et al., 2013). Figure 5.3c shows the mapped domain normalized to an
orthogonal 2D-space. For each chamber, a characteristic curve at the top of the
geometry (dashed line in Figure 5.3) was constrained horizontally, while the cross-
section curves extracted from C-C’ and J-J’ were constrained vertically enforcing an
orthogonal domain for direct comparison between the two chambers and different
models. High curvature regions such as the meatus (region 6, 8, 10) situated on
opposing lateral sides of the nasal cavity were compressed during the mapping process.
By using this improved normalization method, a direct comparison between left and
right chambers can be analyzed.
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5.1.2.4 Fluid Flow Boundary Conditions
This study assumes stagnant air and also neglects the human body thermal plume.
The air flow is modelled by using the steady, laminar, incompressible and isothermal
Navier-Stokes equations.
The continuity equation is:
∂ui
∂xi
= 0 (5.1)
The momentum equation is:
ρgui
∂ui
∂xi
= − ∂p
∂xi
+
∂
∂xj
(µ
∂ui
∂xj
) (5.2)
where u and p are the air velocity and the air pressure, respectively. The air
density is dropped out of the continuity equation due to the incompressible fluid
assumption. A laminar airflow representing light breathing was used following Hahn
et al. (1993) and Kelly et al. (2000)’s experimental work, and Keyhani et al. (1997)’s
simulation which suggested laminar flows up to a rate of 24 L/min.
Second-order schemes were used to approximate the momentum equation while
the pressure-velocity coupling was handled through the SIMPLE method. To ini-
tiate inhalation, a pressure difference is created between the lung and the ambient
environment. The boundaries of the external domain in front of the face were set to
constant zero pressure to represent atmosphere pressure, while the extension outlet
was set to a negative pressure outlet. The settings allowed air to flow from the ex-
ternal environment into the nasal cavity at a constant flow rate of 10 L/min and 15
L/min representing a light breathing condition. For the ‘nasal-only’ case without the
external domain, the pressure inlets were located at truncated planes at the nostrils
(A-A’).
5.1.2.5 Particle Tracks Simulation
Particles with sizes from 0.4 µm to 30 µm representing micronsized pollutants were
released uniformly through the external domain in front of the face shown in Figure
5.4. For each particle size 1 × 105 aerodynamic particles with zero velocity were
introduced. For the ‘nasal-only’ model, 1 × 105 particles were released uniformly
on the nostrils at cross-section A-A’. Each individual particle was tracked using a
Lagrangian approach with one-way fluid phase coupling and thus the particles are
assumed to be a dilute disperse phase. The particle tracking was terminated when a
particle either reached the nasal cavity wall, whereby it was assumed to deposit, or
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escaped through the computational domain via the extension of the nasal pharynx.
The deposition efficiency (DE) in the nasal cavity was defined by:
DE =
ND
NI
× 100% (5.3)
where ND is the number of particles depositing in the nasal cavity wall, and NI
is the number of particles inhaled into the nasal cavity.
The gravity and drag force were considered in transporting the particles and its
force balance equation is given as:
dup
dt
= FD(ug − up) + (ρp − ρg)g
ρp
(5.4)
The drag force FD, is dependent on the drag coefficient based on Morsi and Alexan-
der (1972) defined by:
CD = a1 +
a2
Rep
+
a3
Re2p
(5.5)
where the a1, a2 and a3 are empirical constants for smooth spherical particle over
several ranges of droplet Reynolds number. Gravitational settling is given by g and
the density term ρ, disappears when the particle density is much larger than the fluid
in this study (e.g.,ρp  ρg).
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Figure 5.4: Representation of discrete particle release locations for the ‘with-face’
model. 105 particles were released throughout the external domain uniformly.
5.1.3 Results and Discussion
5.1.3.1 Geometry Model and Pressure Drop Comparison
Figure 5.5 and Table 5.1 compares the cross-sectional areas from the nasal cavity
model used in this study (labelled NC03) with other models in the literature. The
cross-sectional area is taken normal to the air flow path along the x-axis from the
nostril tip through to the nasopharynx. From the anterior tip, it decreases to a min-
imum at the nasal valve, labelled ‘B’, then increases to a maximum at the turbinate
region, labelled ‘G’. The cross sectional area decreases again until the two chambers
merge at the choanae region labelled as ‘J’.
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Table 5.1: Comparison of nasal cavity geometry dimensions from the NC03 model
used in this study with those in the literature.
In the region between cross sections ‘C’ and ‘J’, the cross-sectional areas of the
left cavity are larger than those of the right cavity (Figure 5.1c), resulting in a larger
volume (Table 5.1). Other reported data show similar CSA profiles while their total
lengths are 1-2 cm longer than that of NC03.
Figure 5.5: Cross-sectional area variation with x-axis representing the distance be-
tween the tip of nostril and centroids of cross-sections.
Inhaled air flowing through the nasal cavity is driven by a pressure difference
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induced from the negative pressure in the lungs during the expansion stage of respi-
ration. The pressure difference within the nasal cavity itself is then used as a measure
of flow resistance based on the nasal geometry. For flow rates up to 15 L/min, a lami-
nar flow model was applied. Furthermore, to be consistent with existing experimental
and computational results data, the truncated ‘nasal-only’ model was used for the
comparison. Figure 5.6 shows the pressure drop between nostril inlets and the outlet
at the nasopharynx (excluding the artificial extension) for inhalation rates up to 15
L/min. At these flow rates, the corresponding range of Reynolds number at nostrils
is from 0 to 1090. The pressure drop increases in a near-linear profile, and lies within
range of the reported experimental and numerical data.
Figure 5.6: Pressure drop against flow rates (from 0 to 15 L/min) compared with
reported data from Kelly et al. (2004a), Schroeter et al. (2011), Wen et al. (2008),
and Ge et al. (2012).
5.1.3.2 Airflow Pattern
Two velocity magnitude iso-surfaces in the ambient air are shown in Figure 5.7 to
determine the breathing zone caused by an inhalation rate of 15 L/min. At the
nostrils, a ‘nostril-inlet velocity’ is found, which is 0.3 m/s in this case and highlighted
as a red iso-surface. The breathing zone in this study is defined by a velocity iso-
surface that is 10% of the ‘nostril-inlet velocity’, colored by blue surface indicating
a velocity of 0.03 m/s. This is a semi-ellipsoidal region that is approximately 2.5
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cm horizontal and 5 cm vertical to the nose. To better visualize this fluid behavior,
additional streamlines that enter the nostrils are shown along with the breathing
zone in Figure 5.7b. These airflow patterns suggest that particles released far from
the face have to behave like tracer-gases (e.g. <2.5 µm) to follow the fluid streamlines
for particle inhalation to occur. Heavier particles (e.g. >10 µm) will be influenced
by gravitational settling and must be released above the nostrils or within vicinity of
the nostrils, otherwise it is unlikely to be inhaled against gravitational forces.
Figure 5.7: Visualization of fluid velocities (a) by two iso-surfaces indicating the
‘critical velocity’ 0.3 m/s and the boundary of the breathing zone (0.03 m/s) in the
front view; (b) by flow streamlines coupled with iso-surface contours.
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Figure 5.8: Airflow pattern development through the nasal cavity, visualized by axial
velocity contours on five cross sections. (a) Results for ‘with-face’ model and its
comparisons with (b) ‘nasal-only’ model. Comparisons can also be made between left
and right nasal chambers, and between each slice. Local vortices are found by drawing
streamlines of tangential secondary airflow velocities (e.g. v and w velocities).
After inhalation, the flow character changes from a free shear flow to a wall-
bounded flow with irregular walls. Velocity contours of axial velocity, and cross-flow
streamlines, on five cross-sections A-A’, C-C’, E-E’, G-G’ and J-J’ (Figure 5.8) are
shown to highlight the airflow distribution and its development through the nasal
cavity. All cross-section views are presented in proportional size to allow direct com-
parison between sections, and are viewed from the anterior perspective - therefore the
left chamber is depicted on the right-hand side.
For both cases, peak flow velocities are higher in the left chamber which is con-
sistent with its chamber size exhibiting a larger volume than the right (from Figure
5.5). On cross section A-A’, two small vortices (larger in the left chamber) are formed
because of flow separation at the nostril inlets, which is found with the inclusion of
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the external nose, and face. The main flow path is indicated by the bulk flow and
higher velocities in the middle of the cross sections. As the fluid passes through the
nasal chambers, the influence from the walls contribute towards a boundary layer
development and the larger cross-section at C-C’ shows a low flow region at the top
of the cross-section. The vortices in left chamber moves to the middle and bottom
region while the vortices in right chamber dissipate. In contrast, on the ‘nasal-only’
model the main flow path is biased towards the bottom of the cross-section with a
linear variation from top to bottom and no vortices are present in the cross section
A-A’. At cross-section C-C’ the fluid distribution conforms to a plug flow in the left
chamber with a notable inner core flow region.
The airway passage becomes thinner at cross-section E-E’ and this allows the
viscous effects from the near walls to dominate the flow, diffusing the flow distribution.
The flow behavior for both models become similar and gradually becomes nearly
identical at cross section G-G’. In the choanae region J-J’, the two chambers merge
and the fluid from both chambers converge as two jets mixing together. This produces
two large vortices near the bottom of the cross-section. One difference is an additional
small vortex found in the ‘nasal-only’ model at the top left region. Overall the
influence of the external environment and facial features disturbs the flow up until
cross-section E-E’ where the narrowed passageways allow the viscous effects to diffuse
any flow differences between the two models. Beyond the E-E’ cross-section, the flow
distribution becomes similar.
The difference between the two cases are subject to the airflow conditions occurring
at the nostril inlets. The comparison indicates, that inclusion of the external nose and
a breathing zone significantly influences the airflow as far as cross section E-E’, before
the surrounding walls diffuse the variations. Gaining insight into the flow behaviour
can help to understand particle transport properties to:
• predict inhaled particle deposition sites in the nasal cavity;
• determine which regions of the nasal cavity influences the particle deposition
patterns; and
• predict the effects of biased flow rates between the two chambers on different
heavier/ lighter particle transport and; predict whether recirculation regions,
which are caused by the low flow region at C-C’, have any influence on particle
deposition especially on the olfactory sensors.
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5.1.3.3 Verification for Particle Simulation
To verify the particle tracking in the outside space, the aspiration ratio(AR) against
particle size is simulated and compared with Hsu and Swift (1999)’s experimental
result and Naseri et al. (2014)’s numerical result. Hsu and Swift (1999) work showed
that breathing condition do not affect the aspiration ratio significantly, hence the
flow rate in this validation is fixed to 15 L/min. For this verification case, 1 million
particles with the density identical to those in the experiment are released from the
top surface (e.g. the ceiling) of the outside space. The AR is defined as:
AR =
AcVc
AnVn
(5.6)
where Ac is the ‘critical area’ in the top surface and An is the total area of nostrils.
Vc is the settling velocity of the particle Vsettling = ρpd
2
pg/18µf and Vn is the average
velocity on nostrils. Figure 5.9 indicates the numerical results in this study are in
good agreement with both reported data for particles smaller than 40 µm and matches
Naseri et al. (2014) data for particles larger than 40 µm.
Figure 5.9: Aspiration ratio against particle size comparison between numerical re-
sults and reported experimental data by Hsu and Swift (1999) and numerical data
by Naseri et al. (2014).
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For micron sized particles, its deposition can be approximately predicted by the
inertial parameter, I which considers the particle mass to the square power, and the
averaged fluid momentum. The inertial parameter is defined as:
I = d2Q (5.7)
where Q is the volume flow rate (cm3/s) and d (µm) is the aerodynamic diameter.
The deposition efficiencies of particles ranging from 0.4 µm to 30 µm as a function
of inertial parameter are shown in Figure 5.10. For consistency with the reported
experimental and numerical data, particles were released uniformly from the nostrils
using the ‘nasal-only’ model. For inertial parameter less than 104, the numerical
result shows good agreement with Kelly et al. (2004a) (SLA, VIPER) and Schroeter
et al. (2011) (Model A, B, C), and lower than Hsu and Chuang (2012). While for
inertial parameter larger than 104, the numerical result matches Hsu and Chuang
(2012) result more. When comparing with Schroeter et al. (2011) three models of
different surface roughness, the deposition efficiency of NC03 is higher than that of
the smoothest model C, but lower than that of the roughest model A, and fits that
of the model B the best. Considering variation among different nasal cavities, the
numerical result of particle deposition efficiency is within range with reported data.
81
Figure 5.10: Micro particle deposition efficiency comparison between numerical results
and reported experimental data by Hsu and Chuang (2012), Kelly et al. (2004a), and
Schroeter et al. (2011)
5.1.3.4 Particle Behavior Influenced by Different Flow Rate
Despite the inertial parameter, the structure of the breathing zone and the gravity
also have influence on particle behavior. To reveal these two effects on particles,
particle tracks in the outside space and deposition efficiency in the nasal cavity under
two flow rates 15 L/min and 10 L/min are investigated with three particle types
representing low, medium and high inertia (I = 1.6 × 103, 2.5 × 104 and 1.0 × 105).
It’s corresponding particle sizes are 2.5 µm, 10 µm and 20 µm for flow rate 15 L/min,
and 3.06 µm, 12.25 µm and 24.5 µm for a flow rate of 10 L/min (Figure 5.11 and
Figure 5.12).
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Figure 5.11: Breathing zone structure and particle tracks with inertial parameter
I = 1.6e+3, 2.5e+4 and 1e+5 representing low, medium and high inertial types,
respectively, in the outside space (a) Flow rate = 10 L/min, particle size = 3.06 µm,
12.25 µm and 24.5 µm (b) Flow rate = 15 L/min, particle size = 2.5 µm, 10 µm and
20 µm.
A similar breathing zone is found for the two flow rates (Figure 5.11) where the
region extends to 2.34 cm horizontal to the nose tip. The three low, medium, and
high inertial particles were released from location ‘O’ for both flow rates. Similar tra-
jectories for the low and medium inertial particles were found between the two flow
rates. There was a greater difference in the trajectory of the high inertial particle,
caused by the relatively increased influence of gravity. After inhalation the particle
deposition efficiencies (Figure 5.12) indicate that both flow rates produce similar de-
position except for the medium inertial particle (I = 2.5×104), which had a difference
of 8.6%.
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Figure 5.12: Low, medium and high inertial particle deposition efficiency in the nasal
cavity under flow rate 10 L/min and 15 L/min.
5.1.3.5 Particle Deposition at a Flow Rate of 15 L/min
Local particle deposition patterns for 2.5 µm, 10 µm and 20 µm particles representing
PM2.5, PM10 and larger ambient particles respectively, are presented in both 3D
transparent models and mapped 2D domains in Figure 5.13(b-d). The mapping
division for the nasal cavity is shown again in Figure 5.13a as reference. For each
case, the particle deposition in the left chamber is higher than in the right chamber,
caused by the increased flow rate, thereby a higher inertial parameter in left chamber.
In general, there are three highly localized deposition hot spots. Two of these regions
are located at:
• top of vestibule and;
• at the nasal pharynx region.
These locations are downstream of 90-degree bends (from the nostril into the main
nasal passage, and the nasopharynx bend in the posterior nasal cavity) (Wang et al.,
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2009) where the higher inertial particles with reduced particle response times, are
unable turn and follow the curved flow streamlines. The third hot spot is located
at the common boundary of the middle turbinate and the middle meatus (region-8),
as large amount of particles directly impact into it soon after being inhaled into the
nasal cavity.
Figure 5.13: Comparisons of particle depositions in the 3D transparent image and on
the normalized 2D surface-mapped domain. (a) mapping division for the nasal cavity.
(b-d) Deposition patterns in 3D transparent models and in mapped 2D domains for
particle sizes of 2.5 µm, 10 µm and 20 µm respectively.
For 2.5 µm, deposition pattern tends to disperse through the whole nasal cavity.
The only difference between the two modelling cases is that particles are more con-
centrated at the top of vestibule and left olfactory region for the ‘with-face’ model. As
the particle size becomes larger to 10 µm, fewer particles deposit in vestibule region
for the ‘with-face’ model and this is compensated with an increase in deposition in
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the posterior nasal regions. For the ‘nasal-only’ case however, the vestibule region
remains a high deposition region and its deposition efficiency is much higher. When
the particle size increases to 20 µm, significant differences in the deposition patterns
are found between the two models, although deposition efficiency remains similar. For
the ‘nasal-only’ case, particles mainly deposit in four regions: vestibule, nasal atrium,
middle turbinate and septum region. However, for the ‘with-face’ model, there are few
particles depositing near the nostrils, but rather deposition occurs on the nasal atrium
region and inferior turbinate regions. deposition region and its deposition efficiency
is much higher. When the particle size increases to 20 µm, significant differences
in the deposition patterns are found between the two models, although deposition
efficiency remains similar. For the ‘nasal-only’ case, particles mainly deposit in four
regions: vestibule, nasal atrium, middle turbinate and septum region. However, for
the ‘with-face’ model, there are few particles depositing near the nostrils, but rather
deposition occurs on the nasal atrium region and inferior turbinate regions.
5.1.3.6 Influence of Breathing Zone on Particle Transport at 15 L/min
The airflow patterns in the breathing zone has an influence on the inhaled particle
conditions at the nostrils and in turn deposition patterns in the nasal cavity. To
determine the influence of the external nose and breathing zone, the deposition effi-
ciency as a function of inertial parameter is shown in Figure 5.14 for the two models.
For an inertial parameter less than 104, the deposition efficiencies are generally very
similar. However, for the inertial parameter range from 1.5 × 104 to 1 × 105 the
deposition efficiency for the ‘with-face’ model becomes significantly smaller, which
indicates different particle entry positions in the nostrils. For the ‘nasal-only’ model,
heavy particles released uniformly near the nostril edges tend to impact directly on
the vestibule region. This unrealistic boundary condition is avoided when the parti-
cles are transported from outside of the nose and allowed to enter naturally, entrained
in the flow.
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Figure 5.14: Comparison of deposition efficiency between ‘nasal-only’ and ‘with-face’
cases. This inertial range corresponds to particle sizes of approximately 7.8 µm and
20 µm respectively for an inhalation rate of 15 L/min (e.g. 250 cm3/s).
5.1.4 Conclusion
A new numerical nasal cavity model labelled as ‘NC03’, combined with detailed facial
features was reconstructed from CT scans to determine the influence of the airflow
field and breathing zone on micro particle deposition inside the nasal cavity. To gain
better visualization of particle deposition patterns, a surface mapping technique was
used by dividing the nasal cavity into detailed sections according to anatomy, and
further normalizing the mapped domain.
Under a light breathing flow rates of 15 L/min, the airflow in the external domain
remained uniform before entering the breathing zone of 3 cm from nostrils. It was
shown that additional vortices were generated in the nasal cavity from the external
environment which is not found for the ‘nasal-only’ model that omitted the outside
condition. Differences in airflow patterns were found between the two models, partic-
ularly in the vestibule region, but then the flow patterns became similar by the main
nasal passages.
The outside ambient particles were mainly subjected to the gravitational force
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but gradually were influenced by the inhaled air. Within the breathing region, the
particles accelerated rapidly by the inhaled air into a smaller cross section avoiding
direct impaction on the vestibule region. This led to particles penetrating the nasal
cavity deeper transferring to posterior regions. When influenced by the breathing
zone, particle deposition efficiencies of particle size range from 7.8 µm to 20 µm
became significantly lower (maximum of 37.7% lower for 12 µm particles). Particles
of 2.5 µm particles were negligible influenced by the breathing zone and dispersed
through the whole nasal cavity; 10 µm particles were transferred by the vortices to
the posterior nasal regions and; 20 µm particles directly impacted on the nasal atrium
region and inferior turbinate regions.
These results suggest that omitting the external nose and breathing region causes
a change in the fluid flow within the anterior nasal cavity half, and also significant
changes in the deposition efficiency for mid-inertial parameter particles.
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5.2 Influence of the Shape Factor on Nanoparticle
Deposition in Human Nasal Cavity
Abstract:
Welding fume is a complex mixture containing ultra-fine particles in the nanometer
range. Rather than being in the form of a singular sphere, due to the high particle con-
centration, welding fume particles agglomerate into long straight chains, branches, or
other forms of compact shapes. Understanding the transport and deposition of these
nano-agglomerates in human respiratory systems is of great interest as welding fumes
are a known health hazard. The neurotoxin manganese (Mn) is a common element in
welding fumes. Particulate Mn, either as soluble salts or oxides, that has deposited
on the olfactory mucosa in human nasal airway is transported along the olfactory
nerve to the olfactory bulb within the brain. If this Mn is further transported to the
basal ganglia of the brain, it could accumulate at the part of the brain that is the
focal point of its neurotoxicity. Accounting for various dynamic shape factors due to
particle agglomeration, the current computational study is focused on the exposure
route, the deposition pattern, and the deposition efficiency of the inhaled welding
fume particles in a realistic human nasal cavity. Particular attention is given to the
deposition pattern and deposition efficiency of inhaled welding fume agglomerates in
the nasal olfactory region. For particles in the nanoscale, molecular diffusion is the
dominant transport mechanism. Therefore, Brownian diffusion, hydrodynamic drag,
Saffman lift force, and gravitational force are included in the model study. The depo-
sition efficiencies for single spherical particles, two kinds of agglomerates of primary
particles, two dimensional planar and straight chains, are investigated for a range of
primary particle sizes and a range of number of primary particles per agglomerate.
A small fraction of the inhaled welding fume agglomerates is deposited on the olfac-
tory mucosa, approximately in the range 0.1-1%, and depends on particle size and
morphology. The strong size dependence of the deposition in olfactory mucosa on
particle size implies that the occupation deposition of welding fume manganese can
be expected to vary with welding method.
5.2.1 Introduction
Manganese (Mn) is both a neurotoxin and an essential element for normal human
body function. Its uptake from food and drinks occurs via the gastrointestinal tract,
and it is regulated by the liver. Approximately 2-4% of the consumed Mn is absorbed
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and delivered to the blood circulation (Davidsson et al., 1989). Additional uptake of
Mn can occur via inhalation during occupational exposure to airborne welding par-
ticulates containing Mn, leading to deposition in the respiratory tract. Consequently,
there are three possible outcomes:
1. the particles deposit in the gas-exchange regions of the respiratory airway and
slowly dissolve releasing Mn ions into the blood circulation, bypassing the liver
(Lam et al., 1978; Al-Shamma et al., 1979). These Mn ions can reach the blood-
brain barrier and the blood-cerebrospinal fluid barrier (Aschner and Aschner,
1990; Taube, 2012). Some Mn ions can penetrate the barrier and accumulate in
the basal ganglia of the brain (mainly in the globus pallidus). From the globus
pallidus in the basal ganglia, Mn exerts its neurotoxic effects.
2. the particles deposit on the olfactory mucosa and are transported either as
dissolved ions or nanoscale particles along the olfactory nerve to the olfactory
bulb inside the brain. From there, Mn is further distributed within the brain.
However, the relative importance of this transport route to the basal ganglia is
not clear;
3. the particles deposit on other respiratory surfaces that are cleared either by
involuntary sneezing (sternutation) or by mucociliary clearance into the gas-
trointestinal tract, and thus pose no neurotoxic risk if it is continued to be
regulated by the liver.
High concentrations of Mn in the body causes a disease known as manganism. It
is characterized by bradykinesia, dystonia, rigidity, and gait disorder (ADKINS et al.,
1980; McMillan, 2005). Occupational exposure limits (OELs) are generally set at 1
mg m3. Currently, OELs for Mn in the respirable fraction are proposed to set in the
range 20-200 µgm3 (Arnold, 1983; Authority, 2011; ACGIH, 2013). The critical effect
for these lower OELs is subclinical psychomotor/cognitive impairments.
Welders are presumably the largest group occupationally exposed to airborne Mn
(Antonini et al., 2003) due to the welding fumes, metallurgical operations, welding
wires, rods, flux, and base metals, which contain Mn. Its accumulation in the olfactory
bulb of welders has been demonstrated (Sen et al., 2011). In-vivo measurements
have identified Mn particle penetration into the brain via the olfactory bulb (Fechter
et al., 2002; Antonini et al., 2003). Consequently, this can be traced back to inhalation
exposure of airborne Mn particles generated from welding activities (Gray and Hewitt,
1982; Hudson et al., 2001) and its deposition on the nasal olfactory mucosa itself.
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Details of such deposition in relation to the Mn particle size, shape, inhalation flow,
and the nasal airway morphology are generally unavailable.
To complement existing in-vivo experimental data, computer simulations are used
to provide additional information, such as discrete particle trajectories from a con-
taminated environment, and provide particle deposition statistics to characterize
the transport process. Computational fluid dynamics (CFD) simulations have been
widely used in the study of detailed flow patterns and particle transport characteris-
tics around the human body (Kennedy and Hinds, 2002; Anthony and Flynn, 2006a;
Se et al., 2010b; Inthavong et al., 2012a, 2013a; Naseri et al., 2014). Inside the hu-
man respiratory system, Katz and Martonen (1996), Zhang and Kleinstreuer (2001),
Hofmann et al. (2003), Inthavong et al. (2010), and Tian and Ahmadi (2012, 2013)
employed computational models to investigate the airflow, and particle transport
and deposition in the human tracheobronchial airways. Subramaniam et al. (1998),
Matida et al. (2003), Kelly et al. (2004a), Zamankhan et al. (2006), Inthavong et al.
(2011b), Ge et al. (2012) applied the CFD methods in the human nasal/head airways
for airflow and particle transport analysis. These studies provide detailed descriptions
of flow and particle features and allow wider coverage of flow and particle conditions,
which would otherwise be difficult to infer from experimental measurements.
Welding fume is a complex mixture of fine particles consisting of metal oxides,
alkali metals and earth metal salts, fluoride salts, titanium oxides, and silicon oxides
(depending on welding method) existing in the microscale and nanoscale (Voitkevich,
1995; Jenkins, 2003). During arc welding, components of the wire or rod are vapor-
ized/oxidized due to the high temperature. Some distance from the arc, the vapors nu-
cleate, and the primary particles grow by condensation and coagulation/coalescence.
These particles are mostly spherical (Jenkins, 2003; Vishnyakov et al., 2013). When
the temperature is reduced below the melting point, further coagulation leads to
structured agglomerates, such characteristic long straight strings of beads (due to
the magnetic moments of iron, Mn, and nickel oxides). Depending on the welding
method, the actual shapes of the aggregates differ, such as branches or other forms of
compact shapes Figure 5.15 (VE, 2007; Sowards et al., 2010). The primary particles
in the agglomerates appear to be in the size range from 10 to 100 nm, and the length
of the string of beads varies. Micrometer-sized spherical particles have a different
origin. These are generated from being thrown out of the weld pool Figure 5.16d
(Jenkins, 2003).
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Figure 5.15: Welding fume particles: particles collected onto polycarbonate filters
sampled either from the top of a slightly modified welding fume chamber according
to EN ISO 15011-1:2009 (CEN, 2009) or directly from the breathing zone of a welder
using an environmental scanning electron microscope. (a) Zircon-basic shielded metal
arc welding (SMAW) electrode on high-alloyed steel; (b) Rutile-basic SMAW electrode
with high manganese content (>10%) on high-alloyed steel; (c) Rutile flux-cored arc
welding (FCAW) with Ar+CO2 shield gas on high-alloyed steel; (d) Gas metal arc
welding (GMAW) with Ar+CO2 shield gas on un-alloyed steel.
In this study, simulation of the transport and deposition of welding fume ag-
glomerates in a realistic human respiratory airway was performed. Accounting for
the various dynamic shape factors due to particle agglomeration, this study focused
on the exposure route and the deposition pattern in the human upper respiratory
airways. Attention was given to the deposition pattern and rate of inhaled welding
fume agglomerates of Mn composition, in the nasal olfactory region, from which sub-
sequent transport to the olfactory bulb in the human brain could occur. It should
be noted that while the aspiration efficiency in response to the external environment
is an important phenomena in inhalation study of welding fume particles, current
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investigation assumes idealized uniform external concentration and is focused on the
internal deposition. Unique contributions of the current study are as follows:
• no prior work has reported on the transport and deposition of welding fume
agglomerates in human nasal airways and;
• particle deposition pattern and rate in the human olfactory region is not fully
understood.
The current study intends to bring forward such understanding and knowledge.
5.2.2 Method
5.2.2.1 Human Nasal and Upper Respiratory Airway Modeling
A CFD model of the upper respiratory airway containing the nasal cavity, larynx, tra-
chea, and first bifurcation of the bronchial airway tree was developed from computed
tomography scans (Inthavong et al., 2009a, 2010; Shang et al., 2015b) Figure 5.16.
Each model of the respiratory airway is connected to form a contiguous path from
the nostril inlets to the upper tracheal region. Artificial straight tubes were extended
from the first lung bifurcation to allow sufficient flow recovery and improve numerical
convergence in the CFD solution. The nasal olfactory region is labeled in Figure 5.16,
which has a surface area of 10 cm2 or 8% of the total nasal cavity (Leopold et al.,
2000). The inner layer of the olfactory region is covered by olfactory mucosa and
connected to olfactory bulb through receptor neurons. Detailed anatomical regions
of the nasal cavity are given in Figure 5.17. The respiratory airway was added to
a realistic human face exposed to external surroundings containing airborne welding
fume particles. A high-quality mesh (minimum orthogonality > 0.1) incorporating
prism layers was applied to the bounding respiratory walls, and tetrahedral unstruc-
tured mesh filled the airway passage. The final model is shown in Figure 5.16, which
consists of 7 million cells. Further details on the computational model are given in
(Inthavong et al., 2012a).
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Figure 5.16: Human nasal and respiratory airway model and the welding fume particle
release profiles (A - large sample 8 cm×16 cm×10 cm of 81920 particles; B - medium
sample 6 cm×12 cm×8 cm of 36864 particles; C - small sample 4 cm×9 cm x 6 cm
of 13824 particles).
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Figure 5.17: The human nasal cavity with labelled regions.
5.2.2.2 Fluid Flow Simulation
ICRP (1994) presented typical human breathing conditions based on work load,
breathing mode (mouth versus nose), and gender. Selected data from (Bartley and
Vincent, 2011) based on ICRP (1994) are given in Table 5.3. Assuming the cardiac
load of a male welder is between sitting and light exercise, an inspiration flow rate
of 30 L/min was used. Breathing pattern was shown to affect particle deposition for
micron ranged particles between 1 and 5 m (Huermann et al., 2002). Schmees et al.
(2008) investigated the upstream airflow disturbance due to exhalation, and potential
impact to aerosol inhalation was anticipated; however, details of the breathing pat-
tern toward nanoscale particle deposition are not fully understood. To simplify the
simulation, current study employed a steady inhalation model with the assumption
that particle deposition mainly occurs during the inhalation phase (Se et al., 2010a).
For low to moderate steady inspiration flow, laminar flow condition was assumed.
TABLE 1
TABLE 2
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The airflow was simulated using Ansys-Fluent v14.5. The surrounding walls were
set to atmospheric pressure, and inhalation was initiated by a negative pressure dif-
ference at the bronchial bifurcation outlet. This allowed the ambient flow field to be
influenced only by the inhaled air. The continuity and momentum equation of the
fluid flow are as follows:
∂(ρui)
∂xi
= 0 (5.8)
ρui
∂ui
∂xi
= − ∂p
∂xi
+
∂
∂xj
(µ
∂ui
∂xj
) (5.9)
where ρ, u and p are density, velocity, and pressure of the air, respectively. A
second-order upwind scheme was used to approximate the momentum equation, while
the pressure-velocity coupling was handled through the SIMPLE method. Further
details on the fluid flow modeling are given in (Wen et al., 2008).
5.2.2.3 Welding Particle Simulation
Located 30-50 cm below the nose of the welder, the welding arc is a point source
continuously emitting a highly concentrated plume of particle agglomerates. Driven
by a combination of diffusive forces, the welding fume rises. However, the actual
dispersion of the welding fume particles external to the welder at real workplaces will
be random, and therefore, a homogeneous cloud of welding fume particles is assumed.
Suggested by Naseri et al. (2014), non-uniform particle velocity distribution at the
human nostril affects the regional deposition; therefore, particle release should include
breathing far-field and the nostril region. As shown in Figure 5.16, particle-release
profiles in large (8 cm×16 cm×10 cm, 81920 particles), medium (6 cm×12 cm×8 cm,
36864 particles), and small (4 cm×9 cm×6 cm, 13824 particles) regions in front of the
human face were tested (Figure 5.16; regions A, B, C for illustration), and very minor
difference was noticed in the particle deposition efficiency in the nasal and airway
cavities. For this study, 20000 uniform concentrated welding fume agglomerates, 5 cm
in front of the human face within the release profile (Figure 5.16), were released. The
release site can be considered breathing in the far-field of the nose, as it is sufficiently
away from the velocity acceleration zone at the nostril, and thus most realistically
represent the kinetics of the inhaled particles. All particles entered the human nasal
airway. It should be noted that welders usually wear a protective visor, 2.5-7.5 cm in
front of the face. In the current study, it is assumed that the whole volume of the air
surrounding the welder is filled with uniform concentrated welding fume. The effect
96
of the visor toward inhalation profile and the effect of varying external conditions
were not modeled in this study.
5.2.2.4 Dynamic Shape Factor of Particle Agglomerates
The hydrodynamic drag force, FD, experienced by a particle during its motion is as
follows:
FD =
1
2
CDρU
2A (5.10)
where U is the slip velocity, CD is the slip correction factor, ρ is the fluid density,
and A is the projected area of the particle in the flow direction. Based on the spherical
drag formulation, the drag of non-spherical particles is determined from experimental
investigations of the free falling velocity in a viscous fluid, and empirical correlations
of the dynamic shape factor is inferred. Lasso and Weidman (1986) studied the Stokes
drag on hollow cylinders and conglomerates of spheres, and Haider and Levenspiel
(1989) described the non-spherical particle drag coefficient correlation to its equivalent
surface area. The empirical formulation by Tran-Cong et al. (2004) was used to
describe the drag coefficient of elongated shapes, which has been validated and used
in Inthavong et al. (2013b) and Inthavong et al. (2008b) for fiber deposition in the
nasal cavity. The model covers an infinite set of irregular shaped particles formed by
orderly arrangement of connected smaller spheres, which is suitable for describing the
welding fume agglomerates. In this formulation, CD is:
CD =
24
Re
dA
dn
[1 +
0.15√
c
(
dA
dn
Re)0.687] +
0.42(dA
dn
)2
√
c[1 + 4.25× 104(dA
dn
Re)−1.16]
(5.11)
where dA is the surface equivalent sphere diameter, dn is the volume equivalent
sphere diameter, and c is the surface sphericity given by pidA/Pp, Pp is the projected
particle perimeter, and Re is the particle Reynolds number:
Re =
ρpdnU
µ
(5.12)
here ρp is the particle density and µ is the fluid dynamic viscosity.
The simplified welding fume agglomerates are formulated by assembly of mono-
dispersed spheres. Table 5.2 shows long straight chains consisted of either 8, 20,
or 60 spheres, while compact agglomerates consisted of 3 and 5 spheres (Table 5.2.
Primary (spherical) particles of 10-150 nm in diameter, and Mn composition were
used. Micron-sized particles were not included.
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5.2.2.5 Particle Tracking
The Lagrangian particle tracking method is used where each particle’s trajectory is
computed. The particle equation is as follows:
dup
dt
=
1
Cc
FD +
(ρp − ρg)g
ρp
+ FL + FB (5.13)
where up is the particle velocity, t is the time, g is the gravitational constant, and
ρp is the particle density. In this study, both gravitational and buoyancy forces can
be neglected. FD is the drag force given by Equation 5.10 and Equation 5.11. Cc is
the Cunningham correction given by:
Cc = 1 +
2λ
dn
(1.257 + 0.4e−1.1
dn
2λ ) (5.14)
here is the molecular mean free path. FL in Equation 5.13 is the Saffman lift
force, and FB is the Brownian diffusion force with amplitude of:
FB = ζ
√
piS0
∆t
(5.15)
here ζ is a zero mean, unit variance independent Gaussian random numbers. ∆t
is the time step for particle integration and S0 is a spectral intensity function (Li and
Ahmadi, 1992):
S0 =
216νkT
pi2ρd5n(
ρp
ρ
)2Cc
(5.16)
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Table 5.2: Welding fume agglomerates in the computational study.
Table 5.3: Human breathing condition.
here ν is the fluid kinematic viscosity, k is the Boltzmann constant, and T is the
absolute temperature of the inspiratory air in the nasal cavity. The simulation was
carried out with Ansys-Fluent v14.5’s discrete phase model. The nanoscale dynamic
shape factor CD and Cc for the welding fume agglomerates were given by a user-
defined functions. The model assumes the agglomerates are oriented randomly, and
therefore, the orientation dependent drag coefficient was neglected.
The particle trajectory, deposition pattern, and deposition efficiency were calcu-
lated based on a steady inspiratory flow. A statistically independent number of 20
000 inhaled particles were modeled. Deposition onto the respiratory walls occurred
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when the particle was within dn distance away from the surface. The deposition effi-
ciency is defined as the ratio of the number of deposited particles to the total number
of particles entering the nose via the nostril (e.g. 20000).
Compared to the exact solution for complex agglomerates, current model has the
following limitations:
• accuracy of the model for handling highly elongated agglomerates needs to be
further evaluated if preferential alignment occur and;
• Brownian motion and Cunningham correction [Equations 5.14, 5.15 and 5.16]
assumes negligible difference between the agglomerates and the effective spher-
ical particles.
5.2.2.6 Model Validation
The particle Equation 5.13 is solved by stepwise integration over discrete time steps
yielding a new particle velocity at each time step. In Ansys-Fluent, the length scale
factor of integration, Ls, controls the integration time step size, and ∆t is a function
of the particle velocity (up) and the continuous airflow phase (uc) velocity:
∆t =
Ls
up + uc
(5.17)
This means that the length scale factor is proportional to the integration time
step, equivalent to the distance that the particle travels before its equations are solved
again and its trajectory updated. A smaller value for the length scale increases the
number of calculations per distance length. Its selection must reproduce the diffusion
dispersion mechanism for nanoparticles. A standard geometry in the form of a pipe
(Figure 5.18a) with analytical solution by Ingham (1975) was used to validate the
particle dispersion. A fully developed flow of 1 and 5 L/min was used which has a
corresponding Re = 312 and Re = 1560, respectively. The particles were introduced
into the pipe with a mass flow rate distributed with a fully developed profile as:
˙m(r) = m˙0(1− r
2
R2
) (5.18)
where m˙0 is the maximum mass flow rate at the pipe centerline, r is the radial
position from the pipe centerline, and R is the pipe radius. Particle deposition in
the pipe over a distance of 0.09 m was compared with the deposition efficiency (DE)
correlation by Ingham (1975).
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DE = 1− (0.819e−14.63∆ + 0.0976e−89.22∆ + 0.0325e−228∆ + 0.0509e−125.9∆2/3) (5.19)
Where
∆ =
DLpipe
4UinletR2
(5.20)
Particle deposition in a pipe length of 0.9 m was compared for length scale factors
of 5×105, 1×105, and 5×106 m, which showed that the deposition was best described
using a value of 1× 105 m.
Figure 5.18: Brownian diffusion validation testing in a pipe geometry. Particle deposi-
tion in a pipe for nanoparticles between 1-20 nm were compared against the analytical
solution by Ingham (1975). Three length scale factors 5 × 105, 1 × 105, and 5 × 106
m were investigated to determine the most suitable value.
5.2.3 Results and Discussion
5.2.3.1 Airflow Patterns
The stream-wise airflow in the nasal airway is shown in Figure 5.19. Ambient air
enters the nostril in an upward direction and turns 90-degree entering the middle and
inferior nasal meatus before a second 90-degree turn at the posterior nasopharynx.
High velocity was observed at the nostril entrance, downstream of the nasal valve,
and at the larynx. A small percentage of the inhaled air reaches the upper olfactory
region but with lower velocity. Figure 5.20 displays the axial airflow velocity contours
at selected cross-sections along the mid-nasal airway. It confirms that the bulk air
passes through the middle and inferior meatus, whereas the superior meatus (nasal
descriptions are shown in Figure 5.17), where the olfactory region is located, has
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less very low-velocity air passing through. The inhaled welding fume particles were
transported by the moving fluid and regions with higher velocity implied high par-
ticle concentrations. The flow pattern provides valuable indication for the potential
deposition of the inhaled particles. Airflow changes, such as a sharp turn, a sudden
shrink, or an expansion of the cross-sectional area, may have profound consequence
for particle deposition if the particle inertial is sufficient.
Figure 5.19: Stream-wise airflow: (a) velocity contour; (b) velocity vectors.
Figure 5.20: Axial velocity contours at selected cross sections along the mid-nasal
airway (nasal olfactory region is located in the nasal superior meatus above the solid
line as shown in cross sections b, c and d).
5.2.3.2 Particle Trajectory
Trajectories of six sample particles from the release site are shown in Figure 5.21.
The size of the primary particle in these agglomerates was 10 nm. The single spheres
(Figure 5.21a) showed the highest random dispersion, while the longest 60-sphere
chains appeared to be perfect flow tracers that followed the flow streamline smoothly.
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All particles followed the main airflow stream though with different levels of local
dispersion. Compact agglomerates of 3- and 5-sphere chains showed relatively high
Brownian diffusion, while the effect of Brownian diffusion weakened as the particle
agglomerates became longer (8-, 20-, and 60-sphere chain). As a result, single spheres
had a more disperse profile at the nostril, whereas it was more concentrated for
agglomerates that exhibited less Brownian diffusion. Particle velocities generally
conformed to that of the main airflow streamlines, though for particles with high
Brownian diffusion, particle velocity was slightly higher than the local flow velocity
(Figure 5.21 a,b). In general, all particles were affected by flow acceleration in the
vicinity of the nostril and gained significant momentum before entering the nasal
airway. It is also noted that the sample particles entered the nasal airway via the
upper tip of the nostril.
Figure 5.21: Inhalation profile of: (a) single sphere; (b) 3-sphere compact agglomer-
ates; (c) 5-sphere compact agglomerates; (d) 8-sphere chain; (e) 20-sphere chain; (f)
60-sphere chain. (Primary sphere: 10 nm)
Particle trajectories inside the nasal cavity for the six selected sample particles
are shown in Figure 5.22. Single spheres, compact agglomerates, and agglomerates
of shorter span (Figure 5.22 a,d) were more likely to disperse into the low-velocity
region of the superior and inferior meatus, while agglomerates of long straight chain
(Figure 5.22 e,f) were confined in the bulk flow and follow the preferential pathway
along the middle meatus toward the posterior nasal cavity. A very small fraction (one
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in six) of the inhaled particles reached the nasal olfactory region (Figure 5.22 b,d),
which was caused by Brownian diffusion, and corresponds to the particles of higher
Brownian activity, such as single spheres, compact, and short agglomerates.
Figure 5.22: Particle trajectories in the nasal cavity: (a) single sphere; (b) 3-sphere
compact agglomerates; (c) 5-sphere compact agglomerates; (d) 8-sphere chain; (e)
20-sphere chain; (f) 60-sphere chain. (Primary sphere: 10 nm)
5.2.3.3 Particle Deposition Patterns
Figure 5.23 shows the deposition pattern of the different particle agglomerates in the
human nasal cavity. High deposition was observed for single spheres downstream of
the nostril on the anterior nasal septum before the nasal channel makes the 90-degree
turn into the mid-nasal airway. High deposition was also observed in the posterior
nasal cavity in the vicinity following the second 90-degree turn at the nasopharynx.
The majority of the particle deposition in the mid-nasal airway occurred in the middle
meatus. A small fraction of the inhaled particle was scattered across the superior
meatus where the olfactory mucosa was located. This random deposition pattern
implied minimum flow influence on olfactory deposition. A similar deposition pattern
was observed for particle agglomerates of compact shape and short span (Figure
5.23 b,c), which possessed greater Brownian diffusion. One trend observed was that
agglomeration reduced the particle deposition where significantly less deposition was
found for agglomerates of long straight chains (Figure 5.23 e,f). A more random
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deposition pattern and lower correlation with the main flow feature indicated low
diffusion governing the deposition process of these agglomerates.
Figure 5.23: Particle deposition pattern in the nasal cavity: (a) single sphere; (b) 3-
sphere compact agglomerates; (c) 5-sphere compact agglomerates; (d) 8-sphere chain;
(e) 20-sphere chain; (f) 60-sphere chain (primary sphere: 10 nm).
The effect of primary particle size on deposition is shown in Figure 5.24, where the
agglomerates are made up of a larger primary particle spheres of 100 nm. Comparing
the deposition pattern with primary spheres of 10 nm, a significant reduction in
the deposition was observed, especially for single spheres and compact agglomerates
(Figure 5.24 a-c). No clear trend, with respect to the deposition characteristics,
can be inferred. However, the deposition patterns were similar across agglomerates
considered, where the preferential deposition sites were the anterior olfactory superior
edge, the middle meatus of the nasal airway, and downstream of the nasopharynx.
The deposition sites were also scattered, which implied that for a primary particle
size of 100 nm, the single particle and its agglomerates follow the main bulk flow,
and the deposition occurs along the bulk flow path mainly due to geometric induced
interception and only to a minor degree due to diffusion. There is less variation with
respect to the different forms of particle agglomeration for primary spheres of 100
nm.
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Figure 5.24: Particle deposition pattern in the nasal cavity: (a) single sphere; (b) 3-
sphere compact agglomerates; (c) 5-sphere compact agglomerates; (d) 8-sphere chain;
(e) 20-sphere chain; and (f) 60-sphere chain (primary sphere: 100 nm).
5.2.3.4 Particle Deposition Efficiency
Figure 5.25 shows the deposition efficiency in the nasal cavity for different primary
sphere diameters. Deposition efficiency is defined as the ratio of the number of de-
posited particles to the total number of particles entering the nose. For primary
spheres larger than 50 nm, the deposition efficiency is low (<3%) and there is neg-
ligible variation with primary sphere diameter. For particle and agglomerates with
primary sphere smaller than 50 nm, deposition is highly sensitive to the agglomerate
and size of the primary sphere. In general, higher Brownian particles exhibit greater
deposition, and for particle agglomerates with the low Brownian diffusion, minimum
deposition is observed. The sequence of high to low deposition efficiency is as follows:
single spherical particle, 3-sphere compact agglomerates, 5-sphere compact agglom-
erates, 8-sphere chain agglomerates, 20-sphere chain agglomerates, and the 60-sphere
chain agglomerates. In the entire nasal cavity, the deposition efficiency reaches 15%
and decreases to 3% with increasing primary particle size.
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Figure 5.25: Particle deposition efficiency in the nasal cavity.
To evaluate the deposition pattern in the nasal olfactory, the total and regional
deposition efficiencies are shown in Figure 5.26. The total deposition is the amount of
particles depositing on the olfactory mucosa divided by the total number of particles
inhaled. The regional deposition efficiency is the ratio of the number of particles
deposited on olfactory mucosa to the number of particles deposited on the entire nasal
cavity. The overall total olfactory deposition is nearly 0.1%, across all primary particle
sizes and agglomerates (Figure 5.26a). The highest total olfactory deposition occurred
for high Brownian diffusion particles of single spheres and compact agglomerates
composed of 10-nm primary particles (1.8-0.3%). With increasing primary particle
diameter, the single spherical particles and the agglomerates exhibit similar levels
of total deposition in the olfactory region. The regional deposition (Figure 5.26b)
indicates that as high as 12% of the nasal deposition could occur in the olfactory
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region. However, the relative deposition efficiency is nearly 4%. Higher regional
deposition occurred for single spherical particles and compact agglomerates made of
smaller sized primary spheres (10-30 nm). However, as the primary sphere is increased
(40-150 nm), the agglomerates of long straight chain increased the regional deposition
efficiency. This implied the transition from diffusion-driven particle deposition to
inertial impaction driven deposition. For reference, data shown in Figure 5.26 are
given in Table 5.3.
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Figure 5.26: Nasal olfactory deposition: (a) olfactory total deposition efficiency; (b)
olfactory regional deposition efficiency.
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Table 5.4: Nasal olfactory deposition efficiency (%)
The overall deposition pattern through the respiratory airway is shown in Figure
5.27 for a single sphere and 60-sphere agglomerate chain with a primary particle
sphere of 10 nm. High deposition is found mainly in the upper superior half of the
airway for spherical particles. For the 60-sphere agglomerate chain, the deposition
density is relatively low. The deposition site across the airway appears scattered,
and any variation in particle deposition in various regions of the airway is indistinct.
Selected deposition efficiencies of particle agglomerates with 10-, 50-, and 150-nm
primary spheres are given in Figure 5.28. The main deposition occurs in the nasal
cavity followed by the larynx while deposition in the trachea and bronchial is the
lowest. The effect of the primary particle sphere on deposition distribution shows
large variation in the regional deposition distribution for particles and agglomerates
with the smallest primary particle size (10 nm). As the primary particle size increases,
the variation becomes less significant. It is worth noting that in all simulations particle
deposition efficiency in the left and right bronchi is different. Further investigation
reveals higher airflow rate in the right bronchial due to upstream asymmetry. This
implies a shorter particle residence time and therefore less deposition in the right
bronchial. The predicted regional distribution is similar to that of Naseri et al. (2014)
for micron particles; however, large variation in regional distribution was observed for
particles of larger diameters (>20 m), contrary to what is observed in this study. This
again implies the distinct deposition mechanisms for the nanoscale and microscale
particles.
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Figure 5.27: Particle deposition pattern in the nasal, larynx, trachea, and upper
bronchial airway: (a) single sphere side view; (b) single sphere front view; (c) 60-
sphere chain side view; and (d) 60-sphere chain front view (primary sphere: 10 nm).
5.2.3.5 Implications for Inhaled Mn-containing Particles
The results showed a very low deposition rate (<0.4%) for inhaled submicron par-
ticles on the olfactory mucosa. This agrees with the experience that a forced deep
breath is needed to induce olfaction of a fragrance. At the ceiling of the superior
meatus, the olfactory region requires a diffusion dominant transport mechanism. The
low deposition rate does not indicate that one should exclude this entry route. Sen
et al. (2011) showed that, for welders, Mn was transported to the olfactory bulb.
Depending on welding method, the concentration of agglomerates with a diffusion
equivalent/mobility diameter less than 25 nm could vary in the range 3-100 L−3,
(Lidn, 2014). At an inhalation of 0.625 L every 5 s and a deposition efficiency of
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nearly 1%, this would deposit 0.1 − 1 × 109 particles in the olfactory mucosa per
working day. As presented above, it is well established that Mn in welding fume can
reach the olfactory mucosa, and therefore be carried along the olfactory nerve into the
olfactory bulb inside the brain. Once inside the brain, the Mn is behind the defense
barriers of the brain and could be transported to adjacent or connected parts.
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Figure 5.28: Particle deposition in the regions of human upper respiratory airways
including nasal cavity, larynx, trachea, and left and right bronchial: (a) primary
sphere 10 nm; (b) primary sphere 50 nm; and (c) primary sphere 150 nm.
The results presented make it possible to compare the potential deposition in the
olfactory mucosa from welding fume particles generated by different welding methods,
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provided that the Mn mass-weighted diffusive equivalent diameter size distribution is
known. This can be determined with the Nano-ID Select spectrometer (Naneum Ltd,
Canterbury, UK) as evaluated by Gorbunov et al. (2009). Similar studies are found
in the work of Hewett (1991, 1995), Esmen et al. (2002), Johnson and Esmen (2004),
Elihn et al. (2011), and Gorbunov et al. (2013).
What so far has not been addressed is how the Mn in the inhaled welding fume
particles will be transported along the olfactory nerveas dissolved ions, individual
primary particles (assumes that the agglomerates can be broken up in the mucosa),
as agglomerates or as folded/compacted agglomerates. The solubility of Mn in welding
fume particles depends on the method and composition of welding flux. High amount
of iron causes a low solubility, whereas high amounts of fluorine and alkali metals
cause a high solubility. The smallest diameter of the olfactory neuron axons was
reported as 200 nm Elder et al. (2006). Welding fumes from many (but not all)
methods have count median mobility diameters below or approximately equal to this
size and can therefore be transported along the nerve if deposited on the olfactory
mucosa. Agglomerates with an interception diameter exceeding this value cannot be
transported unless somehow folded/compacted or dissolved. Welding fumes consisting
of high amounts of iron, Mn, and nickel usually consist of straight chains of primary
particles, presumably arranged due to the magnetic moment of the metal ions, and
therefore, this type of welding particles will not tend to fold/compact.
5.2.4 Conclusion
In this CFD study, transport and deposition of welding fume agglomerates in the
human nasal and upper respiratory airways are examined. Particular attention is
given to the deposition pattern and deposition efficiency of welding fume agglomerates
in human nasal olfactory mucosa from which a direct entry route into the brain exists.
Depositions of spherical particles and agglomerates (generated from primary particles
in the size range 10-150 nm, either as straight chains or compact two-dimensional
structures) in the nasal cavity, the larynx, the trachea, and the bronchial are given.
The current study intends to reveal the transport route, the deposition site, and
the pattern of inhaled welding fume agglomerates, and correlate these to the airflow,
airway morphology, and the welding particle morphology. The following conclusions
were drawn:
1. Of all the upper airway sections considered, the nasal cavity is most effective
in capturing inhaled agglomerates. Most deposition in the human nasal cavity
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occurred on anterior nasal septum and posterior nasal cavity near nasopharynx.
In the mid-nasal airway, the majority of the deposition occurred in the middle
meatus. A very small fraction of the inhaled welding fume agglomerates is
dispersed into the nasal olfactory region and the deposition is extremely low.
It should also be noted that, for the range of particles considered, the majority
pass through the nasal barrier and penetrate deep into the lung.
2. For nanoscale welding fume agglomerates (primary sphere diameter < 20 nm),
the primary particle size and morphology of the agglomerate both influence the
deposition efficiency. Smaller primary particle size and more compact agglom-
erate morphology result in higher deposition. Long straight chain agglomerates
tend to be less disturbed by Brownian diffusion when following the main flow
and low deposition occur. For agglomerates consisting of primary particles
whose size equals or exceeds 50 nm, the deposition efficiency is less dependent
on primary particle size and agglomerate morphology.
3. Downstream of the nasal cavity, the larynx is the next highest deposition site.
The deposition in trachea and the first level bronchial is low. The variation
in regional deposition distribution is inversely associated with primary particle
diameter.
4. The motion of the inhaled nanoscale welding fume agglomerates is governed by
convection due to airflow movement, Brownian diffusion due to molecular col-
lision, and is size dependent. The size and shape dependency of the deposition
indicated a transition from diffusion to inertial transport.
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Chapter 6
Comparative Study of Wall Shear
Stress between Human and Rat
Nasal Cavities
The main findings of this chapter have been published in:
Computational fluid dynamics analysis of wall shear stresses between human and
rat nasal cavities. European Journal of Mechanics B/Fluids, 61, Part 1, 160-169
Abstract:
Toxicology studies often use laboratory animals as surrogates for human subjects
because of the relatively similar nasal anatomy that allows data extrapolation between
species. An understanding of nasal airflow patterns, particularly wall shear stress can
help better understand the causes of toxicant distribution and local dosimetry. A
laminar, steady state flow was used to simulate light inhaled air. The WSS occurring
inside a human nasal cavity was compared with a rat nasal cavity. The results showed
that average WSS was highest in the anterior nasal region, i.e. vestibule (rat - 755 mPa
and human - 153 mPa). In the human model, the lower septal wall, and nasopharynx
region also exhibited high WSS regions. Local high WSS regions on the nasal cavity
wall were identified by plotting the WSS distribution plotted as peaks on a normalised
2D domain. This visualisation technique displays peaks for locally high WSS values
which were primarily caused by the airway geometry intruding into the airflow paths
and causing high shear. Velocity vectors on the 2D domain also correlated high WSS
with flow acceleration that was caused by a reduction in the cross-sectional area of a
local region in the nasal passage.
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6.1 Introduction
The nasal cavity serves as a front line defence for the lungs by filtering foreign airborne
contaminants, and conditioning the inhaled air. The delicate lungs and olfactory
regions are vulnerable to airborne contaminants caused by exposure to the inhaled
air. Furthermore, the nasal epithelium is continuously subjected to shearing forces
from the moving air passing over the nasal walls, which is the wall shear stress (WSS).
Excessive WSS can lead to mechano-receptors in the epithelial lining of the nasal
cavity triggering mucus secretion from the goblet cells (Elad et al., 2006). This was
also confirmed by Even-Tzur et al. (2008) and Davidovich et al. (2011) whom showed
the occurrence of significant mucus secretion increase in response to WSS stimuli
compared with unstressed conditions.
The compact size and complex nasal cavity geometry makes in-vivo nasal airflow
studies challenging leading preference for in-vitro experiments in nasal airway cast
models. Hahn et al. (1993) provided detailed velocity measurements in a 20 enlarged
right-nasal cavity. Both inhalation and exhalation breathing at five cross-sectional
planes were measured using a hot-film anemometer. It was found that 50% of inhaled
air flowed through the combined middle and inferior passage and 14% through the
olfactory region for all studied flow rates. Schreck et al. (1993) performed pressure
measurements, flow visualization and hot-wire anemometry studies using a 3 enlarged
model. Significant pressure drop was observed at the anterior nasal cavity during
inhalation, and a number of vortices were formed posterior to the nasal valve. Kelly
et al. (2000) conducted detailed particle image velocimetry (PIV) measurements over
2D lateral fields and sampled parallel planes through the right chamber of a nasal
cavity. The resulting vector plots demonstrated airflow was laminar at 125ml/sec and
peak velocities occurred at the nasal valve and the inferior airway.
To obtain very detailed data, computational fluid dynamics (CFD) methods are
widely applied (Subramaniam et al., 1998; Tian et al., 2007; Inthavong et al., 2009a,
2013a; Xi et al., 2014; Doorly et al., 2008a). Keyhani et al. (1995) simulated airflow
in the right chamber of a healthy adult nose under quiet breathing conditions, and
showed that nearly 30% of the inhaled air flowed through the inferior turbinate region,
and 10% through the olfactory region. Wen et al. (2008) detailed the airflow features
through CFD simulations adopting laminar steady flow conditions, and demonstrated
the differences between the left and right chambers. Other CFD studies found gen-
eral agreement of the persistent gross flow features, including high velocities in the
constrictive nasal valve region and close to the septum walls, and vortex formations
117
posterior to the nasal valve and olfactory regions Ishikawa et al. (2006); Garcia et al.
(2007); Hrschler et al. (2006); Xi et al. (2016). Elad et al. (2006) presented WSS
distributions based on a simplified human nose-like model, which showed high WSS
regions at the narrowest passages such as the nasal valve region, and the anterior
middle turbinate. Doorly et al. (2008c) approximated WSS distributions on the nasal
septum and observed a flow stagnation point below the leading edge of the turbinate
together with high WSS regions. More recently studies have begun looking at exploit-
ing the olfactory region for nanoparticle intrusion into the blood stream to bypass the
tightly bounded blood-brain-barrier (Garcia et al., 2015; Garcia and Kimbell, 2009;
Schroeter et al., 2006).
In toxicology studies, laboratory animals (mostly rat or mice) are widely used as
surrogates for human subjects due to the relatively similar nasal anatomy to allow
data extrapolation between species. Morgan et al. (1991) studied inspiratory nasal
airflow in transparent acrylic replicas of rat and monkey nasal passages using a water-
dye siphon system. Based on dye streamlines, the anterior rat nasal airway model
was considered to play an important role in local mixing of inhaled air. Garcia and
Kimbell (2009) numerically modelled nanoparticle deposition in the olfactory region
of a rat, which was largely dependent on the flow patterns. Their results indicated
that only 20% of inhaled air was diverted to the olfactory region, while most the flow
exited the nasopharynx. Meanwhile, site-specific nasal lesions have been recognized
in rats after inhalation exposure to chemical toxicants such as formaldehyde (Cassee
et al., 1996; Kimbell, 2006; Schroeter et al., 2014).
Toxicant distribution and dosage within nasal cavities is highly dependent on the
combined effects of anatomical structure and airflow patterns, especially at the air-
wall interface. Therefore, an understanding of nasal airflow patterns, particularly wall
shear stress, for both laboratory animals and human can help to reduce uncertain-
ties during in-vivo exposure studies and advance the data extrapolation from rat to
human. In particular is the predictions of particle deposition in the olfactory region.
Despite extensive experimental and numerical investigations of nasal cavity airflows
in the literature, no WSS distribution analysis has been conducted for the rat nasal
model, and therefore there is no WSS comparison between human and rat models.
Furthermore, visualisation of WSS distributions on the entire nasal cavity surface
remains challenging due to the highly overlapping 3D nasal structure, and possible
information of local concentrated stresses can be hidden behind these structures (e.g.
the shell-like turbinates). To fulfill the knowledge gap on the WSS distribution com-
parison between human and rat nasal cavities, realistic computational models of the
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nose were reconstructed from CT images, and numerical comparison of the airflow
patterns and WSS distributions were performed under a steady state laminar flow.
A technique to visualise the 3D domain onto a 2D space was presented to visualise
the WSS distribution over the entire nasal cavity surface.
6.2 Methods
6.2.1 Nasal Cavity Models
The remarkable nasal functions are accomplished by a delicate geometrical structure
which balances the convection of airflow with heat and mass transfer by diffusion,
while distributing mucus secretion within the nasal cavity. Thus, the reconstruction
of rat and human nasal cavity geometries need to be well addressed. In this study,
the rat nasal model was reconstructed from CT images (resolution 768px × 768px) of
a 400g Sprague-Dawley rat with resolution of 0.05 mm. Similarly, the human nasal
model was reconstructed from CT images (resolution 512px × 512px) of a 48-year-old
Asian male, with resolution 0.5 mm. The human model has slightly deviated septum
and slightly obesity. It has been used in previous studies Shang et al. (2015b); Dong
et al. (2016). The external facial features were included to ensure realistic inhalation
at the nostrils which have shown to affect the downstream flow inside the nasal cavity
Xi et al. (2014); Shang et al. (2015b); Doorly et al. (2008c).
Figure 6.1 presents the reconstructed nasal cavity models for rat (labelled RNC01)
and human (labelled NC04), inclusive of the paranasals sinus, pharynx and larynx
anatomy. Cross-sectional slices with nasal cavity dimensions are given in Figure
6.1b to highlight the size and shape difference between the two species. The main
differences include: the length of the main nasal chamber, rat model was 3.6 cm long
while the human model was 9.8 cm; there were many turbinate structures producing
highly curved cross-section slices in the rat model (slice b-b’) while in the human
model there were only three turbinates producing a relatively simpler geometry (slice
B-B’). Detailed geometry information is given in Table 6.1, which includes chamber
volume and hydraulic diameters at the inlet and outlet. I note that the human nasal
cavity volume (without sinuses) is 58× greater than of the rat, despite the human to
rat nasal cavity legnths ratio is only 2.7×. This suggests that the human nasal cavity
exhibits a relatively wider passageway relative to length. A contributing factor to
this is the rat’s highly curved olfactory region which has a significant number of folds
and curved structures. These structures jut into the geometry thereby increasing the
surface area and reducing the overall volume.
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Figure 6.1: Nasal cavity geometries. (a) Reconstructed nasal models (green) including
facial features (grey) from CT data and their relative locations to the cranial bones.
(b) Iso-view of right nasal chamber with septum removed and selected cross-sections
of left chamber showing its profile for (i) rat RNC01 and (ii) human NC04. Two
cross-section slices (A-A’ and B-B’ for the rat model; and a-a’ and b-b’ for the human
model) are labelled which are displayed later for analysis.
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Table 6.1: General information of rat and human geometries.
The hydraulic diameter is defined as 4Ac/P , where Ac is the area, and P is the
perimeter of the cross-section. The human nasal model excluding maxillary sinuses
was asymmetric, with right chamber volume (14109 mm3) 26.0% larger than the left
chamber (11201 mm3). Though the right chamber is wider than the left, the addition
of the larger left maxillary sinus volume makes up the difference between the two
chamber volumes, and this difference reduces to 9.6% difference. The rat nasal model
exhibits a more symmetric geometry with a volume difference of 9.5% between left
and right chamber (without sinuses).
The scanned data came from existing scans and its release was approved by the
ethics committee of Shengzhou Chinese Medicine Hospital, China. All private infor-
mation (e.g. name, address and ID) of patients were erased before uploading to our
secured server.
6.2.2 Inhaled Airflow Simulation
The models were meshed using Ansys-ICEM 16.0 software, where there were 5.0 mil-
lion cells for the rat model and 3.9 million cells for the human model. The mesh was
smoothed and optimised so that all cells were above 0.5 in quality (aspect ratio), and
attached to 5 prism layer cells at the nasal walls and face surface. The flow outlet
at the larynx was set as velocity outlets to simulate the air being driven by the lung
from the external ambient air. This generated realistic inhaled flow streams which
are critical to airflow behaviour in the anterior nasal chambers, and a naturally bi-
ased airflow distribution between the two nasal chambers based on caused by nasal
resistance (Shang et al., 2015b). Low breathing conditions were used with flow rates
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of 0.4 L/min and 15 L/min for rat and human cases, respectively (ICRP, 1994; Kim-
bell et al., 1997). At these flowrates the airflow regime was treated as laminar and
incompressible, and the steady state equations of airflow were solved in Ansys-Fluent
16.0 software. For higher flow rates (0.8 L/min for rat case and 32 L/min for human
case), the SST Transitional k- turbulence model was used for obtaining pressure drop
validation through the nasal cavities.
The inhalation process is clearly unsteady with an oscillatory motion. In order to
assess the importance of the unsteadiness on the mean or average flow characteristics
obtained through a steady solution, the Womersley number,
α =
D
2
(
ω
νg
)0.5
(6.1)
where D is the characteristic length which is taken as the inlet hydraulic diameter
of the nostrils equals 0.01 m: νg is the kinematic viscosity of air, and ω is the breathing
frequency equal to ω = 2pif and the Strouhal number,
S =
ωD
uave
(6.2)
where uave can be used. It has, however, been shown experimentally that the
oscillatory effects are not present until α > 4 (Isabey and Chang, 1981). Other
studies have also concluded that under most conditions, especially low flow rates, the
nasal airflow can be considered quasi-steady (Chang, 1989; Hahn et al., 1993). In
the case of sniffing, then clearly an unsteady flow behaviour is dominant (Zhao et al.,
2006b; Jiang and Zhao, 2010).
6.2.3 Anatomical Division and Surface-mapping Strategy
A surface-mapping technique was used to visualise WSS distribution across the entire
wall surface. The technique unwraps surfaces from a 3D domain and projects it onto
a 2D flat domain. Its application to nasal cavities was first proposed by Inthavong
et al. (2014), introducing fundamental mapping strategies by slicing the 3D nasal
model along the floor of the geometry and projecting the 3D surface into a flat 2D
space. To identify anatomical regions of significance from the 2D domain and refer
it back to the original 3D geometry, the technique was further developed (Shang
et al., 2015a,b) by dividing the nasal cavity into several pre-defined regions with the
computational codes written in Matlab and Mathematica software.
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Table 6.2: Comparisons of areas of nine major anatomical regions for rat and human.
In this paper, the rat and human nasal surfaces were divided into nine anatomical
regions primarily based on their epithelial lining. The sub-regions were: vestibule,
upper passage, middle passage, lower passage, olfactory, upper septum, lower septum,
nasal pharynx and maxillary sinus. The vestibule regions are covered by squamous
epithelium where no mucus secretion occurs. The olfactory regions contain olfactory
epithelium lining. The middle passage region of the human nasal cavity is comprised
of middle meatus, middle turbinate and superior meatus. The location of each region
is shown in the left nasal chambers only, presented in 3D lateral and septal views
(Fig 2i, ii), and in 2D mapped domains reshaped into orthogonal axes (Fig 2iii). The
regions are colour coded, allowing direct comparisons of WSS distributions between
human and rat. The roof apex of each nasal cavity chamber was selected as the
dividing line separating the chamber into lateral and septal regions. The lengths
of the vestibule, main passage and pharynx in 2D domain were normalised to 1:3:1
ratios.
The maxillary sinus region was included in the human model to be consistent
with the rat model which contained the maxillary sinus. The septum wall of both
models were divided into an upper septum, and a lower septum (yellow and pink
coloured region in Figure 6.2) along a curve that separated the region in half. This
separation helps distinguish WSS patterns caused by upper and lower airflow streams.
The upper passage of the human model slightly extended its anterior boundary into
contact with its dorso-posterior vestibule boundary, so that the effect of any upwards
airflow leaving the nasal valve region could be captured by the segmented upper
passage region (green coloured region in Figure 6.2).
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Figure 6.2: Anatomical regions of human and rat cases in 3D view (i, ii) and mapped
view (iii). Regions are labelled by different colours accordingly. In the 3D view, only
right chambers are shown and they are cut along the floor of geometries to unwrap
into 2D domain. The mapped domain is separated into lateral and septal side by
profile curve at the top of the geometry.
Cross-section slices in the anterior and posterior nasal cavities of the rat and
human models are shown in Figure 6.3. In the rat model, slice locations are located
at x = 14.5 mm (A-A’) and x = 23.4 mm (B-B’) from the vestibule tip. In the
human model these locations are located at x = 27 mm (a-a’) and x = 56 mm (b-
b’) from the vestibule tip. I observe the complexity in the rat model beginning in
the anterior slice and becomes excessively complex in the posterior slice where many
airway partitions develop superiorly. Comparatively the human airway exhibits a
relatively simple elongated pair of strips in the anterior slice, developing to three
main partitions caused by the three turbinate bones. The scale in the figure also
shows that the human nasal airway is approximately 5x the size of the rat model.
124
Figure 6.3: Cross sections extracted from the rat and human nasal cavity models.
Cross-section outlines are coloured by anatomical regions defined in Fig 2. Five flow
mainstreams in rat anterior cross section: DM-dorsal medial flow, DL-dorsal lateral
flow, VL-ventral lateral flow, VM-ventral medial flow and M-middle flow (Kimbell et
al., 1997). Additional abbreviations are: 1ED, dorsal scroll of first ethmoturbinate;
2ED, dorsal scroll of second ethmoturbinate; 2EV, ventral scroll of second ethmo-
turbinate; 3ED, dorsal scroll of third ethmoturbinate; 3EV, ventral scroll of third
ethmoturbinate.
6.3 Results and Discussion
6.3.1 Airflow Resistance Comparison
In this study, airflow resistance was described byaaaaaa the pressure drop in the
airway between the nostrils and nasopharynx. The pressure drop against airflow
rates was compared with reported data for (a) rat case (with flow rate range 0.1-0.8
L/min) and (b) human case (with flow rate range 5-32 L/min), shown in Figure 6.4.
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The pressure drop for the rat model compared well with published results where the
simulation data is located between the experimental data from Kelly et al. (2001), and
simulated data from Schroeter et al. (2012). In Kelly et al. (2001)’s study, a replica
airway model of an F344 male rat approximately 220g was used while in Schroeter
et al. (2012)’s study, a Sprague-Dawley rat weighing approximately 600g was used.
For an equivalent airflow rate, a larger airway geometry is expected to produce a lower
pressure drop due to less resistance through the larger cross-sections. Considering the
weight of the rat used in this study is approximately 400g (in between the literature
data), the pressure drop is consistent relative to the size of the rat.
Figure 6.4: Pressure drop between nostrils and nasal pharynx against inspiratory flow
rate (L/min) for (a) rat and (b) human cases compared with data in the literature.
In Fig 4(b), the pressure drop of the human model is slightly higher than Kelly
et al. (2004b)’s experimental data and Schroeter et al. (2011)’s simulated data. De-
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spite this, the increasing pressure drop trend against flow rate is consistent with the
reported results. The relatively higher pressure drop in our results was primarily
caused by the smaller airway with a reducing cross-sectional area from choanae to
nasopharynx, where the hydraulic diameter decreased from 16.1 mm to 9.02 mm
respectively (Table 6.1). As the nasal pharynx is located downstream of the nasal
cavity, it does not significantly influence the airflow and WSS distribution in the
vestibule and main cavity. Clinical measurements by Hirschberg et al. (1995) showed
the range of pressure drop reported in healthy male adults was 110 ± 62.5 Pa.
6.3.2 Comparisons of WSS on Different Anatomical Regions
Average WSS on anatomical regions were calculated under rest breathing conditions
(0.4 L/min for rat, and 15 L/min for human). The characteristic Reynolds numbers
for left and right human nostrils were 661 and 1341, while for left and right rat nostrils
were 354 and 344. These Reynolds numbers were less than 2000 and consistant with
the laminar flow regime assumption. For both models, the highest average WSS
values were found at the vestibule regions (rat 755 mPa and human 153 mPa) and
the lowest values were in the sinus regions (rat 2.8 mPa; and human 0.165 mPa).
Such low WSS values in the maxillary sinus regions are negligible and consistent with
airflow results in Xiong et al. (2008) and Ge et al. (2012) which found a mass flow
rate less than 0.006% of the total inhalation that flowed through the ostium and into
the maxillary sinus. High WSS value in the rat model was concentrated solely in the
vestibule region with a value at least 6 times larger than in other regions. For the
human case, the lower septum (122 mPa) and nasopharynx (133 mPa) regions also
exhibited high WSS values which were comparable to the vestibule region.
Table 6.3: Average WSS on anatomical regions of rat and human nasal cavities. In-
halation flow rate for relaxing breathing conditions are 0.4 Litre/min and 15 Litre/min
for rat and human, respectively.
WSS is generated by airflow velocity gradients adjacent to the nasal wall and can
be derived from pressure drop within the airway. To confirm this correlation, the
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pressure drop in three major nasal cavity regions: the vestibule, main nasal passage,
and nasopharynx, were calculated (Fig 5a) and compared with its average WSS (Fig
5b). Similar to WSS distribution, the pressure drop for the rat model was dominated
by the vestibule region, with a value of 68.8 mPa, approximately 5 times larger than
the pressure drop in the rest of the nasal cavity. For the human case, both the
vestibule and nasopharynx regions have equivalent pressure drop of nearly 9.5 Pa. A
strong correlation between pressure drop and WSS is observed when comparing Fig
5a and Fig 5b. Both the lowest pressure drop and lowest average WSS were found
in the main nasal passage and this is due to the volume expanding from the small
nostrils into the larger openings of the main passage. The expansion in chamber
volume reduces the airflow velocity, which reduces the WSS.
6.3.3 WSS Peak Comparison
To identify local high WSS regions on the nasal cavity wall, the WSS distribution was
plotted as peaks on a normalised 2D domain, allowing direct comparisons with the
two models (Fig 6). Since the WSS was negligible in the sinus region this was omitted
in the visualisation. Consequently, four small holes (white colour circles) representing
the ostium connection to the sinus are produced. The WSS peaks displayed went from
0 to 1000 mPa but the colorbar range was defined between 0 and 500 mPa to give
better visualisation. Figure 6.5b shows the WSS on the rat vestibule surface was on
average 10 times greater than in the main nasal passage and nasopharynx. In fact the
local peaks reached as high as 12000 mPa but these values were clipped to 1000 mPa
in Figure 6.6a to provide better comparisons across the entire nasal surface walls.
Furthermore, the vestibule region is covered by squamous epithelium and no mucus
secretion can be induced by the high WSS in this region, which also justifies the WSS
limiting.
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Figure 6.5: Pressure drop comparison in the vestibule, main cavity and pharynx
regions between rat and human airway under low breathing conditions (a). The pres-
sure drop is compared to average WSS on the nasal walls of each region. For the
rat nasal cavity, the magnitudes of pressure drop and average WSS are significantly
dominated by the vestibule region. Whereas for the human nasal cavity, they are rel-
atively evenly distributed across the three regions. Overall, the average WSS exhibits
positive correlation with the pressure drop.
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Figure 6.6: WSS distributions visualised by peaks on the mapped domains of rat (a)
and human (b). WSS on sinuses were negligible, and were removed leaving white
holes indicating the ostium connection to the sinus. Five local peaks are labeled from
’A’ to ’F’ in the rat model, and ’a’ to ’e’ in the human model.
For the rat model, three main WSS peaks were found at: (A) the vestibule; (B)
the anterior intersection of upper and middle nasal passage and; (C) the anterior
intersection of middle and lower nasal passage. Three minor peaks are found at: (D)
the intersection of upper and lower septum and; (E) the middle nasal passage and (F)
the posterior olfactory region. For the human model, three major WSS peaks were
found at: (a) the nasal valve region located from the posterior vestibule and anterior
main nasal passage; (b) the middle nasal passage and; (c) the posterior nasopharynx
region. Two minor peaks are found at: (d) the intersection of the upper and lower
septum and; (e) the anterior lower passage. Due to the asymmetry between left and
right human nasal chambers, the airflow rate is relatively higher in the right chamber.
As a result, more minor peaks were observed on the vestibule and at the intersection
of the main nasal passage and nasopharynx in the right chamber.
I investigated the mechanisms leading to high WSS production which is caused
by the air flowing over specific nasal structures. The WSS distribution were depicted
with filled contours from a top-view of the 2D domain and shown in Figure 6.7.
For each model, the direction of the highest WSS locations (top 1%) in the main
cavity and nasopharynx regions were indicated by vectors with its length scaled to
its WSS value. This determined the air flow direction passing over the high WSS
locations which showed that the isolated high WSS at region-B (rat model), and its
equivalent in region-b (human model), were surrounded by large areas of low WSS.
Dispersed vectors in all directions surrounded these region indicating air streamlines
separating away from each other due to the nasal structure. This vector pattern
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differs to other high WSS regions that exhibit relatively uni-directional vectors. Such
a pattern type indicates the high WSS is caused by acceleration of velocity due to a
geometry reduction in the nasal passage.
Figure 6.7: WSS contours visualized with vectors indicating the direction of shear
stress for (a) rat and (b) human nasal cavities.
6.3.4 Fluid Dynamic Characteristics Leading to High and
Low WSS
The mechanisms causing high WSS locations described in Figure 6.7 were analysed
again in 3D domain using flow streamlines. Figure 6.8 shows air streams (colored
by velocity magnitude) passing through the airway overlayed onto WSS distribution
(white-red surface colourmap) along the left nasal chamber. In this figure the inner
septum wall has been removed to visualise inside the left nasal chamber. The nasal
cavity cross-sectional area significantly expands posteriorly from the nasal valve (near
slice a-a’) and the airflow divides into three streams. Stream 1 flows into the superior
passage with low velocity and forms a large recirculation region located in the space
anterior to the olfactory region. This flow continues with a slow and steady air stream
flowing through the olfactory region. The recirculation region interacts with a large
area and produces extremely low WSS which was observed in Figure 6.6b - the low
valley surrounded by peaks a, b, d and e. Stream 2 flows into the middle passage but
is directed superiorly. It has significant influence on the high WSS at peak-b (from
Figure 6.6b) and is subsequently split into two sub-streams: stream 2-1 flows through
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the passage between upper septum and middle turbinate; stream 2-2 flows through
the middle meatus. Stream 3 remains along the floor of the nasal cavity. The four
streams gradually merge into one coinciding with the two nasal chambers merging.
The nasal passage reduces in cross-section as it transforms into the nasopharynx
causing flow acceleration, producing another local high WSS region.
Figure 6.8: Airflow streamlines passing through the left chamber of the human nasal
cavity. The septal wall has been removed and the view is inside the lateral wall.
Velocity contours are plotted on two cross-section slices. The WSS distribution is
plotted with white-red colour map.
Considerable differences were found in the rat model, using the same visualization
method with the inner septal wall removed from the left nasal chamber (Figure 6.9).
The streamlines showed a wider recirculation region formed in the posterior vestibule
region from floor to ceiling. At the nasal chamber expansion after the vestibule, the
airflow divided into two streams: stream 1 flowed through the superior passage slowly
and entered the olfactory region; stream 2 passed through the middle region Kimbell
et al. (1997) that is surrounded by the upper, middle and lower passages. It is shown
in the zoomed image panel of Figure 6.9 that the middle flow streamline path has a
direct impact on the local WSS peak at peak-B (from Figure 6.6b) and which splits
into two sub streams. Stream 2-1 firstly remains in the middle passage but then
gradually flows into the lower passage, while stream 2-2 flows through the middle
passage. These three streams (1, 2-1 and 2-2) gradually merge into one main stream
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posterior to the cross-section B-B’ as it flows into nasopharynx region. Compared
to the human model, there is no high WSS region generated in the rat nasopharynx
region because the cross-section area remains the same.
Figure 6.9: Air streams released from a cross-section adjacent to the end the vestibule
and they flow through septum-removed human left nasal chamber. Velocity contours
are plotted on two cross-sections. The WSS distribution is plotted with white-red
colour map.
The narrowest cross-sections were located at the vestibule entrance for rat and
vestibule exit for the human models. These two portals and it locations wield sig-
nificant influene on the downstream flow field. Using the 3D contour visualisation
on the normalised unwrapped rat and human geometries (same as Figure 6.6), the
pressure distributions were plotted in Figure 6.10. For the rat case, the pressure
dropped rapidly and significantly, approximately 80 Pa inside the vestibule, from the
narrowest cross-sectional area, the nostril entrance. Thereafter, in the main nasal
passage and olfactory region, there is a more steady and slow pressure drop. For the
human model, the pressure drop across the nasal cavity was approximately 25 Pa
from the nostril entrance to nasopharynx. Locally I observe a rapid pressure drop in
the vestibule region, followed by a smooth and slow pressure drop in the main nasal
passage. At the nasopharynx there is a second rapid pressure drop. This correlates
with the existence of the two so-called ‘valves’ that exist in the nasal cavity. The first
being the anterior nasal valve that separates the anterior (vestibule) region with the
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main nasal passage. The second is the posterior nasal valve known as the choanae
and is an opening between the main nasal passage and the nasopharynx. Both these
valves exist close to the regions of rapid pressure drops in the nasal cavity.
Figure 6.10: Pressure distributions visualised by peaks on the mapped domains of rat
(a) and human (b). Pressure on sinuses were negligible, and were removed leaving
white holes indicating the ostium connection to the sinus. Pressure stages are labeled
stage 1-3 in the rat model, and stage 1-2 in the human model.
6.4 Conclusion
Based on the inhaled airflow and its interaction with the nasal passages, the fluid
dynamics supporting nasal function, air conditioning, and sensation becomes clearer.
For both human and rat models, the wall shear stress peaked around the nasal valve
due to the significantly reduced cross-sectional area. Despite the nasal epithelium at
this region constantly subjected to substantially elevated shear, the majority of the
epithelium cells are keratinised, which is adaptive to the high shear stress environ-
ment. Both air conditioning and sensation functions require sufficient contact between
nasal epithelium and inhaled airflow. The inner curved turbinates not only increase
the surface area of the nose, but also divide and redistribute the nasal-valve-filtered air
flow into many sub-streams with relatively lower flow velocity. With sufficient mass
and heat transfer between the main passage and the airflow, the air is conditioned to
a state ready for entry into the delicate lungs.
For the human nose, the olfactory region located at the uppermost nasal cavity
is the only site in human body where the central nervous system has potential to
directly interact with the external environment. This means that inhaled gases within
the air itself reaching the olfactory region must be low velocity and clean for gas
diffusion process involved in olfaction. Based on the flow streamlines and velocity
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in Figure 6.9a, a well aligned streamline with extremely low velocity was observed,
which facilitates gas diffusion. Geometry analysis of the models showed the olfactory
region in the human superiorly positioned, away from the bulk flow. For the rat
nasal cavity, the olfactory region is located posteriorly, aligned with the horizontal
axis of the geometry, and preceded by complex shaped turbinate bone intrusions.
The significant number of turbinates re-direct the bulk flow away from the olfactory
region, leaving behind a low airflow region (Figure 6.9). It is notable that the WSS
and olfaction functions rely on the flow splitting by the upstream turbinate walls,
resulting in locally-peaked WSS in the main passage. Therefore, the nasal epithelium
cells may be more vulnerable of tissue damage compared with other regions.
The results in this work aimed at contributing towards the research gap in WSS
comparisons between rat and human nasal cavities since the two species are used in-
terchangebly in many exposure studies. Visualisation of the WSS over the entire nasal
cavity wall surface was revealed by using a 3D into 2D surface unwrapping technique
(Inthavong et al., 2014). Additional fluid dynamics analysis provided insight into the
physical flow behaviour that led to locally high WSS. These findings could be used
as a first step towards a larger sampled study of many nasal cavities to determine if
the gross flow patterns are persistent between many samples.
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Chapter 7
Comparative Studies of Particle
Deposition Patterns between
Human and Rat Nasal Cavities
The main findings of this chapter have been published in:
• Comparative numerical modeling of inhaled micron-sized particle deposition in
human and rat nasal cavities. Inhalation Toxicology, 27(13):694-705
• Comparative numerical modeling of inhaled nanoparticle deposition in human
and rat nasal cavities. Toxicological Sciences, 152(2):284-96
136
7.1 Comparative Study of Microparticle Deposi-
tion in Human and Rat Nasal Cavities
Abstract:
Micron-sized particle deposition in anatomically realistic models of a rat and hu-
man nasal cavity was numerically investigated. A steady laminar inhalation flow rate
was applied and particles were released from the outside air. Particles showing equiv-
alent total particle deposition fractions were classified into low, medium and high
inertial particle. Typical particle sizes are 2.5, 9 and 20 µm for the human model and
1, 2 and 3 µm for the rat model, respectively. Using a surface-mapping technique the
3D nasal cavity surface was ‘unwrapped’ into a 2D domain and the particle deposition
locations were plotted for complete visual coverage of the domain surface. The total
surface area comparison showed that the surface area of the human nasal model was
about ten times the size of the rat model. In contrast, the regional surface area per-
centage analysis revealed the olfactory region of the rat model was significantly larger
than all other regions making up nearly 55.6% of the total surface area, while that
of the human nasal model only occupying 10.5%. Flow pattern comparisons showed
rapid airflow acceleration was found at the nasopharynx region and the nostril region
for the human and rat model, respectively. For the human model, the main passage
is the major deposition region for microparticles. While for the rat model, it is the
vestibule. Through comparing the regional deposition flux between human and rat
models, this study can contribute towards better extrapolation approach of inhalation
exposure data between inter-subject species.
7.1.1 Introduction
To evaluate the health risk by inhalation exposure, particle dosimetry models have
been developed to predict the fate of inhaled airborne particles in the respiratory
passages (Kelly et al., 2005; Asgharian et al., 2014). This requires information re-
garding the amount of particles escaping from the nasal cavity. Particles that deposit
onto the nasal cavity have two possible uptake routes. They can cross the respira-
tory epithelium and reach the underlying blood vessels, or be adsorbed through the
olfactory epithelium, transporting along the olfactory bulb and reach the brain, as
demonstrated in rat subjects (Oberdrster et al., 2004; Bai et al., 2010). The relevance
of this data can be difficult to extrapolate to human subjects because of the different
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anatomical geometryin humans the olfactory mucosa represents 5-10% of the total
nasal mucosa but 50% in rats (Schroeter et al., 2008).
Early in-vivo studies of ultrafine particle deposition in rats using exposure cham-
bers include Wolff et al. (1984) and Gerde et al. (1991). Later, Kelly et al. (2001,
2002) investigated particle deposition fraction in rats where all particles were either
directly inhaled or particles were inhaled naturally using head-only units and whole
body chambers. The deposition fractions varied between the inhalation methods
tested, since particle inhalability inherently differs for each method. This suggests
that the breathing region and external nose should be considered in model studies.
In-vitro experiments using replica molds have also received intensive research efforts
which investigated the influence of the human nasal cavity (Cheng et al., 1996a; Dai
et al., 2007; Golshahi et al., 2011) and the rat nasal cavity (Cheng et al., 1990; Kelly
and Kimbell, 2001; Ahmed et al., 2012) morphology on particle deposition.
Computational fluid dynamics (CFD) modeling studies have determined airflow
patterns, gas uptake and particle deposition in rats (Garcia and Kimbell, 2009;
ACGIH, 2013; Jiang and Zhao, 2010; Schroeter et al., 2012; Wei et al., 2013), and
humans (Oldham, 2000; Inthavong et al., 2008b; Ghalati et al., 2012; Ghahramani
et al., 2014; Dastan et al., 2014). These studies revealed the main deposition sites for
different particle sizes, and used non-dimensional numbers (i.e. inertial parameter,
Stokes number, and Peclet number) to incorporate the influence of particle size with
combinations of flow rate and airway geometry.
Interspecies modeling comparisons have been performed by Zhao et al. (2006a)
investigating the influence of sniffing conditions on odorant transport; Schroeter et al.
(2008) studying acrolein uptake; and Corley et al. (2012) which considered high-
resolution models of the respiratory airway from nose to deep lung branches for vapor
uptake analysis.
Although inhaled particle deposition characteristics have been considerably stud-
ied both experimentally and numerically, limitations still exist in terms of deposition
analysis and data extrapolation among species. The nasal cavity is an extremely
complicated geometry that is difficult to visualize without a 3D viewer. This makes
particle deposition patterns in nasal cavities inaccessible in some regions. Further-
more, the anatomical geometries of the nasal cavity differ among species causing
different fluid-particle interactions and leading to different deposition regions for the
same particle sizes.
This study aims to provide detailed particle deposition characteristics of micron-
sized particles within anatomically accurate rat and human nasal passages, to re-
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veal their deposition similarities and differences. Unlike previous studies, this article
presents a systematic method to visualize the respiratory surface by converting the 3D
nasal cavity surface into a 2D domain. This allows data access to the entire wrapped
nasal cavity walls. The outer face of both species is included to account for real-
istic particle inhalation. This comparative study can contribute towards improving
extrapolation from monitored exposures of laboratory animals to possible human ex-
posure scenarios, and better understanding the cause-and-effect relationship between
particle exposure risk and health consequences.
7.1.2 Methods
7.1.2.1 Nasal Models
Computational models of the human (48-year-old healthy male) and rat (Sprague-
Dawley, 400 g) nasal passages were developed based on CT images. The models
were truncated at the anterior trachea to focus on particle deposition in the upper
respiratory tract. Figure 7.1a shows the airway reconstructed from CT images. The
models include both left and right nasal passages, and the nasopharyngeal duct.
Detailed model reconstruction and its verification have been reported in the author’s
previous article (Inthavong et al., 2009a). To better represent the flow conditions at
and around the nostril inlets, the external nares, facial features, and the surrounding
environment near the face were included (Figure 7.1b) (Doorly et al., 2008c; Se et al.,
2010b; Ge et al., 2013; Inthavong et al., 2012a, 2013a).
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Figure 7.1: (a) Contiguous nasal airway passage (green) extracted from CT-scans.
Additional anatomical features are overlayed in gray color for the outer face, and green
color for bone structure. (b) CFD model showing the face-nasal cavity computational
domain exposed to micron particles from the surrounding air. The human nasal cavity
used in this study is labeled as NC04 and the rat nasal cavity is RNC01.
The nasal surface was divided into seven regions based on a combination of
anatomical features and epithelial tissue types (Gross et al., 1982; Schroeter et al.,
2012, 2015). These regions are: the (i) vestibule (squamous epithelium); (ii) upper
passage (mainly transitional epithelium); (iii) middle and (iv) lower passage (mainly
respiratory epithelium), (v) olfactory (olfactory epithelium), (vi) septum and (vii)
pharynx.
The surface-mapping technique originally developed by Inthavong et al. (2014) was
adopted to unwrap the nasal cavity morphology from its 3D domain (Figure 7.2 a,b)
onto a planar 2D domain and normalized its length and width (Figure 7.2 c,d). The
model was first sliced along the centerline of the nasal passage floor; where the lateral
and septal wall sides meet inferiorly. The 3D surface coordinates were transformed
into a new set of coordinates in 2D space, which mimics the surfaces being unfurled
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and laid out with the top and bottom boundaries representing the initial centerline
slice along the nasal passage floor, and the left and right boundaries representing
the nostril inlet, and nasopharynx exit respectively. Finally, the 2D surface was
normalized into an orthogonal shape allowing direct comparisons between species.
Figure 7.2: (a) and (b) 3D domain of the human nasal cavity and (c) and (d) 2D
unwrapped models of the Human NC04 and Rat RNC01 nasal models separated,
and labeled with seven major nasal anatomical types. As surfaces were significantly
distorted in 2D domains during normalization, absolute surface areas of the vestibule
(I), main passage (II) and pharynx (III) are given.
The computational models were meshed using ICEM-CFD (ANSYS Inc., Canons-
burg, PA) with unstructured tetrahedral elements. Prism layers were applied in near
wall regions to provide accurate near wall particle behavior. The number of indepen-
dent mesh elements for the human and rat models were 3.8 million and 4.2 million,
respectively.
7.1.2.2 Inhalation and Particle Deposition Modelling
Physiological reasonable steady flow rates (15 L/min for the human model and 0.4
L/min for the rat model) are used to simulate rest breathing conditions (Kelly et al.,
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2004a). The flow was treated as laminar and incompressible using the commercial
CFD package, ANSYS-Fluent v14.5 (ANSYS).
To ensure similarity with particle exposure experiments, micron-sized particles
were released in front of breathing zone (Figure 7.1b). It was reported that par-
ticle deposition fraction approaches 100% in human nasal cavities when particle
diameters>20 µm (Inthavong et al., 2006), while for rats, this occurs for particle
diameters>5m (Kelly and Kimbell, 2001). Therefore, this study is mainly focused on
particle diameter within the range of 0.5-20 µm for the human model and 0.5-5 µm
for the rat model.
The particle Stokes number (Stk) was calculated to compare the different fluid-
particle behavior caused by interspecies differences between the human and rat mod-
els. It is commonly used in respiratory deposition studies (Wang et al., 2009; Inthavong
et al., 2011b; Schroeter et al., 2012; Si et al., 2013) since it considers the flow rate,
particle, and airway geometry, which all contribute towards the inertial character of
the airborne micron particle. These variables come together as:
Stk =
2ρd2Q
9piµd3c
(7.1)
The calculation of the Stk largely depends on a characteristic diameter dc that
is determined from the airway geometry, which wields significant influence. In this
study, the characteristic diameter is estimated by the total nasal volume V and the
total nasal surface area S (Garcia and Kimbell, 2009; Golshahi et al., 2011; Storey-
Bishoff et al., 2008):
dc =
V
S
(7.2)
Typical low, medium and high inertial particles were defined according to their
total deposition fractions 3, 40 and 100% in the human and rat nasal cavities. The
correspond in particle sizes are 2.5, 9 and 20 µm for the human model, and 1, 2 and 3
µm for the rat model. However, the corresponding Stokes numbers are quite different,
with 3.0, 39.0 and 193.3 for human and 1.2, 4.8 and 10.9 for rat (Table 7.1).
7.1.2.3 Particle Deposition Visualization
Previous studies have demonstrated that particles deposit on the skin-like squamous
epithelium in the vestibule region can be cleared from the nose, and those enter into
nasopharynx region are likely to deposit in lower respiratory tract therefore damaging
the lung (Schroeter et al., 2008). Three main nasal areas (Figure 7.2) were defined
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to evaluate and compare the nasal filtering function for all three typical particles.
These areas are: area-I (includes the nasal vestibule); area-II (includes the main
nasal passage) and area-III (includes the nasopharynx).
Although regional particle deposition fraction analysis has been extensively inves-
tigated in previous studies (Schroeter et al., 2008; Garcia and Kimbell, 2009; Schroeter
et al., 2015), direct interspecies comparisons remains difficult due to the inconsistency
during the anatomical region mapping, geometrical variations of nasal models and sig-
nificant anatomy differences between human and rat nasal models. To allow direct
comparisons, I visualize the particle deposition pattern across the entire nasal cavity
surface using the unwrapped surface technique.
The particle deposition pattern was visualized using 10000 particle deposition
locations on the 3D transparent nasal domain (side view and top view), and the
corresponding unwrapped 2D domain. In addition, cross-sectional particle densities
were extracted along the nasal passage to reflect the deposition depth of hot spots.
Therefore, particle deposition hot spots can be visualized in 3D, 2D and 1D, which
enables an effective way to distinguish different sized particle deposition patterns and
quantify the particle deposition penetration.
7.1.3 Results and Discussion
7.1.3.1 Nasal Cavity Measurements and Comparison
Anatomical measurements of the major epithelial regions were compared between the
human and rat models in Table 7.2. The total surface area of the human model was
almost 10 times of the rat model. The largest surface area coverage for the human
model were the middle (26.9%) and lower passages (25.9%) which combined together
to make up approximately 52.8% of the total surface area. In contrast, the rat middle
and lower passage only took up 16.3% in total. The largest area coverage for the rat
model was the olfactory region which contributes 55.6%, enabling the region to have
greater exposure to inhaled particles. This compared with the human model that
showed a value of 10.5%.
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Table 7.1: Comparison of deposition fractions, particle sizes, inertial parameters and
Stokes numbers for the rat and human models.
Table 7.2: Geometrical comparison of major anatomical regions for rat and human
nasal models.
Comparisons with available data from literature were made for the vestibule and
olfactory regions. There is generally good agreement for the human and rat model
based on the epithelia mapping. The rat vestibule and olfactory region is slightly
greater than the reported values in the literature. These two regions were selected
for comparison as they have important roles in basic nasal functions. As the most
anterior part of nasal cavity, the vestibule is covered by vibrissae (short and thick
hairs), enhancing particle filtration while the olfactory region is rich in olfactory
sensory neurons and capillaries, allowing olfaction. The nasal volume of the human
model is 39 times of the rat model. However, the characteristic length of human
model (1.27 µm) is only around five times of the rat model (0.28 µm), indicating that
the nasal structure of rat is more complex than that of human (Table 7.2).
7.1.3.2 Inhalation Flow Patterns
Tracing flow streamlines provides insight to the likely path trajectory an airborne
particle may follow. Flow streamlines were traced from the outside air as it enters
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the nostril inlet (Figure 7.3). By including the facial features, natural flow paths are
produced (Doorly et al., 2008c; Corley et al., 2012) which differs to cast replica model
studies or computational models that omit the face and outside air region.
Figure 7.3: Representative flow streamlines in the human, and rat nasal cavities
showing regions of high velocity. A cross-section slice taken at a-a’ in the human
model and b-b’ in the rat model shows velocity magnitude contours.
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For the human model, the streamlines predominantly distribute through the cen-
ter rather than the ceiling or the floor of the airway. Swirling flow is found near
the olfactory region and this can be attributed to the lower flow velocities found
in the upper airway region to allow gases to be taken up by olfactory nerves, but
prevent larger micron-sized particles from reaching the nerves and damaging them.
The single streamline shows flow acceleration immediately after the nostril inlet, and
high acceleration at the nasopharynx caused by the airway passage decreasing to a
smaller cross-sectional area. These regions of acceleration propel the airborne parti-
cles forwards, increasing the particle inertia. This increases the likelihood of particle
impaction when the flow streamline changes path and the particle inertia is too great.
This flow feature makes the anterior nasal half and the nasopharynx region acting as
a gravimetric sampling filter. The cross section shows a flow preference to the left
nasal chamber which is caused by the larger volume found from the scanned data,
linked to the regulating nasal cycle.
For the rat model flow enters the nose and immediately turns sharply, followed
with a U-shaped turn and a further 90-degree bend before entering the main nasal
passage. These sharp turns provide significant filtration function. The initial sharp
acceleration increases the velocity from the ambient zero velocity to 10 m/s in the
space of a few millimeters. In the human model, the acceleration in the nostril region
increases the velocity to 2.5 m/s and in the nasopharynx increases to 6.5 m/s. The
rapid velocity increase over a short distance in the rat airway significantly increases
the particle deposition for micron-sized particles. This has significant implications
when direct comparisons are made for deposition models with human nasal cavity
airways that have a more relaxed acceleration through the nasal vestibule.
Although the olfactory regions of both human and rat are located in the dorso-
posterior region, the olfactory region of human is located superiorly relative to the
nostril entry for inhaled air while the rat model it is in-line with the nostril entry.
For the rat model particles or gases that are able to penetrate the anterior nose are
easily taken up by the olfactory region, particularly since the region has 50% surface
coverage of the entire nasal cavity. The cross-section slice shows the rat passage has
a more complicated geometry. The flow concentrated along the floor of the airway
and this is because the lower region connects to the pharynx.
7.1.3.3 Particle Deposition Fraction Comparison
The particle deposition fraction was defined as the ratio of the number of particles
depositing in the nasal cavity to the total amount of particles inhaled. This was
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plotted against the particle inertial parameter I = ρd2Q where ρ is the particle
density (g/cm3), d is the particle diameter (µm) andQ is the volume flow rate (cm3/s).
Comparisons were made with existing literature data to confirm the reliability of the
computational model simulations.
Figure 7.4: Particle deposition fraction as a function of the inertial parameter I
comparison between the results obtained from the human NC04 model simulation
with data in the literature.
Figure 7.4 compares the simulation results for the human NC04 model with: in-
vitro data from Kelly et al. (2004a) that used a human nasal replica made from
MRI scans of a Caucasian male subject; CFD simulations by Schroeter et al. (2011)
that modified Kelly et al. (2004a)’s model into model A, B and C with three different
surface roughness; and in-vivo data by Hsu and Chuang (2012) that studied nine male
and female volunteers from Taiwan with ages ranging from 23 to 45. The predicted
deposition fraction profile produced an S-shaped inertial deposition curve and showed
good agreement with the existing data; especially well matched with Model B from
Schroeter et al. (2011). The deposition fraction remains < 10% when the inertial
parameter I < 104g · µm2/s. As the inertial parameter I increases, the deposition
profile increases sharply and reaches complete deposition when I < 105g · µm2/s.
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Figure 7.5 compares the simulation results for the rat RNC01 model with: in-vivo
data from Kelly et al. (2001) that studied particle exposure experiments on 22 female
Long-Evans rats; and in-vitro data from Kelly and Kimbell (2001) using a nasal
replica cast model from one Long-Evans rats. The comparison shows that for inertial
parameter I < 10g · µm2/s, the numerical simulation slightly under predicts with
the in-vivo results (triangle symbols) but fits better with the in-vitro results (circle
symbols). For inertial parameter I > 10g ·µm2/s, the numerical model compares well
for both experimental results with a slight under prediction when inertial parameter
I approaches 102g · µm2/s.
Figure 7.5: Particle deposition fraction as a function of the inertial parameter I
comparison between the results obtained from the rat RNC01 model simulation with
data in the literature.
7.1.3.4 Deposition in the Human NC04 Model
Figure 7.6 shows a majority of particles depositing in the main nasal passage (II)
capturing 2.12, 35.8 and 77.4% of particles for the low, medium and high inertial, re-
spectively. Preferential deposition in this region occurs because the airway opens up
from the anterior nose allowing more particles to access the main passage. Although
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the vestibule is the second preferred deposition site, the deposition fractions are neg-
ligible for low (0.95% deposition) and medium (2.85% deposition) inertial particles.
It increases significantly to 21% for high inertial particles. The nasopharynx (III)
region has the lowest deposition for all particle sizes due to its posterior location.
Figure 7.6: Regional particle deposition fraction comparison for the human NC04
model using semi-log axes.
Figure 7.7 shows the deposition pattern in the human NC04 model. Deposition
of 2.5 µm particles shows a large, widely dispersed deposition pattern with a total
deposition fraction of 3.5% (left chamber: 1.1%, right chamber: 2.4%). The depo-
sition pattern in 3D space is cast onto the 2D domain which reveals the extent of
dispersion (Figure 7.7c). This is characteristic of low inertial particles that are more
likely to adapt to the changing inhaled flow paths as it is being transported through
the nasal cavity and penetrate the nasal cavity further. For a particle size of 9 µm,
the total deposition fraction is 40.0% (left chamber: 17.7%, right chamber: 22.3%)
as the particle inertia is increased. This leads to fewer particles able to follow the
airflow, and its deposition pattern region reduces. For 20 µm particles, deposition
fraction reaches 100% with a majority 70% depositing in the right chamber. Particles
are mainly concentrated in the main nasal passage (area II) by direct impaction. The
deposition pattern cast onto the 2D domain shows local concentration of particles
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near the entrance to the main nasal passage. In both cavities, deposition occurs on
the nasal septal wall side. More particles deposited in the right chamber compared
to the left chamber for all three particle sizes tested. This was mainly due to the
asymmetric geometry of the human NC04 model, where its right nasal chamber is
slightly larger than the left, allowing more airflow through with less flow resistance
(which was found in the cross section contour in Figure 7.3). I analyzed the mass
flow attribution in each chamber which showed a 32:68% flow rate distribution in
the left to right chambers. Figure 7.7c shows particle deposition is more disperse
and broad in the right cavity compared to the left cavity. One major reason is the
degree of the uneven flow rates between the two chambers producing irregular path
trajectories. Particles prefer to deposit at sites where the airflow velocity decreases
sharply. This is consistent with the cross-sectional contour of the human model in
Figure 7.3 (bottom-left panel) where the airflow in the right cavity exhibits much
higher velocity gradient than that in the left cavity, causing particles to scatter more
around the cavity.
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Figure 7.7: Particle deposition patterns for the human NC04 model in the 3D do-
main (a and b), 2D planar domain (c) and deposition penetration distribution (d).
Particle sizes are colored based on the low (2.5 µm, blue), medium (9 µm, green)
and high inertial (20 µm, red) according to their deposition fractions reported. The
x-coordinate in (d) is normalized by the maximum penetration depth from nostril to
nasopharynx.
The deposition penetration distribution in 7.7d indicates that particles are con-
centrated in four hot spots labeled as ‘A’, ‘B’, ‘C’ and ‘D’ in the human nasal cavity.
Location ‘A’ and ‘D’ are located at the top of vestibule of right cavity and posterior
septum of right cavity, respectively. These regions in the right chamber are preferen-
tial deposition sites for all three particles. Further inspection of the geometry shows
that region is a consequence of the airflow entering the nostril inlet at higher momen-
tum, while location ‘D’ exhibits a minor deviated septum causing flow disturbance.
Location ‘B’ has high deposition of high inertial particles (20 µm) only for both
chambers. This location is located at the ‘nasal valve’ which is close to the common
boundary of vestibule and septum of both cavities. Location ‘C’ exhibits high depo-
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sition for medium (9 µm) and high (20 µm) inertial particles. The deposition occurs
at the anterior septum for both chambers and at the common boundary of septum
and upper passage of left cavity.
7.1.3.5 Rat RNC01 Model
Local deposition fractions for the rat model (Figure 7.8) exhibit a different profile to
the human model. For all particles, deposition predominantly occurs in the vestibule
(I) region with deposition fractions of 2.4, 38.9 and 100% for the low, medium, and
high particle inertial, respectively. This suggests that the region behaves as a signifi-
cant particle filter. This correlates with the anatomy which shows highly curved and
narrowing vestibules that accelerate the air from stagnant velocity to a peak of 10 m/s
within the curved vestibule. The influence on a 3 µm particle is profound displaying
complete inertial impaction at the nostril bend, thus offering a good protection for
the olfactory region and the lung.
Figure 7.8: Regional particle deposition fraction comparison for the rat RNC01 model
using semi-log axes.
The high velocity combined with the small airway geometry in the rat model
produces highly sensitive behavior for incremental changes in particle size. When
the particle size reduces from 3 µm to 2 µm the deposition fraction decreases from
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100 to 40% and a further reduction to 1 µm produces only 3% deposition. The
implication is that experimental rat studies become highly susceptible to variability
in the controlling the production of monodispersed particles for exposure. In this
study using the rat model RNC01, particles spanning a few microns in size exhibit
vastly different deposition behavior. The micron particle size range sensitivity will
increase further in general if the peak velocity is greater, and the airway geometry is
smaller. Conversely the size range will be greater when the peak velocity is smaller
and the airway geometry is generally larger, as found for the human model NC04.
The deposition patterns for the rat RNC01 model (Figure 7.9) showed significant
differences to those in the human model. The majority of high (3 µm) and medium
(2 µm) inertia particles deposited at the sharp bend of the nasal vestibule, and only
the finest 1 µm particles penetrated and dispersed through the main nasal passages.
This is primarily due to the rapid acceleration of air as it enters the nose which is
then confronted with two curvatures in the airway resembling an 180-degree bend
and a 90-degree bend. This anatomical feature creates a natural filtering function,
trapping inertial particles on the upper wall of the nostril bend. This is exemplified
by deposition of the 3 µm particles occurring on the upper wall of the nostril bend,
and the 2 µm particles depositing across the narrow radial strip around the nostril
inlet. For 1 µm particles a more distributed pattern occurs through the nasal cavity,
although this also exhibits a preference for the nostril inlet region. Schroeter et al.
(2012) simulations indicated particles do not achieve 100% deposition fraction until
particle sizes reach 5 µm, which is much larger than the 3 µm found in this study.
I believe this is due to the larger Sprague-Dawley rat size used in Schroeter et al.
(2012), which had a weight 50% heavier than the rat used in this study. A larger
specimen would have wider nasal passages, allowing slower velocity magnitude and
lower resistances.
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Figure 7.9: Particle deposition patterns for the rat RNC01 model in the 3D domain (a
and b), 2D planar domain (c) and deposition penetration distribution (d). Particle
sizes are colored based on the low (1 µm, blue), medium (2 µm, green) and high
inertial (3 µm, red) according to their deposition fractions reported. The x-coordinate
in (d) is normalized by the maximum penetration depth from nostril to nasopharynx.
The deposition penetration distribution in Figure 7.9d shows three high concen-
tration spots (‘A’, ‘B’ and ‘C’) which are all located at the vestibule region. The 3 µm
particles have direct impaction concentrated at upper region of the first nostril bend
(location ‘A’) when inhaled into nostrils with high-speed airflow. With lower inertia,
2 µm particles penetrate slightly further and deposit on the lateral wall (location ‘B’)
located between the first and second nostril bends. Although 1 µm particles pass
through the first bend, the majority of them are captured at the second bend at loca-
tion ‘C’. Apart from the vestibule, the olfactory region also exhibits some significant
deposition (location ‘D’) but this only occurs for 1 µm particles.
A comparison of the deposition fractions for the low, medium and high inertial
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particles shows reasonably consistent values between the rat and human models. The
deposition fraction is highly sensitivity to particle size for rats as there is a jump
from 3 to 100% for an increase from 1 to 3 µm particles. In comparison, the same
increase in deposition fraction in the human model occurs from a particle size of 2.5
to 20 µm. The rat airway geometry is relatively symmetric in this RNC01 model.
The cross sectional contour in Figure 7.3 shows nearly 0.2 L/min air flow through
each chamber, which produced nearly equal amounts of particle deposition in both
chambers.
7.1.3.6 Extrapolation from Rat to Human
I calculate the deposition fraction in the seven anatomical/epithelial tissue regions
defined in Figure 7.2. The deposition fraction is then normalized by the regional area
fraction (which is simply the regional area divided by the total surface area). This
creates a deposition flux value and can be written as:
f =
nregional/ntotal
Aregional/Atotal
(7.3)
where nregional is the quantity of particles deposit in a particular region and ntotal
is the quantity of particles inhaled into the nasal cavity. Aregional is the regional area
and Atotal is the total nasal surface area.
Table 7.3: Comparison of particle deposition dose-metric (deposition per unit area)
between rat and human.
Table 7.3 summarizes the deposition flux for the human and rat model to evaluate
the possible deposition extrapolation for low, medium and high inertial particles. In
general, for all particles, highest f value is found in the vestibule region. While
the upper passage typically exhibits the lowest deposition flux. To enable direct
deposition data extrapolation, regional scaling factor is introduced as the variations
between the rat and human models are not linear for each region. Scaling factors X
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are calculated based on the ratio of the f of the human model to the rat model. The
values show that direct extrapolation is not applicable for high inertial particles since
no particles with size 3 µm or greater can penetrate the rat vestibule. The maximum
scaling factor (X=82) occurs in the septum region for medium inertial particles. This
is mainly attributes to the medium inertial particles can travel deeper downstream in
the human nasal model, while majority of them are filtered by the vestibule region
for the rat model. Similarly, due to this efficient filtration, the vestibule shows a
minimum scaling factor (X=0.068) for medium inertial particles. For low inertial
particles, upper passage, lower passage and olfactory regions exhibit the closest 1:1
matching for data extrapolation.
7.1.4 Conclusion
Results obtained from exposure studies using rat models are typically extrapolated to
human subjects. The objective of this study was to gain further insight for extrapo-
lating inhalation exposure data between inter-subject species. The anatomy, airflow,
and particle deposition in a rat and human nasal cavity was investigated using CFD.
Anatomy comparisons showed that the cavity surface area of the human model was
about ten times the size of the rat. The largest surface area coverage for the human
was the middle and lower passages which combined to make up 52.8% of the total
surface area, while for the rat model, the olfactory region made up 55.6% of the total
surface area. These regions were also the preferential sites for deposition of 2.5 µm
particles. The other major anatomical difference is the shape of the nasal vestibule
which plays a significant role in producing the inhaled airflow streamlines. A sharp
U-turn (180-degree) bend is found in the rat model which accelerates the inhaled air
to a peak velocity of 10 m/s despite an inhalation rate of 0.4 L/min. Comparatively
the human model exhibits a 90-degree bend at the nasal vestibule and accelerates
the flow to 2.5 m/s for an inhalation rate of 15 L/min. To account for these differ-
ences we used the total deposition fraction to determine appropriate particle sizes for
low, medium, and high inertial properties. It was found that the particle size range
suitable to represent these three inertial regimes was 2.5 to 20 µm for the human
model and 1 to 3 µm for the rat model. This places stringent limitations for par-
ticle size selections for rat inhalation exposure studies. We introduced a deposition
flux parameter which compares the deposition fraction per regional area fraction for
the human and rat models. A direct comparison showed that a scaling factor was
needed in order to extrapolate the deposition data from one species to another. Low
inertial particles show the closest scaling factor of 1:1 matching. Although this study
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only investigated a single subject specific model for rat and human species, the key
anatomical differences and deposition pattern is expected to be reasonably common
across different models.
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7.2 Comparative Study of Nanoparticle Deposi-
tion in Human and Rat Nasal Cavities
Abstract:
To gain a better understanding of nanoparticle exposure in human nasal cavities,
laboratory animals (e.g. rat) are used for in-vivo studies. However, due to anatomical
differences between human and rodent nasal cavities, direct particle deposition com-
parisons between species are difficult. This paper presents a comparative nanoparticle
(1 nm, 10 nm, and 100 nm) deposition study using anatomically realistic models of a
human and rat nasal cavity. The particle deposition fraction was highest consistently
in the main nasal passage, for all nanoparticles tested, in the human model; whereas
this was only the case for 10 nm, and 100 nm particles for the rodent model, where
greater deposition was found in the anterior nose for 1nm particles. A deposition
intensity (DI) term was introduced to represent the accumulated deposition fraction
on crosssectional slices. A common and preferential deposition site in the human
model was found for all nanoparticles occurring at a distance of 3.5 cm inside the
nasal passage. For the rodent model maximum DI occurred in the vestibule region at
a distance of 0.3 cm, indicating that the rodent vestibule produces exceptionally high
particle filtration capability. We also introduced a deposition flux which was a ratio
of the regional deposition fraction relative to the region’s surface area fraction. This
value allowed direct comparison of deposition flux between species, and a regional
extrapolation scaling factor was found (e.g. 1/10 scale for vestibule region for rat to
human comparison). This study bridges the in-vitro exposur experiments and in-vivo
nanomaterials toxicity studies, and can contribute towards improving inter-species
exposure extrapolation studies in the future.
7.2.1 Introduction
Current nanotechnology prosperity has produced various products based on nano-
materials such as quantum dots, carbon nanotubes and nano-medicines, leading to
increased human exposure to airborne nanoparticles (Abbott and Maynard, 2010;
Raj et al., 2012; Vance and Marr, 2015). A number of studies have investigated
the biological impact of nanoparticles on physiological systems and its translocation
between organs across physiological boundaries (Knudsen et al., 2014; Liu et al.,
2011; Wu and Tang, 2014). Oberdrster et al. (2004) concluded from their studies
that inhaled ultrafine solid particles could translocate into the brain by depositing
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on the olfactory mucosa of the nasal region and translocating along the olfactory
nerve into the olfactory bulb. Its entry into the central nervous system occurs via
the unique connection of olfactory and the trigeminal nervous system between the
brain and external environment. The existence of this pathway for viral infection of
the brain has long been recognized (Doty, 2015). Particles can also translocate to
extra-pulmonary sites (interstitium, lymph and blood circulation, neurons) if they
are taken up via epithelial cells (Elder and Oberdrster, 2005).
Our previous results showed that nanoparticles may translocate via the olfactory
bulb and olfactory nerve, then distribute in the hippocampus, cerebral cortex and even
cerebellum - although only a small amount entered the brain tissues when compared
to exposed doses (Wang et al., 2008a,b; Zhang et al., 2011; Boyes et al., 2012; Zhang
et al., 2012; Bai et al., 2014). If nanoparticles are trapped in the sinuses, then sino-
mucus inflammation, chronic rhino-sinusitis and paranasal sinus mucosal thickening
(Lai et al., 2011) are expected. If deep deposition in the lung occurs, nanoparticles can
penetrate the alveolar epithelial and translocate into the circulatory system, causing
pulmonary diseases and degeneration of other organs (Aalapati et al., 2014; Lu et al.,
2014b).
Increased human exposure to nanomaterials mandates a full understanding of its
toxicology for health risk assessments. The field of toxicology generally relies on large
scale in-vitro cell incubation testing with a presumption that it sufficiently reflects
real human exposure and predicts the same tissue responses in-vivo (Seagrave et al.,
2005; Sayes and Warheit, 2008). This task is hindered by the need to apply correct
dosimetry which is often applied blindly. Oberdrster et al. (2005) highlighted this
challenge reporting that many in-vitro studies indeed report false-positive risk iden-
tification of toxic nanoparticles which otherwise would be safe if a realistic in-vivo
dosimetry were applied. Meanwhile, in-vivo methods applying intratracheal instilla-
tion (Driscoll et al., 2000) remains independent of the external inhalation exposure
conditions and how to match the instillation amount of test material with realis-
tic regional particle exposure dose remains challenging (Geiser and Kreyling, 2010),
since variables such as nasal morphology, inhalation flow rate, and particle size play
a role. Hyun et al. (2008) conducted silver nanoparticles exposure on rats in an ex-
posure chamber, and evaluated the respiratory epithelium cells response. Biological
response from intratracheal instillation is difficult to directly compare with exposure
chamber measurements, unless the normalised dosimetry and deposition rates can be
determined and applied.
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To investigate the particle deposition in human nasal cavities, in-vitro studies us-
ing human nasal replicas have been conducted (Zhang and Martonen, 1995; Zwartz
and Guilmette, 2001; Kelly et al., 2004b; Liu et al., 2010). Although qualitative in-
sights were provided based on disposition patterns, local quantitative dosimetry values
(e.g. olfactory deposition) remain limited. As an alternative approach, nanoparticle
deposition analysis in realistic 3D models of human or rat nasal cavities can also
be realized by Computational Fluid Dynamics (CFD). The work by Inthavong et al.
(2011c) demonstrated that 1nm particle deposition patterns were widely dispersed on
the human nasal epithelial wall, with substantial deposition in the middle turbinate
region. In contrast, Schroeter et al. (2012) found that for the same sized nanopar-
ticle, deposition in a rat nasal cavity was dominant in the anterior region and not
the middle passages. Therefore, direct interspecies comparison remains very limited.
Recently Garcia et al. (2015) compared nanoparticle olfactory dose estimates between
human and rat nasal models, detailed regional particle exposure analysis and data
extrapolation from rat to human were not mentioned. Our recent study (Shang et al.,
2015a) examined the micronsized particle deposition characteristics in human and rat
nasal cavities using identical nasal models and inhalation rates as this current study,
its findings could not be applied for nanoparticles due to the different particle motion
mechanisms. For micron-sized particles, it is driven by inertia and drag forces, while
for nanoparticles, it is by diffusion due to the Brownian motion. A key distinction
between the type of particle behaviour is that the deposition fraction increases with
particle diameter for micron particles (from 1 µm to 100 µm), while it decreases with
particle diameter for nanoparticles (e.g. from 1 nm to 100 nm). Additionally, some
nanoparticles are more toxic than their respective micron-sized material due to in-
creased surface area and reactivity. Therefore, this paper aims to present a detailed
comparative study of the nanoparticle deposition in realistic human and rat nasal
cavities. To advance local particle deposition analysis and direct inter-species com-
parison, a surface mapping technique was applied to unwrap the complex 3D nasal
cavity onto a 2D planar surface for complete data access (Inthavong et al., 2014;
Shang et al., 2015a,b). This study demonstrated an approach to assess regional nasal
epithelium exposure dose to inhaled nanoparticles and inter-species deposition differ-
ences between human and rat nasal cavities were identified. This study bridges the
in-vitro exposure experiments and in-vivo nanomaterials toxicity studies, and can
contribute towards improving inter-species exposure extrapolation studies.
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7.2.2 Materials and Methods
7.2.2.1 Nasal Cavity Models
Anatomical models of a human (48-year old healthy male) and a rat (Sprague-Dawley,
400 g) nasal passage were reconstructed from CT images. The models were trun-
cated at the anterior trachea to focus on particle deposition in the upper respiratory
tract (Figure 7.10). Both models included the left and right nasal passages, and the
nasopharyngeal duct. Detailed model reconstruction and its verification have been
reported in the author’s previous paper (Inthavong et al., 2009b).
Figure 7.10: Extracted airways models (in green) from head CT-scans for (a) Human
and (b) Rat.
To enable visual access of the complex nasal surfaces, the surface-mapping tech-
nique originally developed by Inthavong et al. (2014) was adopted to unwrap the nasal
cavity morphology from its 3D domain onto a planar 2D domain and normalized its
length and width (Figure 7.11. The 2D surface was normalized into an orthogonal
shape where the shape is the same between species, allowing direct comparisons. To
facilitate regional particle deposition analysis, both the human and the rat nasal ep-
ithelium surface were divided into seven regions (Figure 7.12 based on a combination
of anatomical features and epithelial tissue types (Gross et al., 1982; Schroeter et al.,
2012). These regions are: the 1) vestibule (squamous epithelium); 2) upper passage
(mainly transitional epithelium); 3) middle and 4) lower passage (mainly respiratory
epithelium), 5) olfactory (olfactory epithelium), 6) septum, and 7) pharynx.
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Figure 7.11: Surface unwrapping methodology involving the 3D model separated into
its left or right nasal chamber. The model is then sliced along the floor of the model
and unwrapped. The outlets, and inlets were chosen as the boundaries to which
normalization would occur.
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Figure 7.12: (a), (b) 3D domain of the human nasal cavity and (c), (d) 2D unwrapped
models of the Human NC04 and Rat RNC01 nasal models separated, and labelled
with seven major nasal anatomical types (Shang et al., 2015a)
7.2.2.2 Numerical Modeling
The computational models were meshed using ICEM-CFD (ANSYS Inc., Lebanon,
NH) with unstructured tetrahedral elements. Prism layers were applied in near wall
regions to provide accurate near wall particle motion behaviour. After mesh inde-
pendence tests, the number mesh elements for the human and rodent models were
3.8 million and 4.2 million, respectively (Shang et al., 2015a). Steady flow rates (15
L/min for the human model and 0.4 L/min for the rodent model) were used to simu-
late rest breathing conditions (Kelly et al., 2004b). Reynolds numbers at the nostrils
of both human and rodent models were calculated (human Re = 913, rat Re = 314),
and the flow was treated as laminar and incompressible. To ensure a whole-body
exposure condition and better represent the flow conditions at and around the nostril
inlets, the external facial features including the breathing region and external nose
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were considered in the current numerical model, and nanoparticles were released in
front of breathing zone (Figure 7.13). In the current study, nanoparticles were as-
sumed as solid spherical discrete aerodynamic particles (e.g. density of 1000 kg/m3).
We assumed no particle rebound from the nasal walls, meaning that particles were
deemed deposited after coming into contact with the wall. This was based on the
assumption that the nasal wall is highly wet, and once a particle hits the wall, it
would most likely be trapped. The Lagrangian discrete phase model was used to
predict nanoparticle motion within the nasal chambers. As particle size is in the
nanoscale, gravitational force was neglected, and particle motion is dominated by
drag and Brownian forces. The Brownian force is a random force resulting from the
collision between the suspended nanoparticle and constantly moving air molecules,
modelled as a Gaussian white noise excitation (Li and Ahmadi, 1992). The inten-
sity of noise is specified by its spectral intensity which is dependent on the particle
diameter and temperature. The nanoparticles were assumed sufficiently dilute hav-
ing negligible effect on the airflow. Numerical simulations were conducted using the
commercial CFD package, ANSYS-Fluent v16 (ANSYS Inc., Lebanon, NH).
Figure 7.13: Boundary conditions and particle release locations for human and rodent
models.
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7.2.3 Results
7.2.3.1 Anatomical Comparison
Table 7.4. compares anatomical differences of the major epithelial regions between
the human and rodent models. The total surface area of the human model was
almost 10 times of the rodent model, and its two largest regions were the middle and
lower passages, which combined to make up approximately 52.8% of the total surface
area. While the rodent model showed significant anatomical differences, in which
the middle and lower passages only covered 16.3%. As an important functional area,
the olfactory region remained the largest region for the rodent model with 55.6%
coverage, leading to larger proportion and opportunity for olfaction. For the human
model, the olfactory region covered just 10.5% of the total surface area. Comparison
with data in in the literature for the vestibule and olfactory regions showed a good
agreement was found for the human and rodent models, indicating consistent epithelia
mapping strategy with other researchers. Although morphological differences between
individual models lead to differences in the regional dose exposure within the nasal
passages and subsequently in the lung, these differences were not accounted for in this
study. This study focused on only one comparison using single nasal passage sample
for both species.
Table 7.4: Geometrical comparison of major anatomical regions for rat and human
nasal models.
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7.2.3.2 Airflow Patterns Comparison
The inhaled air acted as a carrier transporting the particles through the nasal cavity.
Therefore, flow streamlines provide insight to the likely path trajectory an airborne
particle may follow. These paths were traced from the outside air as it enters the
nostril inlet (Figure 7.14). By including the facial features, natural flow paths are
produced (Corley et al., 2012; Shang et al., 2015b,a), which differs to cast replica
model studies or computational models that omit the face and outside air region
(Doorly et al., 2008c).
Figure 7.14: (a) Airflow streamlines relative to the airway and external face geome-
tries. (b) Velocity magnitude contours taken at three coronal slices across the nasal
cavity.
Streamlines in the human model distributed predominantly through the centre
rather than the ceiling or the floor of the airway, and swirling flow was found near
the olfactory region, attributed to its lower velocities (Figure 7.14a). As a conse-
quence, gases can diffuse upwards and taken up by olfactory nerves. Flow accelera-
tion occurred immediately after the nostril inlet due to the narrowed airway passage
(slice H1-H1’ in Figure 7.14b), and at the nasopharynx where its cross-sectional area
has decreased. These regions of acceleration propel the airborne particles along the
streamlines, increasing the likelihood of impaction onto the surrounding walls when
flow streamlines change paths and the particle inertia is too great. Additionally, the
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cross sectional velocity contours (Figure 7.14b) for the human nasal model show a
flow preference in the left nasal chamber due to the volume difference between the
left and right chambers.
Flow streamlines in the rodent model show air turning sharply after entering the
nostrils, followed with an n-shaped turn and a further slight bend before entering
the main nasal passage. These sharp turns are accompanied with a significant cross-
sectional area reduction which accelerate the ambient air velocity from rest to 10
m/s in the span of a few millimetres, while the acceleration in the human model is
more gradual (from rest to 2.5 m/s) over a few centimetres of the nostril region. The
rat airway expands in volume posteriorly ending at the olfactory region which has
50% surface area coverage of the entire nasal cavity. This suggests that particles or
gases that penetrate the anterior nose can be easily taken up by the olfactory region,
which is highlighted by the serpentine passages as shown in Figure 7.14b. The flow
is concentrated along the floor of the airway as it is connected to the pharynx which
is located inferiorly.
7.2.3.3 Model Evaluation
The particle deposition fraction is defined as the amount of deposited particles in
the nasal cavity with respect to the total number of particles inhaled. To confirm
the reliability of the numerical simulation, the deposition fraction results for particle
diameters in the range of 1 nm to 100 nm were compared with existing published
experimental data.
Figure 7.15 compares the deposition results of the human nasal model at a flow
rate 15 L/min with in-vitro data from Cheng et al. (1995),Kelly et al. (2004b), and in-
vivo data from Cheng et al. (1996b). Particle deposition fraction reduced dramatically
with increase in particle size, and the deposition curve fits within the range of the
experimental data. In particular, close agreement was found with the Viper replica
(Kelly et al., 2004b) for 5-30 nm sized particles. While for particles larger than 30
nm, the predicted curve matched better with (Cheng et al., 1996b).
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Figure 7.15: Deposition fraction results obtained for the computational human nasal
cavity model NC04 and its comparison with data in the literature.
Similarly, deposition comparison for the rat nasal model at an inhalation flow rate
of 0.4 L/min is shown in Figure 7.16. In-vitro data from Cheng et al. (1990), and in-
vivo data from Gerde et al. (1991) were used, while two numerical studies performed
by Garcia and Kimbell (2009),Schroeter et al. (2012) were also included. Compared
to the human case, a more rapid deposition fraction drops from 96.7% to 8.1% was
found for particles from 1 nm to 100 nm. The predicted deposition curve matched
best with Garcia and Kimbell (2009) for 1-10 nm particles, while, for particles>10
nm, the curve fits best with Cheng et al. (1990).
Figure 7.16: Deposition fraction results obtained for the computational rat nasal
cavity model RNC01 and its comparison with data in the literature.
Due to the inter-individual variations, the current numerical simulation cannot
match all referred data points. For example, the data reported by Schroeter et al.
(2012) was produced from a 600g Sprague-Dawley rat, while the rodent model used
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in the current study was a 400g Sprague-Dawley rat. Despite the differences, the gen-
eral particle deposition curves and deposition mechanisms between those two species
remain consistent.
7.2.3.4 Inter-species Particle Deposition Comparisons
Deposition fractions for 1, 10, 100 nm particles in the three major regions vestibule,
main passage and pharynx were calculated and plotted with a log scale in Figure
7.17. The total particle deposition comparison between human to rat subjects were:
71% to 97% for 1 nm; 17% to 24% for 10 nm and; 7% to 8% for 100 nm. For 1
nm particles, Brownian diffusion motion dominates and the smaller airway passage in
the rodent model produced greater deposition. As the particle size increased to 100
nm, particle diffusion reduced and the particle behaved like a gas tracer. In this case
the influence of airway geometry was less significant, allowing a significant number of
particles to leave the nasal cavity and enter the pharynx (93% for the human model
and 92% for the rodent model).
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Figure 7.17: Particle deposition fraction summary in the vestibule, main passage and
pharynx for (a) human and (b) rat nasal models.
Regionally, there was clear preferential deposition in the main nasal passage for the
human model with contributions of 74%, 78%, and 71% of 1 nm, 10 nm, and 100 nm
deposited particles. In contrast, the rodent model showed a different pattern. The 1
nm particles exhibited peak deposition in the vestibule (accounts for 62% of the total
deposition), while 10 nm and 100 nm particles exhibited peak deposition in the main
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passage (72% and 55% of deposited particles for 10 nm and 100 nm, respectively).
This difference in the regional particle deposition distribution is a reflection of the
inherent inter-species airway geometries which play a dominant role in traversing the
particles through the airway and its eventual deposition.
The regional deposition value in Figure 7.17 provides a broad determinant, and
direct comparison of the nasal epithelium exposure dosimetry between species is un-
clear. To account for surface area, a particle deposition density parameter (i.e. depo-
sition fraction per unit surface area) was used as an exposure indicator in Balashazy
et al. (1999). However, due to the large volume and surface area differences between
human and rat nasal cavities, regional areas need to be normalized for inter-species
comparison. In this study, a deposition flux value f (Shang et al., 2015a) was used,
f =
nregional/ntotal
Aregional/Atotal
(7.4)
where nregional is the number of particles depositing on a particular region with
area Aregional, and ntotal is the total number of particles inhaled into the nasal cavity
with a total surface area Atotal. Therefore, the deposition flux f indicates the particle
deposition fraction over a normalized regional surface. Figure 7.18 plots the deposition
flux for 1 nm and 100 nm particles as surface contours in 3D. The human model
exhibited a disperse deposition pattern for 1nm particles, with only a small region
of high concentration near the superior vestibule (particularly in the right chamber),
the nasal septum of left chamber, and middle passage of both chambers. The rodent
model also exhibited a disperse distribution, but its deposition concentration regions
are greater in size and magnitude. The majority of 1 nm particles were captured
by the vestibule with the remaining particles depositing in the middle passage and
septum. No visible deposition was observed in the olfactory region. This result was
consistent with particle plots in Schroeter et al. (2012).
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Figure 7.18: Particle deposition flux contours for the human and rat cases.
When particle size increased to 100 nm, the deposition pattern was similar but
the distribution was sparse because of the lower deposition fraction. Similar high
deposition regions were found but the flux magnitude was greatly reduced from 10 to
1.5. Similar to the 1 nm results, an asymmetric particle deposition flux distribution
was found for the human nasal model, with a greater proportion of particles depositing
in the right chamber (top view). This is attributed to the slightly larger right chamber
allowing more airflow through with less resistance.
The 3D representation of the deposition flux in Figure 7.18 in both lateral and
top view is still obstructed by the irregular geometry and complete visual access of
the entire nasal surface is difficult to present due to overlapped outer wall surfaces.
We converted the 3D results into a 2D domain by unwrapping the data (similar to
Earth’s representation in atlases as a 2D flat domain) using a technique published
in our previous studies (Inthavong et al., 2014; Shang et al., 2015b). Figure 7.19
shows the decomposed 2D space with separated anatomical regions. While the high
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deposition regions for 1 nm particles in the human model unsurprisingly correlate with
the surface contours in Figure 7.18, the unwrapped model reveals minimal deposition
flux in the lower passage region and part of the septum-upper passage interface region.
Deposition flux in right-hand side of the pharynx is greater than on the left. For the
rodent model, the extremely high deposition flux in the vestibule region becomes
apparent. Common regional boundaries in the main passage also receive a high
deposition flux, however there is almost no deposition in the olfactory region.
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Figure 7.19: Particle deposition flux comparison for 1 nm and 100 nm.
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Table 7.5: Comparison of particle deposition flux between rat and human.
For 100 nm particles, the deposition flux reduces dramatically over the whole
model for both species, due to the reduced total deposition fraction. Compared with
the 1 nm deposition pattern, the high deposition flux regions in both models are
scattered into small clusters. For the human model, the overall deposition pattern
remains similar with the 1 nm case. While for the rodent model, a more evenly
scattered deposition flux distribution was found. Of note is the sizeable deposition
flux appearance in the olfactory region which was not found in the rodent model
for 1nm particles. Although the magnitude is relatively low (around 0.25), it is
comparable with deposition flux in the human olfactory region.
Table 7.5 presents a quantitative summary of the regional deposition flux for the
human and rodent models. For all particles, the highest deposition flux generally oc-
curred in the vestibule region for both species. The upper passage exhibits the lowest
deposition flux for the human model, while for the rodent model both the olfactory
and pharynx regions remained the lowest. For human to rat data extrapolation, a
regional scaling factor X based on the ratio of the corresponding deposition flux was
introduced. The scaling factor was not applicable for 1nm particles in the olfactory
region as almost no particle deposition was found for the rodent model. Apart from
this, the largest scaling factor (X = 4.43) occurred in the pharynx for 100 nm particles
due to the extremely low particle capture in the rat pharynx. The smallest scaling
factor (X = 0.15-0.18) occurred in the upper passage for all particle sizes, and this
was attributed to its superior location in the human model. This limited particle ex-
posure because the main airflow paths travelled through the middle or lower region of
the main passage (Figure 7.14). This scaling factor enables direct data extrapolation
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for particle exposure assessment that considers the differences in human (15 L/min)
and rat (0.4 L/min) inhalation conditions and anatomical morphology.
Toxicant-induced nasal lesions in laboratory animals generally exhibit characteris-
tic, site specific distribution patterns (Morgan and Monticello, 1990; Morgan, 1994).
Histologic analysis through sectioning is the production of very thin slices from a
tissue sample. It is an essential procedure to detect lesion locations and analyze the
tissue toxicological response under site-specific toxicant dosimetry. Therefore, deter-
mining the precise location of the induced lesion in the nose of the laboratory rodents
effectively is of great importance in understanding the critical factors involved in
the pathogenesis discoveries. In this study, we present a novel numerical sectioning
operation applied on both human and rat nasal models, where the 3D nanoparticle
deposition fraction results were sliced along the predominantly stream wise direction
for the whole nasal cavity. The accumulated deposition fraction on each slice over
the total nasal deposition fraction was calculated and named as deposition inten-
sity (DI), and this was plotted along the normalized distance (Figure 7.20). The
deposition intensity is given as:
DI =
nslice
ntotal
/
nnasal
ntotal
(7.5)
where, nslice is the number of particles depositing on the slice, nnasal is the total
deposited particle number within the nasal cavity, and ntotal is the total number of
particles inhaled into the nasal cavity. Therefore, deposition intensity (DI) indicates
a ratio of localized (slice-based) particle deposition over the whole nasal deposition.
Thus the location with peak deposition intensity can be effectively located, which
is informative for preparation of histologic analysis. Since this is an area-based-
integration calculation, the peak deposition intensity location found may differ from
the peak particle deposition flux location in Figure 7.19.
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Figure 7.20: Particle deposition intensity distribution along nasal passageway for (a)
human and (b) rat nasal models.
For the human model, the nasal depth of 3.5 cm displayed common maximum
deposition intensity for the three particle sizes. This was mainly attributed to the
combination of the lower particle filtration capacity of the vestibule and the relatively
larger surface area proportion of the main passage (55.6% of the total surface area).
In addition, secondary peaks were found at the vestibule (depth of 0.7 cm) for 1 nm
particles, nasal valve region (depth of 1.5 cm) for 100 nm particles, and posterior
of main passage (depth of 6.6 cm) for both 10 nm and 100 nm particles. For the
rat nasal model, the common maximum deposition intensity for all particle types
is located at the vestibule region with a depth of approximately 0.3 cm, indicating
an extremely high particle filtration function. After this region, a relatively stable
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particle deposition intensity profile was found for the three particle sizes in the anterior
part of the main passage. Similar with the human NC04 model, a secondary peak
was established at the posterior of main passage with a depth of 2.5 cm for the 100
nm particles. This was due to the notable deposition in olfactory region (Figure 7.19)
and its large area proportion (55.6% of total surface area). Additionally, when the
nanoparticles travelled further downstream, the deposition intensity increased with
the increasing of particle size for both models.
7.2.4 Discussion
Growing evidence suggests human exposure to engineered nanomaterials are inevitable
and may lead to adverse health effects (Nalwa and Zhao, 2007; Chen and Chen, 2012).
Since the underlying toxicity mechanisms are not well understood, there is a great
need for efficient and cost-effective toxicological screening methods to quickly and
precisely characterize relationships between inhaled nanomaterials and their biologi-
cal effects (Zhang et al., 2012; Meng et al., 2013; Yin et al., 2015; Pang et al., 2016).
Nanoparticles not only implement toxicity when entering the circulation through the
lungs, but can also cause neurotoxicity by distributing in the brain after deposition
on the olfactory bulb. Similarly, the fraction of ultrafine particles of air pollution
leads to neurodegenerative diseases through this same delivery pathway (Caldern-
Garcidueas et al., 2010; Fagundes et al., 2015). At present, knowledge on inhalation
toxicity and risk assessment is primarily from animal tests, and not human subjects.
Extrapolation of animal data to human dosimetry usually constitutes the bottleneck
of risk assessment.
Particle toxicity is determined by the effective particle deposition and its even-
tual fate after inhalation into the body, and it has been demonstrated various sized
particles have significantly different deposition characteristics in the respiratory tract
(Oberdrster et al., 2005). To estimate the dose an organism receives, deposition
should be clearly defined. There is a wide usage of Multiple Path Particle Dosime-
try (MPPD) model in dose evaluation in the nanotoxicology research field, however
this model was originally developed for estimating dose in the lower respiratory tract
based on particle size dependent deposition with actual anatomic data (Anjilvel and
Asgharian, 1995; Cassee et al., 2002). To date, no CFD model has reported the entire
deposition field down to the complex bronchial and acinar airways in the lungs. The
present work provides supplemental data of the size-dependent deposition rates in
the nasal cavity (i.e. from the upper airways) for dose estimates by the MPPD model
(i.e. in the lower airways). The deposition estimates in the upper airway provides
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valuable information for determining the pollutant concentration introduced into the
lungs while, the deposition rate on the olfactory epithelium is also an important is-
sue in the neurotoxic potential of nanomaterials when considering the nose-to-brain
exposure route. Furthermore, the clearly defined regional scaling factor between hu-
man and rat can assist the data extrapolation from animal to human for inhalation
exposure risk assessment.
Garcia et al. (2015) estimated the olfactory nanoparticle dose in human nasal
models and compared with their previous published rat studies, which firstly com-
pared the nanoparticle deposition patterns between humans and rats, with attention
on the olfactory dose. In the current study, the highest olfactory dose (fhuman=0.9)
for the human model was observed when nanoparticle size was 1 nm, and it decreased
continuously to fhuman=0.084 when nanoparticle size was 100 nm. In contrast, for the
rodent model, the olfactory region received maximum dose (frat=0.10) when nanopar-
ticle size was 10 nm, and was an extremely low dose level for both 1 nm (frat=0.005)
and 100 nm (frat=0.032). All these findings agreed well with their findings. However,
due to the inter-individual nasal anatomy variations, olfactory region mapping strate-
gies, as well as the inhalation flow rates differences, the current regional deposition
results cannot precisely match the olfactory dose curves reported by them, but the
deposition trends remain similar.
Toxicant-induced nasal lesions in laboratory animals generally exhibit site-specific
patterns as different epithelial cells produce distinctly different response to the same
toxicant (Gross et al., 1994). The nasal epithelium response is also dose dependent
and concentration-dependent in epithelial responses (Andersen et al., 2008). There-
fore, the current regional mapping strategy and the results presented can contribute
towards better estimations of intratracheal instillation dosimetries. Additionally, the
numerical sectioning results in terms of deposition intensity can prospectively aid his-
tologic analysis in locating the correct slices under high pollutant exposure. Through
tissue slice sampling from a known location where nasal epithelium receives the most
particle dose, the procedure will become more efficient.
In summary, a clear preferential deposition in the main passage for the human
nasal model was found, which contributed 74%, 78%, and 71% for 1 nm, 10 nm,
and 100 nm deposited particles, respectively. In contrast, the rodent model showed a
different pattern. The 1 nm particles exhibited peak deposition in the vestibule (62%
of the total deposition), while 10 nm and 100 nm particles exhibited peak deposition
in the main passage (72% and 55% of deposited particles for 10 nm and 100 nm,
respectively).
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The human model exhibited a disperse deposition distribution for 1 nm particles,
with only a small region of high concentration near the superior vestibule (particularly
in the right chamber), the nasal septum of left chamber, and middle passage of both
chambers. Although the rodent model exhibited a disperse distribution, its deposition
concentration regions were greater in size and magnitude. The majority of 1 nm
particles were captured by the vestibule with the remaining deposition in the middle
passage and septum. No visible deposition was observed in the olfactory region.
When particle size increased to 100 nm, the overall deposition pattern for the human
model remained similar with the 1 nm case. While for the rodent model, a more
evenly scattered deposition flux distribution was found with notable deposition in
the olfactory region.
Some limitations should be noted. Firstly, the nasal surface mapping strategy
was based on a combination of anatomy and epithelial type, and may not reflect
the exact extent of each region in reality. Secondly, only one human and one rat
nasal model were used for analysis, while airflow and particle transport may differ
considerably due to the individual anatomy differences. The internal upper airway
geometry exhibits inter-subject variability, and even varies in a single person as they
age. Despite these differences, studies have shown common geometrical features that
are persistent among all human nasal cavities, and persistent gross flow features. This
includes the airflow turning at the nasal valve region, passing medially through the
main nasal passage with small recirculations superiorly, and inferiorly, before turning
again down into the nasopharynx (Ge et al., 2012; Inthavong et al., 2012a, 2009a).
This suggests that the particle deposition behavior will be similar among all subjects,
but would vary due to the fine geometrical inter-individual differences. To minimize
differences, nasal cavities from similar weight, body-size, sex, and ethnicity has a
greater chance of providing similar geometric features. This applies to rat species as
well.
Lastly, the widely applied steady nasal airflow assumption may have some effect
on the overall results. In reality, airflow through rat/human nose is not steady but
characterized by acceleration and deceleration of a wide range of flow rates and alter-
ing frequencies. Shi et al. (2006) demonstrated that the particle concentration fields
changes due to cumulative effects, and more nanoparticles drift towards the posterior
nasal cavity during deceleration phase, resulting a higher nanoparticle concentration
in comparison with steady flows. Despite such differences between steady and cyclic
airflows, Jiang and Zhao (2010) claimed the steady assumption of the nasal airflow
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field is still valid over 70% of the cycle period, and the averaged nanoparticle depo-
sition results during breathing cycles can be estimated based on steady cases using
empirical correlations, which significantly reduces the computational costs. A major
hurdle in resolving this issue is the treatment of the particles that escape the com-
putational domain - how many deposit in the tracheobronchial airway or right down
to alveolar; what fraction re-enters the domain, and at what velocity, location, tra-
jectory, concentration, and time? These limitations remain to be included in futures
studies.
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Chapter 8
Summary and Future Studies
Inhaled micron- and nano-sized particles may exhibit therapeutic or toxic effects on
the human nasal cavity. Various in-vivo and in-vitro studies have investigated airflow
behaviour and particle deposition in the nasal cavity. Alternatively, experiments on
labooratory rats have been conducted and extrapolated to predict human’s toxico-
logical response to inhaled particles. With the development of medical imaging and
computational algorithm, Computational Fluid Dynamics, have been widely adopted
to predict particle deposition patterns in localised regions and their toxicological ef-
fects. However, two major research gaps remain between these preliminary studies
and clinical applications. Because of the intricate nasal geometry, it is difficult to
accurately visualise the results inside the nasal cavity or on the nasal wall. Due to
significant nasal geometric difference, the reliability of existing extrapolation from rat
to human is questioned.
To bridge these research gaps, this thesis proposed practical and cost-effective
methods, to better understanding the fluid dynamics and particle depositin patterns
within human and rat nasal cavity models. The main contributions are:
• Development and opimisation of surface-mapping technique to conveniently
compare pressure, wall shear stress and particle deposition locations between
different nasal models, regardless of individual and inter-species variations.
• Inclusion of the facial feature and the irregular particle shape factors for better
simulating the particles’ motion.
• Introducing a scaling factor for regional toxicological extrapolation from rat to
human
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8.1 Application of Surface Mapping Technique
A surface-mapping technique was introduced to transform CAD models of nasal cav-
ities from 3D domain into a 2D domain, regardless of individual differences of age,
gender and geometrical difference between species (human and rat).
Using this visualization technique, flow parameters along the nasal surface wall
that was typically difficult to visualize and analyse can be conveniently presented
to provide a deeper insight into the physiological mechanisms involved with respira-
tory airflows. Distributions of physical variables such as pressure, wall shear stress,
temperature and particle deposition concentration, were mapped into the 2D domain
with the background of layout of anatomical regions. Their patterns were compre-
hensively visualized for direct analysis without any rotating or opacity adjusting in
post-processing, and this method significantly enhances the quality of analysis.
The 2D domain was normalised into a rectangular shape and well designed by
introducing characteristic lines that divide the domain into vestibule, lateral/septal
main passage and pharynx. The lateral main passage was further divided into sub-
regions of upper/middle/lower passages according to anatomy. Therefore, this tech-
nique can be reasonably adopted for both human and rat nasal cavities models for
comparative studies, regardless of individual variations such as age, gender, health
conditions and geometrical difference between species.
The surface mapping technique significantly extends the capability of current CFD
technology in visualising the fluid flow dynamics and particle deposition patterns.
Furthermore, an executable program for data management was developed as part of
the mapping methodology and this is available online at http://www.cfdresearch.com/tt-
uvUnwrapping.php.
8.2 The Airflow Patterns in the Human Nasal Cav-
ity
CFD simulation showed that the inclusion of facial features and the breathing zone
play significant role in the airflow behaviour inside and outside the human nasal
cavity. Under light breathing flow rates, the airflow in the external domain remained
uniform before entering the breathing zone of 3 cm from nostrils. However, when
focusing on the breathing zone and anterior region of nasal cavity, it was found
that additional vortices were generated in the vicinity of nostrils of the with-face
model when comparing with the nasal-only model that omitted the facial features.
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Differences in airflow patterns were found between two models, particularly in the
vestibule region. As the airflow was conditioned by the nasal structure, the flow
patterns became similar in the regions that are posterior to the main nasal passages.
These results suggest that omitting the external nose and breathing region causes a
change in the fluid flow within the anterior nasal cavity half.
The wall shear stress (WSS) that is caused by the interactions between airflow
and epitheliums plays an important role in supporting nasal functions such as air
conditioning and sensations. The WSS map on the nasal cavity walls indicate that the
high stress peaked around the nasal valve due to the sharply reduced cross-sectional
area. This result is consistent with the fact that the majority of the epithelium cells
in this region are keratinized and adaptive to the high shear stress environment.
The nasal air conditioning and nasal sensation also depends on sufficient contact
between nasal epithelium and inhaled airflow. The airflow patterns coupled with
WSS distribution showed the sufficient mass and heat transfer between the main
passage and the airflow is achieved not only by increasing the surface area of the nasal
cavity, but also by dividing and redistributing the airflow into many sub-streams with
relatively lower flow velocity, therefore the air is conditioned to a state ready for entry
into the delicate lungs.
The olfactory region located at the uppermost nasal cavity is the only site in
human body where the central nervous system has potential to directly interact with
the external environment. Based on the flow streamlines and the velocity contour, the
superiorly positioned olfactory region is away from the bulk flow. The well aligned
streamline with extremely low velocity facilitates the gas diffusion process involved
in olfaction.
8.3 The Particle Deposition Patterns in the Hu-
man Nasal Cavity
Before entering the nasal cavity, the outside ambient particles were mainly subjected
to the gravitational force but influenced by the inhaled air. The main stream of
particles was rapidly accelerated by the airflow within the breathing region and con-
centrated into a smaller cross-section. This formed a realistic particle distribution at
the nostrils and avoided direct impaction on the vestibule region. The comparison
between with-face and nasal-only models showed that the realistic particle distribu-
tion led to deeper penetration into the posterior regions of the nasal cavity and also
significant changes in the deposition efficiency for mid-inertial parameter particles.
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When influenced by the breathing zone, particle deposition efficiencies of particle size
range from 7.8 µm to 20 µm became significantly lower (maximum of 37.7% lower for
12 µm particles). Deposition of 2.5 µm particles remained low and were negligible in-
fluenced by the breathing zone, and dispersed through the whole nasal cavity; 10 µm
particles were transferred by the vortices to the posterior nasal regions and; 20 µm
particles directly impacted on the nasal atrium region and inferior turbinate regions.
While for spherical nanoparticle deposition in the human nasal cavity region, a
clear preferential deposition in the main passage was found, which contributed 74%,
78%, and 71% for 1 nm, 10 nm, and 100 nm deposited particles, respectively. The
human model exhibited a disperse deposition distribution for 1 nm particles, with only
a small region of high concentration near the superior vestibule, the nasal septum of
left chamber, and middle passage. When particle size increased to 100 nm, the overall
deposition pattern for the human model remained similar with the 1 nm case.
Additional to the spherical particle deposition, transport and deposition of irreg-
ular shaped welding fume agglomerates, which usually exhibits forms of long straight
chains, branches, compact groups etc., in the human nasal upper respiratory airways
were investigated. Particular attention was given to the deposition pattern and depo-
sition efficiency of welding fume agglomerates in human nasal olfactory mucosa from
which a direct entry route into the brain exists. Depositions of spherical particles
and agglomerates (generated from primary particles in the size range 10-150 nm, ei-
ther as straight chains or compact two-dimensional structures) in the nasal cavity,
the larynx, the trachea, and the bronchial were given and the transport route, the
deposition site, and the pattern of inhaled welding fume agglomerates were revealed.
Correlations of agglomerates deposition sites and the airflow, airway morphology,
and the particle morphology were analysed. In the entire upper airway region, the
nasal cavity was most effective in capturing inhaled agglomerates. Downstream of the
nasal cavity, the larynx is the next highest deposition site. The deposition in trachea
and the first level bronchial is low. The variation in regional deposition distribution
is inversely associated with primary particle diameter.
For the nasal cavity region, similar with the spherical particle deposition patterns,
majority of inhaled agglomerates deposition in the human nasal cavity occurred on
anterior nasal vestibule and posterior nasal cavity near nasopharynx. In the main
passage, the majority of the deposition occurred in the middle meatus. Consistent
with the spherical particle simulation, a very small fraction of the inhaled welding
fume agglomerates was dispersed into the nasal olfactory region and the deposition
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was extremely low. It should also be noted that, for the range of particles considered,
the majority passed through the nasal barrier and penetrated deep into the lung.
For welding fume agglomerates with primary sphere diameter less than 20 nm,
both the size and morphology of the agglomerate influence the deposition efficiency.
Smaller primary particle size and more compact agglomerate morphology result in
higher deposition. Long straight chain agglomerates tend to be less disturbed by
Brownian diffusion when following the main flow and low deposition occur. As the
size of agglomerates increases, the deposition efficiency becomes less dependent on
particle size and agglomerate morphology.
8.4 Airflow and Particle Deposition in the Rat Nasal
Cavity
A complete rat nasal cavity model including facial features and maxillary sinus was
reconstructed from the Micro-CT data. The geometry of rat nasal cavity was much
more complex than that of human, especially in the olfactory region, which presented
multiple folds in the rat case. The olfactory region of the rat nasal cavity is located
posteriorly, aligned with the horizontal axis of the geometry, and preceded by complex
shaped turbinate bone intrusions. Anatomy comparisons showed that the cavity
surface area of the rat model was about 1/10 the size of the human. On the contrary,
the largest surface area coverage for the rat was the olfactory region made up 55.6% of
the total surface area, while for the human model, the olfactory region made up only
10.5%. Instead, the middle and lower passages of the human model were combined
to make up 52.8% of the total surface area.
The significant number of turbinates redirect the bulk flow away from the olfac-
tory region, leaving behind a low velocity region. The flow splitting by the upstream
turbinate walls resulted in locally-peaked WSS in the main passage. Therefore, the
respiratory epithelial cells in the main passage may be more vulnerable of tissue dam-
age compared with other regions. The major anatomical difference between human
and rat cases was the shape of the nasal vestibule which plays a significant role in
producing the inhaled airflow streamlines. A sharp U-turn (180) bend was found in
the rat nasal vestibule which accelerated the inhaled air to a peak velocity of 10 m/s
despite an inhalation rate of merely 0.4 L/min. Comparatively the human model
exhibits a 90 bend at the nasal vestibule and accelerates the flow up to 2.5 m/s for
an inhalation rate of 15 L/min.
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Exposure experiments based on rat models are typically extrapolated to human
subjects. To compare the micron-sized particle deposition patterns between species,
the total deposition fraction was used to determine appropriate particle types of low,
medium and high inertial properties. It was found that the particle size range suitable
to represent these three inertial regimes was 2.5-20 µm for the human model and 1-3
µm for the rat model. To gain further insights for extrapolating inhalation exposure
data between inter-subject species, we introduced a deposition flux parameter which
compares the deposition fraction per regional area fraction for the human and rat
models. A direct comparison showed that a scaling factor was needed in order to
extrapolate the deposition data from one species to another. Low inertial particles
show the closest scaling factor of 1:1 matching.
For the nano-sized particle deposition patterns, it was found that the 1 nm par-
ticles exhibited peak deposition in the vestibule (62% of the total deposition), while
10 nm and 100 nm particles exhibited peak deposition in the main passage (72%
and 55% of deposited particles for 10 nm and 100 nm, respectively). Although the
nanoparticle deposition in the rat nasal cavity exhibited a dispersed distribution sim-
ilar with the human case, its deposition concentration regions were greater in size and
magnitude. The majority of 1 nm particles were captured by the vestibule with the
remaining deposition in the middle passage and septum, and no visible deposition
was observed in the olfactory region. As the particle size increased to 100 nm, a
more evenly scattered deposition distribution was found with notable deposition in
the olfactory region.
8.5 Future Studies
This thesis presented a computational approach to enhance understanding of the
airflow features and particle deposition patterns in the human and rat nasal cavities.
A series of studies can be conducted following this study.
Firstly, although surface-mapping technique greatly enhances the quality of vi-
sualization of airflow and particle deposition in the nasal cavity, it should be noted
that the nasal surface mapping strategy was based on a combination of anatomy and
epithelial type, and may not reflect the exact extent of each region in reality. This
work lays a foundation for investigations that incorporates toxicology and health re-
sponses to local inhalation of gases and particles in the sub-nasal wall layers, such
as mucus, cilia, tissue and blood vessels. After deposition on the nasal walls, the
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particles interact with these structures in the following few hours before being ab-
sorbed by tissue. It has been a research gap to simulate the particle transport (e.g.
dissolution, diffusion, convection and absorption) in sub-nasal structures because it is
difficult to generate conventional mesh grid due to the large ratio of the mucus layer
thickness (nearly 10 µm) and the nasal cavity scale. Also because the scale ratio,
the influence of the deformation of epithelium map in the 2D domain on the particle
transportation is negligible. Based on the unwrapped 2D domain, multiple sub-layers
can be extruded to represent the sub-nasal wall layers. Complex mathematical mod-
els describing the interactions between particles, mucin and cilia can be applied to
the uniform computational domain.
Secondly, the CFD analysis of physical flow behavior that led to locally high wall
shear stress in human and rat models. However, only one human and one rat nasal
model were used for analysis and comparison, while airflow and particle transport
may differ considerably due to the individual anatomy differences. Therefore, this
study could be used as a first step towards a larger sampled study of many nasal
cavities to determine if the gross flow patterns are persistent between many samples
with individual human variations such as age, gender, weight, body size and health
conditions as well as the differences between species such as human, rat, mouse and
monkey. Apart from the widely applied steady nasal airflow assumption may have
some effect on the overall results. In reality, airflow through rat/human nose is not
steady but characterized by acceleration and deceleration of a wide range of flow
rates and altering frequencies. For example, the particle concentration distribution
changes due to cumulative effects, more nanoparticles drift towards the posterior
nasal cavity during deceleration phase, resulting a higher nanoparticle concentration
in comparison with steady flows, and particles may re-enter the nasal cavity during
exhalation. These problems need to be investigated in the future studies.
Lastly, this study only investigated the nasal cavity and its extended regions of
nasopharynx, oral pharynx and larynx. However, the major deposition site for parti-
cle size ranging from 10 nm to 10 µm is located at lower respiratory system including
trachea, bronchia and alveolar. It has been challenge to simulate the airflow in the
trachea-bronchial airways because the branches become extremely narrow which are
beyond the resolution of the conventional CT machine. Future studies should fo-
cus on reconstructing the bronchial branches in the lung region by using automated
algorithms, achieving data with higher resolution from more advanced CT equip-
ment and obtaining augmented CT data using techniques such as positron emission
tomography.
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Appendix A
Functions for Surface-mapping
Data Arrangement
(*1–––––––––––{X, Y, Z,W,FACE} = ReadData[filename]––––− –− –––––*)
ReadData[filename ]:=Module[{data, textp, text, start, regions,FACEI,FACEJ,
tnum,RW, inum, iname, i, j,XI,YI,ZI,WI,FACE, X, Y, Z,W,R,LINEALL, lines,
vectors, linelength, lmin2, lmax2,FACElmt,FACEname},
data = Import[filename, “Data”];
(*–––––− Partitioning ––––––− *)
text = Cases[data, { String}];
tnum = Flatten[
Map[StringCases[#, “Nodes=” ∼∼ inum ∼∼ “,” :→ inum]&, text]
]//ToExpression;
textp = Flatten[Position[data, { String}]];
start = Union[{1},
textp[[Flatten[Position[textp[[2;;− 1]]− textp[[1;;− 2]], x /;x > 1]] + 1]],
{Length[data] + 1}];
regions = Table[data[[start[[i]];;start[[i+ 1]]− 1]], {i, 1,Length[start]− 1}];
FACEI = Map[Cases[#, { Integer}]&, regions];
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RW = Map[Cases[#, { Real}]&, regions];
{XI,YI,ZI,WI} = Table[
Map[Flatten,Table[
Part[RW, i, (j − 1)Ceiling@(tnum[[i]]/5) + 1;;jCeiling@(tnum[[i]]/5)],
{i, 1,Length@regions}
]
], {j, 1, 4}
];
FACEJ = FACEI + Prepend[Table[Total@tnum[[1;;i− 1]], {i, 2,Length[tnum]}], 0];
FACE = Flatten[FACEJ, 1];
{X, Y, Z,W} = Map[Flatten, {XI,YI,ZI,WI}];R = Transpose[{X, Y, Z}];
(*–––––– Measurelmaxandlmin ––––––− *)
lines = Map[
Sort,Flatten[FACE/.{a , b , c } :→ {{a, b}, {b, c}, {a, c}}, 1]
]//DeleteDuplicates;
vectors = Map[R[[#[[1]]]]−R[[#[[2]]]]&, lines];
linelength = Map[Total[#∧2]&, vectors];
{lmax2, lmin2} = {Max[linelength],Min[linelength]};
FACElmt = Length/@FACEJ;
(*For[i = 2, i ≤ Length[FACElmt], i++,
FACElmt[[i]] = FACElmt[[i]] + FACElmt[[i− 1]]]; *)
FACEname = (StringCases[#, “T=\”" ∼∼ iname ∼∼ “ S” :→ iname]&/@text)//Flatten;
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(*–––––––− Return ––––––––− *){
R,W,FACE,
√
lmin2,
√
lmax2,FACElmt,FACEname
}
]
(*2–––FixCracks–––*)
FixCracks[R ,W ,FACE ]:=Module[{Rout,Wout,FACEout, numOriginal, dupl,
Multi2Dupl, dupl2, numRule, i,minus,minusRule},
(*–––––– FindMultiple− PointRulesdupl –––––*)
numOriginal = Length[W ];
dupl = GatherBy[Range[numOriginal], R[[#]]&];
dupl = DeleteCases[dupl, {a }];
If[dupl == {},Rout = R; Wout = W ; FACEout = FACE,
Multi2Dupl[x List]:=Module[{temp, y},
If[Max[Map[Length, x]] == 2, x,
temp = Replace[x, {a , b , c } :→ Sequence[{a, b}, {a, c}], {1}];
Multi2Dupl[temp]
]
];
dupl = Multi2Dupl[dupl];
(*––––––– DeleteRedundentPoints –––––− *)
dupl2 = dupl[[All, 2]];
Rout = Delete[R, dupl2/.x Integer :→ {x}];
Wout = Delete[W, dupl2/.x Integer :→ {x}];
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(*––––––– ReplaceDeletedPointNumbers –––––*)
numRule = Range[numOriginal];
For[
i = 1, i ≤ Length[dupl], i++,Part[numRule, dupl[[i, 2]]] = dupl[[i, 1]]
];
FACEout = Map[numRule[[#]]&,FACE];
(*––––––– UpdateAllPointNumbers –––––––*)
minus = ConstantArray[0, numOriginal];
For[i = 1, i ≤ Length[dupl2], i++,
minus[[dupl2[[i]] + 1;;− 1]] = minus[[dupl2[[i]] + 1;;− 1]] + 1;
]
minusRule = Range[numOriginal]−minus;
FACEout = Map[minusRule[[#]]&,FACEout];
];
(*–––––––− Return –––––––––––––− *)
{Rout,Wout,FACEout}
]
(* 3. Export OBJ file for mapping*)
ToOBJ[R ,FACE ]:=Module[{dataout1, dataout2, dataout},
dataout1 = Prepend[Transpose[R],ConstantArray[v,Length[R]]];
dataout2 = Prepend[Transpose[FACE],ConstantArray[f,Length[FACE]]];
dataout = Join[Transpose[dataout1],Transpose[dataout2]];
Export[NotebookDirectory[] <> “\\Geometry.obj”,
dataout, “Table”, “FieldSeparators”→ “ ”]
]
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(*4 Read UV data and modify the 3D data*)
ReadUV[R ,W ,FACE , filename ]:=
Module[{UVData, str, r, faceAll,FACE1, r2R,R1,W1},
UVData = Import[filename, “Data”]//Flatten//StringSplit;
r = Cases[UVData, {“vt”, str , “0”} → {str}];
r = Map[Internal`StringToDouble, r, {2}];
faceAll = Cases[UVData, {f, str } → {str}];
faceAll = StringSplit[#, “/”]&/@faceAll;
faceAll = ToExpression[faceAll];
FACE1 = (Flatten/@faceAll)[[All, {2, 4, 6}]];
r2R = Flatten[faceAll, 1]//DeleteDuplicates;
r2R = SortBy[r2R,Last][[All, 1]];
R1 = R[[r2R]]; W1 = W [[r2R]];
{R1,W1,FACE1, r, r2R}
];
(*5––––CalculatetheAreaofaTriangle–––––− *)
S[r ]:=Module[{a, b, c, d},
{a, b, c} = Norm/@{r[[1]]− r[[2]], r[[1]]− r[[3]], r[[2]]− r[[3]]};
d = (a+ b+ c)/2;
Sqrt[Abs[d(d− a)(d− b)(d− c)]]
];
(*6 Read Particles*)
ReadP[filename ]:=Module[{pdata, str,Rp},
pdata = Import[filename, “Data”]; pdata = pdata[[3;;− 1]];
pdata = Map[StringCases[#, “(( ” ∼∼ str ∼∼ “) ”→ str]&, pdata]//Flatten;
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pdata = Map[Internal`StringToDouble, StringSplit/@pdata, {2}];
Rp = pdata[[All, 1;;3]]
];
(*7.separatetheregion––––––− *)
SplitVolume[R ,FACE ,Rp , numZone ]:=
Module[{FACEcentre,RpMin,RpMax, zone, IJK, i, j, n, x, y},
FACEcentre = Map[Total[R[[#]]]/3&,FACE];
RpMin = Min/@Transpose[Rp];
RpMax = Max/@Transpose[Rp];
RpMin = RpMin− (RpMax− RpMin) /106 ;
zone = ConstantArray[{}, {numZone, numZone, numZone}];
Monitor[
For[i = 1, i ≤ Length[FACE], i++,
IJK = DeleteDuplicates[
Map[Ceiling[(#− RpMin)/(RpMax− RpMin) ∗ numZone]&, R[[FACE[[i]]]]]
];
IJK = Delete[IJK,Replace[Position[IJK, n /;n > numZone‖n < 1], {x , y } :→ {x}, {1}]];
If[IJK 6= {},6 6
For[j = 1, j ≤ Length[IJK], j++,
zone[[Apply[Sequence, IJK[[j]]]]] = Append[zone[[Apply[Sequence, IJK[[j]]]]], i];
]
]
],
i
];
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{FACEcentre, zone,RpMax,RpMin}
];
(*Prepare for 8*)
Project[{r1 , r2 , r3 }, r0 ]:=Module[{v, k, p, d2, area, in},
v = Cross[r1− r2, r1− r3];
k = Dot[r1− r0, v]/Total[v∧2];
p = r0 + kv;
d2 = Total [(p− r0)2] ;
area = S/@{{r1, r2, r3}, {p, r1, r2}, {p, r1, r3}, {p, r2, r3}};
If[(Total[area[[2;;4]]]− area[[1]])/area[[1]] < 0.05, in = 1, in = 0];
{p, d2, in}
];
(*8–––ProjectaparticletoatriangleFindthecorrespondingtriangle––*)
Findp2FACE[R ,FACE ,FACEcentre ,Rp1 , lmax , zone ,RpMax ,RpMin , numZone ]:=
Module[{IJK, index, points, temp, results, distance2, i, j, k, p2FACE,Rpout},
IJK = Ceiling[(Rp1− RpMin)/(RpMax− RpMin) ∗ numZone];
index = zone[[Apply[Sequence, IJK]]];
temp = Position[Abs[FACEcentre[[index, 1]]− Rp1[[1]]], l /;l ≤ lmax]//Flatten;
index = index[[temp]];
temp = Position[Abs[FACEcentre[[index, 2]]− Rp1[[2]]], l /;l ≤ lmax]//Flatten;
index = index[[temp]];
temp = Position[Abs[FACEcentre[[index, 3]]− Rp1[[3]]], l /;l ≤ lmax]//Flatten;
index = index[[temp]];
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points = Map[Part[R,#]&,FACE[[index]]];
results = Map[Project[#,Rp1]&, points];
i = Flatten[Position[results[[All, 3]], 1]];
If[i=={},
p2FACE = {}; Rpout = {},
If[Length[i] == 1,
k = i[[1]],
distance2 = results[[i, 2]];
j = Flatten[Position[distance2,Min[distance2]]][[1]];
k = i[[j]];
];
p2FACE = index[[k]]; Rpout = results[[k, 1]];
];
{Rpout, p2FACE}
]
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Appendix B
Codes for Data Visualisation
(*3D and 2D geometries reading*)
filename = NotebookDirectory[] <> “NC04 with sinus 16LPM tec.dat”;
{R,W,FACE, lmin, lmax,FACElmt,FACEname} = ReadData[filename];
{R,W,FACE} = FixCracks[R,W,FACE];
ToOBJ[R,FACE];
filename = NotebookDirectory[] <> “NC04 with sinus 16LPM tec finalcut.txt”;
{R,W,FACE, r, r2R} = ReadUV[R,W,FACE, filename];
(*Rearrange UV structure*)
x = r[[All, 1]];
y = r[[All, 2]];
left = Position[y, ?(# < 0.5&)]//Flatten;
right = Position[y, ?(# > 0.5&)]//Flatten;
y = 1− y;
x[[left]] = Rescale[x[[left]], {Min[x[[left]]],Max[x[[left]]]}];
x[[right]] = Rescale[x[[right]], {Min[x[[right]]],Max[x[[right]]]}];
y[[left]] = 0.45Rescale[y[[left]], {Min[y[[left]]],Max[y[[left]]]}];
197
y[[right]] = 0.45Rescale[y[[right]], {Min[y[[right]]],Max[y[[right]]]}];
y[[right]] = y[[right]] + (1− 0.45);
r = Transpose[{x, y}];
Save[NotebookDirectory[] <> “Geometry Human”,
{R,W,FACE, r, r2R, lmin, lmax,FACElmt,FACEname}];
Get[NotebookDirectory[] <> “Geometry Human”];
(*WSS and Pressure Visualization*)
Unprotect[ColorData];
ColorData[“Jet”] = Function[x,Blend[Transpose[{{0, 0.1, 0.3, 0.5, 0.7, 0.9, 1.0},
{Darker[Blue],Blue,Cyan,Green,Yellow,Red,Darker[Red]}}], x]];
Protect[ColorData];
color = Map[ColorData[“Jet”][#]&, 2Rescale[W, {0, 1}]];
LINEStemp = Map[Sort,FACE/.{a , b , c } :→ Sequence[{a, b}, {a, c}, {b, c}]];
LINEStemp = Cases[Tally[LINEStemp], {x , 1} :→ x];
temp = r[[#]]&/@LINEStemp;
LINESpoint = SortBy[#,First]&/@temp;
LINESforSort = DeleteDuplicatesBy[Transpose[{LINEStemp,LINESpoint}],Last];
LINES = LINESforSort[[All, 1]];
(*Looking for dashed lines*)
x = r[[All, 1]];
y = r[[All, 2]];
xl = x[[#]]&/@LINES;
yl = y[[#]]&/@LINES;
i1 = Position[yl[[All, 1]], ?(0.295 < # < 0.305&)]//Flatten;
i2 = Position[yl[[All, 2]], ?(0.295 < # < 0.305&)]//Flatten;
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i3 = Position[xl[[All, 1]], ?(# < 0.68&)]//Flatten;
i4 = Position[xl[[All, 2]], ?(# < 0.68&)]//Flatten;
is3 = Position[xl[[All, 1]], ?(0.2 < # < 0.38&)]//Flatten;
is4 = Position[xl[[All, 2]], ?(0.2 < # < 0.38&)]//Flatten;
iDashed1 = Intersection[i1, i2, i3, i4];
iAdd1 = Intersection[i1, i2, is3, is4];
i1 = Position[yl[[All, 1]], ?(0.695 < # < 0.705&)]//Flatten;
i2 = Position[yl[[All, 2]], ?(0.695 < # < 0.705&)]//Flatten;
i3 = Position[xl[[All, 1]], ?(# < 0.71&)]//Flatten;
i4 = Position[xl[[All, 2]], ?(# < 0.71&)]//Flatten;
is3 = Position[xl[[All, 1]], ?(0.2 < # < 0.39&)]//Flatten;
is4 = Position[xl[[All, 2]], ?(0.2 < # < 0.39&)]//Flatten;
iDashed2 = Intersection[i1, i2, i3, i4];
iAdd2 = Intersection[i1, i2, is3, is4];
(*Rearrange index for All LINES*)
DashedPointX = xl[[iDashed1]][[All, 1]];
DashedforSort = SortBy[Transpose[{iDashed1,DashedPointX}],Last];
LINESDashed1 = DeleteDuplicates[LINES[[DashedforSort[[All, 1]]]]//Flatten];
DashedPointX = xl[[iDashed2]][[All, 1]];
DashedforSort = SortBy[Transpose[{iDashed2,DashedPointX}],Last];
LINESDashed2 = DeleteDuplicates[LINES[[DashedforSort[[All, 1]]]]//Flatten];
iSolid = Complement[Range[Length[LINES]], iDashed1, iDashed2];
iSolid = Flatten[{iSolid, iAdd1, iAdd2}];
LINEB = GraphicsComplex[R,Line[LINES[[iSolid]]]];
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LINEBDashed1 = GraphicsComplex[R,Line[LINESDashed1]];
LINEBDashed2 = GraphicsComplex[R,Line[LINESDashed2]];
SURFACE = GraphicsComplex[R,Polygon[FACE],VertexColors→ color];
FIGURE1 = Graphics3D[{
{EdgeForm[], SURFACE},
{LightGray,Thick,LINEB},
{LightGray,Dashed,Thick,LINEBDashed1},
{LightGray,Dashed,Thick,LINEBDashed2}
},
ViewPoint→ {0, 0, Infinity},Boxed→ False,
Lighting→ “Neutral”, ImageSize→ 1000];
FIGURE2 = Graphics3D[{
{EdgeForm[], SURFACE},
{LightGray,Thick,LINEB},
{LightGray,Dashed,Thick,LINEBDashed1},
{LightGray,Dashed,Thick,LINEBDashed2}
},
ViewPoint→ {0, Infinity, 0},Boxed→ False,
Lighting→ “Neutral”, ImageSize→ 1000];
Export[NotebookDirectory[] <> “Human 3D side.png”,FIGURE1, “PNG”];
Export[NotebookDirectory[] <> “Human 3D top.png”,FIGURE2, “PNG”];
(*Draw 2D mapped WSS*)
lineb = GraphicsComplex[r,Line[LINES[[iSolid]]]];
linebDashed1 = GraphicsComplex[r,Line[LINESDashed1]];
linebDashed2 = GraphicsComplex[r,Line[LINESDashed2]];
surface = GraphicsComplex[r,Polygon[FACE],VertexColors→ color];
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figure1 = Graphics[{
{EdgeForm[], surface}, {White,Thick, lineb},
{White,Dashed,Thick, linebDashed1},
{White,Dashed,Thick, linebDashed2}
},
PlotRange→ {{0, 1}, {0, 1}},
ImageSize→ 750];
(*Draw Peak WSS*)
rPeak = Transpose[Append[Transpose[r],W ]];
linebPeak = GraphicsComplex[rPeak,Line[LINES[[iSolid]]]];
linebDashedPeak1 = GraphicsComplex[rPeak,Line[LINESDashed1]];
linebDashedPeak2 = GraphicsComplex[rPeak,Line[LINESDashed2]];
surfacePeak = GraphicsComplex[rPeak,Polygon[FACE],VertexColors→ color];
figure2 = Graphics3D[{
{EdgeForm[], surfacePeak},
{White,Thick, linebPeak},
{White,Dashed,Thick, linebDashedPeak1},
{White,Dashed,Thick, linebDashedPeak2}
},
PlotRange→ {{0, 1}, {0, 1}, {0, 1}},
Boxed→ True,Axes->True,
BoxRatios→ {1, 1, 0.1},
ViewPoint→ {Right,Front,Top},
Lighting→ “Neutral”,
ImageSize→ 1000]
Export[NotebookDirectory[] <> “Human 2D top.png”, figure1, “PNG”];
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Export[NotebookDirectory[] <> “Human 2D iso.png”, figure2, “PNG”];
l = BarLegend[{{Darker[Blue],Blue,Cyan,Green,Yellow,Red,Darker[Red]},
{0, 1}},LegendMarkerSize→ {30, 500}];
Export[NotebookDirectory[] <> “ColorBar.png”, l, “PNG”]
(*Draw 2D mapped frame*)
W = W ∗ 0;
frame = Graphics3D[{
{Black,Thick, linebPeak},
{Black,Dashed,Thick, linebDashedPeak1},
{Black,Dashed,Thick, linebDashedPeak2}
},
PlotRange→ {All,All, {0, 1}},
Boxed→ False,Axes→ False,
BoxRatios→ {1, 1, 0.1},
ViewPoint→ {Right,Front,Top},
ImageSize→ 1000];
Export[NotebookDirectory[] <> “Frame.png”, frame, “PNG”];
(*Particle Visualisation in 2D*)
Rp = ReadP[NotebookDirectory[] <> “particle file.dpm”];
numZone = 10;
{FACEcentre, zone,RpMax,RpMin} = SplitVolume[R,FACE,Rp, numZone];
Print[“Total particles : ” <> ToString[Length[Rp]]];
Monitor[
monitor = i;
temp = Table[
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Findp2FACE[R,FACE,FACEcentre,Rp[[i]], lmax, zone,RpMax,RpMin, numZone],
{i, 1,Length[Rp]}
],
Grid[{{ProgressIndicator[monitor, {1,Length[Rp]}]}, {monitor}}]
];
{Rpfixed, p2FACE, coord} = Transpose[temp];
void = Position[p2FACE, {}]//Flatten;
index = p2FACE/.{} → 1;
{ra, rb, rc} = Transpose[r[[#]]&/@FACE[[index]]];
r1 = ra + coord[[All, 1]] ∗ (rb− ra);
rp = rc + coord[[All, 2]] ∗ (r1− rc);
rp[[void]] = ConstantArray[{},Length[void]];
LINEStemp = Map[Sort,FACE/.{a , b , c } :→ Sequence[{a, b}, {a, c}, {b, c}]];
LINEStemp = Cases[Tally[LINEStemp], {x , 1} :→ x];
temp = r[[#]]&/@LINEStemp;
LINESpoint = SortBy[#,First]&/@temp;
LINESforSort = DeleteDuplicatesBy[Transpose[{LINEStemp,LINESpoint}],Last];
LINES = LINESforSort[[All, 1]];
lineb = GraphicsComplex[r,Line[LINES]];
figParticle = ListPlot[
DeleteCases[rp, {}],
PlotStyle→ Black,
PlotMarkers→ {Automatic, 5}];
Export[NotebookDirectory[] <> “Particle2D.png”, figParticle, “PNG”]
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